<SEC-DOCUMENT>0001178913-24-003001.txt : 20240909
<SEC-HEADER>0001178913-24-003001.hdr.sgml : 20240909
<ACCEPTANCE-DATETIME>20240909061611
ACCESSION NUMBER:		0001178913-24-003001
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20240909
DATE AS OF CHANGE:		20240909

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				813676773
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-281750
		FILM NUMBER:		241285738

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>zk2432003.htm
<DESCRIPTION>424B3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 24.8.1.5246
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><br>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;">Filed pursuant to Rule 424(b)(3)</div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;">Registration No. 333-281750</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">PROSPECTUS</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">8,097,167</font><font style="font-style: italic;">&#160;</font><font style="font-weight: bold;">ADSs Offered by the Selling Shareholders</font></div>
    <div style="text-align: center; line-height: 1.25;"><img width="218" height="114" src="image0.jpg"></div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Chemomab Therapeutics Ltd.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus relates to the resale, from time to time, by the selling shareholders identified in this prospectus (&#8220;Selling Shareholders&#8221;) of 8,097,167<font style="font-style: italic;">&#160;</font>American Depositary Shares (&#8220;ADSs&#8221;). Each ADS represents twenty (20) of our ordinary shares, no par value per share. The 8,097,167<font style="font-style: italic;">&#160;</font>ADSs consist of (i) 4,148,867 ADSs and (ii) 3,948,300 ADSs
      issuable upon the exercise of pre-funded warrants (&#8220;Pre-Funded Warrants&#8221;) (collectively the &#8220;July 2024 Private Placement&#8221;), held by the Selling Shareholders, as further described below under &#8220;Our Company &#8212; Recent Financings &#8212; Private Placement&#8221;.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Selling Shareholders are identified in the table on page 36. No ADS or Pre-Funded Warrants are being registered hereunder for sale by us, and any ADSs subject to resale
      hereunder will have been issued by us and acquired by the Selling Shareholders prior to any resale of such shares pursuant to this prospectus. We will not receive any of the proceeds from the sale of the ADSs by the selling shareholders. In the event
      the Selling Shareholders exercise all of the Pre-Funded Warrants in cash at an exercise price of $0.001 per ADS, we may receive an aggregate of approximately $395 of gross proceeds resulting from such exercises.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Selling Shareholders named in this prospectus and any of their pledgees, assignees and successors-in-interest may offer all or a portion of the ADSs through public or private
      transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. The Selling Shareholders will bear all commissions and discounts, if any, attributable to the sale of the ADSs. For additional
      information about the distribution of securities offered, please see &#8220;Plan of Distribution&#8221; beginning on page 37 of this prospectus.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our ADSs are traded on the Nasdaq Capital Market under the symbol &#8220;CMMB.&#8221; The last reported sale price of ADSs on the Nasdaq Capital Market on September 6, 2024 was $1.89 per ADS.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus, including the additional
      information described under the heading &#8220;Incorporation of Documents by Reference,&#8221; and any amendments or supplements carefully before you make your investment decision.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are an &#8220;emerging growth company&#8221; and a &#8220;foreign private issuer&#8221; as defined under the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) and, as such, we have elected to comply
      with certain reduced public company reporting requirements for this prospectus and future filings.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-weight: bold;">Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described on page 12 of this prospectus under
      the heading &#8220;Risk Factors&#8221; and under the heading &#8220;Risk Factors&#8221; in our Annual Report on Form 20-F for the fiscal year ended December 31, 2023, which is incorporated by reference into this prospectus and which may be amended, supplemented or
      superseded from time to time by other reports we file with the SEC in the future. We may also include specific risk factors in supplements to this prospectus under the caption &#8220;Risk Factors.&#8221; This prospectus may not be used to sell our securities
      unless accompanied by a prospectus supplement.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-weight: bold;">Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any
      representation to the contrary is a criminal offense.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">The date of this prospectus is&#160;September 6, 2024</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Table of Contents</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z461ff9bb38f541bfbdfb2dc280bba7fd" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 90%; vertical-align: top;">&#160;</td>
          <td style="width: 10%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Page</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#ABOUTTHISPROSPECTUS1">ABOUT THIS PROSPECTUS</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#SPECIALNOTEREGARDINGFORWARD-LOOKINGSTATEMENTS1">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#ABOUTCHEMOMABTHERAPEUTICSLTD.1">ABOUT CHEMOMAB THERAPEUTICS LTD.</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#RISKFACTORS1">RISK FACTORS</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">12</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#USEOFPROCEEDS1">USE OF PROCEEDS</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">16</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#CAPITALIZATION1">CAPITALIZATION</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">17</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#DESCRIPTIONOFSHARECAPITAL1">DESCRIPTION OF SHARE CAPITAL</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">18</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#DESCRIPTIONOFAMERICANDEPOSITARYSHARES1">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">26</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#SELLINGSHAREHOLDERS1">SELLING SHAREHOLDERS</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">35</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#PLANOFDISTRIBUTION1">PLAN OF DISTRIBUTION</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">37</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#ENFORCEMENTOFCIVILLIABILITIES1">ENFORCEMENT OF CIVIL LIABILITIES</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">39</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#EXPENSESASSOCIATEDWITHTHEREGISTRATION1">EXPENSES</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">40</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#LEGALMATTERS1">LEGAL MATTERS</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">41</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#EXPERTS1">EXPERTS</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">42</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 90%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;"><a href="#WHEREYOUCANFINDMOREINFORMATIONINCORPORATIONOFINFORMATIONBYREFERENCE1">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</a></div>
          </td>
          <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25;">43</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="text-align: center;">2<br>
    </div>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <!--PROfilePageNumberReset%Num%3%%%-->
  <div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="ABOUTTHISPROSPECTUS1"><!--Anchor--></a>ABOUT THIS PROSPECTUS</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Unless the context suggests otherwise, all references to &#8220;Chemomab Therapeutics,&#8221; &#8220;Chemomab,&#8221; &#8220;the Company,&#8221; &#8220;our company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Chemomab Therapeutics Ltd.
      and its wholly owned subsidiary, Chemomab Ltd.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are filing this registration statement and related prospectus to fulfill our contractual obligations to certain of our securityholders who have registration rights. We are
      registering an aggregate of 8,097,167<font style="font-style: italic;">&#160;</font>ADSs, consisting of (i) 4,148,867 ADSs and (ii) 3,948,300 ADSs issuable upon the exercise of pre-funded warrants, that were purchased in a private placement that closed in
      July 2024. We are not selling any securities and will not receive any proceeds from the sale of the securities under this prospectus.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Neither we nor the selling securityholders have authorized anyone to provide you with additional information or information different from that contained in this prospectus filed
      with the Securities and Exchange Commission (the &#8220;SEC&#8221;) in any supplement to this prospectus filed with the SEC, in any free writing prospectus filed with the SEC, or in the documents described under the heading &#8220;Incorporation of Documents by
      Reference.&#8221; We and the selling securityholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. The selling securityholders are offering to sell, and seeking offers to
      buy, the ADSs only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of our ADSs.
      Our business, financial condition, results of operations and prospects may have changed since that date.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For investors outside of the United States: We and the selling shareholders have not done anything that would permit this offering or possession or distribution of this prospectus
      in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the
      offering of the ADSs and the distribution of this prospectus outside the United States.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus may be supplemented from time to time by one or more prospectus supplements. Such prospectus supplement may also add, update or change information contained in this
      prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement, you must rely on the information in the prospectus supplement. You should carefully read both this prospectus and any
      applicable prospectus supplement before deciding to invest in any ordinary shares being offered.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">To the extent there is a conflict between the information contained in this prospectus, on the one hand, and the information contained in any document incorporated by reference
      filed with the SEC before the date of this prospectus, on the other hand, you should rely on the information in this prospectus. If any statement in a document incorporated by reference is inconsistent with a statement in another document
      incorporated by reference having a later date, the statement in the document having the later date modifies or supersedes the earlier statement.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Chemomab is a trademark of ours that we use in this prospectus. This prospectus also includes trademarks, tradenames and service marks that are the property of other organizations.
      Solely for convenience, our trademarks and tradenames referred to in this prospectus appear without the &#174; or &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable
      law, our rights, or the right of the applicable licensor to our trademark and tradenames.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The terms &#8220;shekel,&#8221; &#8220;Israeli shekel&#8221; and &#8220;NIS&#8221; refer to New Israeli Shekels, the lawful currency of the State of Israel, and the terms &#8220;dollar,&#8221; &#8220;U.S. dollar&#8221; or &#8220;$&#8221; refer to
      United States dollars, the lawful currency of the United States. All references to &#8220;shares&#8221; in this prospectus refer to ADSs, or the ordinary shares, no par value, represented by the ADSs, of Chemomab Therapeutics Ltd.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are incorporated under Israeli law and under the rules of the SEC, we are currently eligible for treatment as a &#8220;foreign private issuer.&#8221; As a foreign private issuer, we will
      not be required to file periodic reports and financial statements with the SEC as frequently or as promptly as domestic registrants whose securities are registered under the&#160;Securities Exchange Act of 1934, as amended, or the&#160;Exchange Act.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete
      information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration
      statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &#8220;Where You Can Find More Information.&#8221;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="SPECIALNOTEREGARDINGFORWARD-LOOKINGSTATEMENTS1"><!--Anchor--></a>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus and the information incorporated by reference contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the
      Exchange Act of 1934, as amended, or the Exchange Act, that involve substantial risks and uncertainties. Although our forward-looking statements reflect the good faith judgment of our management, these statements can only be based on facts and
      factors currently known by us. Consequently, these forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from results and outcomes discussed in the forward-looking
      statements.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All statements other than present and historical facts and conditions contained in this prospectus and the information incorporated by reference in this prospectus including
      statements regarding our future results of operations and financial positions, business strategy, plans and our objectives for future operations, are forward-looking statements. The words &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221;
      &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;seek,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;contemplate,&#8221; &#8220;possible,&#8221; &#8220;forecasts,&#8221; &#8220;aims&#8221; or the negative of these terms and similar expressions are intended to identify
      forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause
      our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze3a05f02de954637b21b117de940711d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we have incurred significant losses since inception and anticipate that we will continue to incur increasing levels of operating losses over the next several years and for the foreseeable future. We are unable to predict the extent of any
              future losses or when we will become profitable, if at all. Even if we become profitable, we may not be able to sustain or increase our profitability on a quarterly or annual basis;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9a9bc5744d6a465c82e584b5e4c68d5a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we have a limited operating history and funding, which may make it difficult to evaluate our prospects and likelihood of success;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5b5bdbf8fdd441e5b4927513abf1e73e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>our business is highly dependent on the success of our lead product candidate, CM-101, and any other product candidates that we advance into clinical studies. All of our programs will require significant additional clinical development;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd614fc0c013f43f9978ebb1f2c5c76b0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>our central objective is to design and develop targeted treatments for inflammation and fibrosis with an initial focus on the neutralization of CCL24 signaling, which is known to regulate fibrotic and inflammatory processes. While we have
              conducted extensive preclinical studies and four successful clinical trials in patients, our approach in the area of fibrotic diseases is novel and unproven and may not result in marketable products;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1782e52162224fe185516f1694751fde" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the successful completion of clinical studies is a prerequisite to submitting a marketing application to the FDA and similar marketing applications to comparable foreign regulatory authorities, for each product candidate and, consequently,
              the ultimate approval and commercial marketing of any product candidates. We may experience negative or inconclusive results, which may result in us deciding, or regulators requiring us, to conduct additional clinical studies or trials or
              abandon some or all of our product development programs, which could have a material adverse effect on our business;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z5f115bc4bfea4e0480e2b289246c582d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we may encounter difficulties enrolling patients in our clinical studies, including any public health emergencies and related clinical development activities could be delayed or otherwise adversely affected;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z115a1a4911ea47b3b5ce7df5506f5ca2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>our ongoing and future clinical studies may reveal significant adverse events or immunogenicity-related responses and may result in a safety profile that could delay or prevent regulatory approval or market acceptance of our product
              candidate;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z59c59c0a8fab44738e50d3525223ec57" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time consuming and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for CM-101 or any other product
              candidates, our business will be substantially harmed;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z04863500a8044f45a322120c47e59ef9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>if we do not achieve our projected development and commercialization goals in the timeframes we announce and expect, the commercialization of our product candidates may be delayed and our business will be harmed;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb6470fd226c943db902507519c4d5a33" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than us;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zde00fed1fbac4307b05853c468ab0710" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we have been granted Orphan Drug Designation for CM-101 in connection with three indications and may seek Orphan Drug Designation for other indications or product candidates, but we may be unable to maintain the benefits associated with
              Orphan Drug Designation, including the potential for market exclusivity, and may not receive Orphan Drug Designation for other indications or for our other product candidates;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z88adb96d613a4713a11a86bb5db837d8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we expect to experience significant growth in the number of our employees over time and the scope of our operations, particularly in the areas of product candidate development, regulatory affairs and sales and marketing. We will therefore
              need to expand our organization, and we may experience difficulties in managing this growth, which could disrupt our operations;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7b840185ba1d40aaa95424a42829446d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>if we are unable to protect our patents or other proprietary rights, or if we infringe the patents or other proprietary rights of others, our competitiveness and business prospects may be materially damaged. In addition, changes in patent
              laws or patent jurisprudence could diminish the value of patents in general, thereby impairing our ability to protect our product candidates;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9509a2ee73734b6a91e74c25b5e6ad69" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>risks related to our operations in Israel could materially adversely impact our business, financial condition and results of operations;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zbfc4190cb60d4128a2bccf30c56f9a0f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>our principal executive offices are located in Israel and the US and certain of our product candidates may be manufactured at third-party facilities located in Europe. In addition, our business strategy includes potentially expanding
              internationally if any of our product candidates receives regulatory approval. A variety of risks associated with operating internationally could materially adversely affect our business;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zab71d5cfa9db4b40b069c41c2d5fc141" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>holders of ADSs are not treated as holders of our ordinary shares;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1d6cf82aaf11464897ee13be10babd59" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>holders of ADSs may not have the same voting rights as the holders of our ordinary shares and may not receive voting materials in time to be able to exercise their right to vote;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zedddb7a897e44d0ebf5519e5d2202824" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>holders of ADSs may be subject to limitations on the transfer of their ADSs and the withdrawal of the underlying ordinary shares;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfd61409c4c17469293326a5ca39d2d09" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we are entitled to amend the deposit agreement and to change the rights of ADS holders under the terms of such agreement, or to terminate the deposit agreement, without the prior consent of the ADS holders;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z56eae1dba4a04133a2bc536bf82f03cc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z79af51c138f94bb4a15bde9bb3616af6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or
              eliminated for non-compliance with these requirements;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za088940f987e485994ae0eb27a276596" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time consuming and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for CM-101 or any other product
              candidates, our business will be substantially harmed;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zbeabc377bd724b9fbb88ef49d3bf0480" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2d0522e7934548f1949885da233b6f6f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>even if we obtain regulatory approval for CM-101 or any product candidate, we will still face extensive and ongoing regulatory requirements and obligations and any product candidates, if approved, may face future development and regulatory
              difficulties;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zec14d71322774736a0caaf4db456bf40" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could hinder our ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products
              from being developed, approved or commercialized in a timely manner or at all, which could negatively impact our business;&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z972a38ee23ae4fa89c9e4b96739cba04" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>if we do not achieve our projected development and commercialization goals in the timeframes we announce and expect, the commercialization of our product candidates may be delayed and our business will be harmed;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0a6b7bca0a2548659e980802d2995848" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than us;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0c5b480c14e34c108a0e58367087df20" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>even if CM-101 or any other product candidate we develop receives marketing approval, it may fail to achieve market acceptance by physicians, patients, third-party payors or others in the medical community necessary for commercial success;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z552b4fd147264a4ebeab0ea968eb16ea" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we rely completely on third-party suppliers to manufacture our clinical drug supplies for our product candidates, and we intend to rely on third parties to produce preclinical, clinical, and commercial supplies of any future product
              candidates;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0c209e525ee24178a5cdf27679b87203" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>if we are unable to establish sales, marketing and distribution capabilities either on our own or in collaboration with third parties, we may not be successful in commercializing CM-101, if approved;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z05d4faf2dd644d1796d612c202b18e7c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a variety of risks associated with operating internationally could materially adversely affect our business;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zae7ecee5041a4eb1819c7e6996170a83" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>conditions in Israel, including the attack by Hamas and other terrorist organizations from the Gaza Strip, possible interventions by neighbouring hostile organizations or states, and Israel&#8217;s war against them, may affect our operations;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd1bbd4d3e4264e1d92b2d89c3834f750" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>because a certain portion of our expenses are incurred in currencies other than the U.S. Dollar, our results of operations may be harmed by currency fluctuations and inflation;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zabdb8a6a37d44f9f9ccde5d4c40972ec" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we received Israeli government grants for certain of their research and development activities as detailed below. The terms of those grants require us to satisfy specified conditions in order to transfer outside of Israel the manufacture
              of products based on know-how funded by the Israel Innovation Authority or to transfer outside of Israel the know-how itself. If we fail to comply with the requirements of Israeli law in this regard, we may be required to pay penalties, and
              it may impair our ability to sell our technology outside of Israel;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zc9dcd09c8fe44e68aaacc5f8aeac3fc8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we will need to raise additional capital to fund our operations, which may be unavailable to us on acceptable terms or at all, or may cause dilution or place significant restrictions on our ability to operate our business;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z678f1dda80724cb7aa27f23ab5ea4542" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the trading price of the ADSs has been highly volatile, and is expected to continue to be volatile;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z74f330dcb92243e294df41ce22ff11e3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we have not paid dividends in the past and do not expect to pay dividends in the future, and, as a result, any return on investment may be limited to the value of the ADSs; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4628588ec9d6469190b354448fa68447" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>if we fail to continue to meet all applicable Nasdaq requirements, Nasdaq may delist the ADSs, which could have an adverse impact on the liquidity and market price of the ADSs.</div>
          </td>
        </tr>

    </table>
  </div>
  <br>
  <div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As a result of these factors, we cannot assure you that the forward-looking statements in this prospectus and the information incorporated by reference in this prospectus and any
      prospectus supplement will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not
      regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame or at all. We undertake no obligation to publicly update any forward-looking statements,
      whether as a result of new information, future events or otherwise, except as required by law.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You should read this prospectus, any prospectus supplement and the information incorporated by reference in this prospectus and any prospectus supplement completely and with the
      understanding that our actual future results may be materially different from what we expect. We qualify all of our forward- looking statements by these cautionary statements.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus, any prospectus supplement and the information incorporated by reference in this prospectus and any prospectus supplement may contain market data and industry
      forecasts that were obtained from industry publications. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we believe the market position, market opportunity and market
      size information included in this prospectus, any prospectus supplement and the information incorporated by reference in this prospectus and any prospectus supplement is generally reliable, such information is inherently imprecise.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to
      us as of the date the statements were made, and while we believed such information formed a reasonable basis for such statements at the time they were made, such information may be limited or incomplete, and our statements should not be read to
      indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements. For additional
      information, please see the section titled &#8220;Where You Can Find More Information; Incorporation of Information by Reference&#8221; elsewhere in this prospectus.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: 400;">
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zbf7ae14e7c704fb2b4b65d51d23471f4">

          <tr>
            <td style="width: 100%; border-color: rgb(0, 0, 0); border-style: solid; border-width: 2px;">
              <div>&#160;
                <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="ABOUTCHEMOMABTHERAPEUTICSLTD.1"><!--Anchor--></a>ABOUT CHEMOMAB THERAPEUTICS LTD.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-style: italic;">The following summary provides an overview of selected information contained elsewhere or incorporated by reference in this prospectus and does not
                  contain all of the information you should consider before investing in our securities. We urge you to read this entire prospectus, including the more detailed consolidated financial statements, notes to the consolidated financial
                  statements and other information incorporated by reference from our other filings with the SEC or included in any applicable prospectus supplement. Investing in our securities involves risks. Therefore, carefully consider the risk factors
                  set forth in any prospectus supplements and in our most recent filings with the SEC including our Annual Report on Form 20-F for the year ended December 31, 2023, as well as other information in this prospectus and any prospectus
                  supplements and the documents incorporated by reference herein or therein, before purchasing our securities. Each of the risk factors could adversely affect our business, operating results and financial condition, as well as adversely
                  affect the value of an investment in our securities.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Company Overview</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet
                  needs. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, we have developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has demonstrated the
                  potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have pioneered the therapeutic targeting of CCL24, a chemokine also known as eotaxin-2, which promotes various types of cellular processes that regulate inflammatory
                  and fibrotic activities through the CCR3 receptor. CCL24 is expressed in various types of cells, including immune cells, endothelial cells and epithelial cells. We have developed a novel CCL24 inhibiting product candidate with dual
                  anti-fibrotic and anti-inflammatory activity that modulates the complex interplay of these inflammatory and fibrotic mechanisms, which drive abnormal states of fibrosis and fibrotic diseases. This innovative approach is currently being
                  developed for difficult-to-treat rare diseases, also known as orphan indications or diseases, such as primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc) for which patients have no established disease-modifying or
                  standard-of-care treatment options. We estimate that there are approximately 77 thousand patients suffering from PSC in the United States., European Union and Japan, representing a more than $1 billion market opportunity, and
                  approximately 170,000 patients suffering from SSc in those same markets, representing a more than $1.5 billion market opportunity.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">CM-101, our lead clinical product candidate, is a first-in-class humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major
                  inflammatory and fibrotic pathways. We have demonstrated that CM-101 interferes with the underlying biology of inflammation and fibrosis through a novel and differentiated mechanism of action. We are currently conducting a Phase 2
                  clinical study in PSC, a rare obstructive and cholestatic liver disease, with sites in the United States, Europe and Israel. Positive topline results from the double-blinded portion of this trial were reported in July, 2024.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The randomized, placebo-controlled study design included two doses of CM-101 (10 or 20mg/kg) vs placebo, administered once every three weeks for 15 weeks, as well as an
                  open label extension in which all eligible patients could receive CM-101 for an additional 33 weeks. In the Phase 2 study, CM-101 achieved its primary endpoint of safety and tolerability and demonstrated anti-fibrotic, anti-inflammatory
                  and anti-cholestatic effects across a broad range of disease-related secondary efficacy endpoints, including statistically significant improvements in liver stiffness, a key PSC disease marker, after just 15-weeks of treatment. Moreover,
                  CM-101 is among the first investigational drugs to show a reduction in total bilirubin, an important marker of cholestasis and liver health, as well as reductions in pruritis, a cholestatic indicator of great relevance to patients. CM-101
                  is the first investigational drug being developed for PSC to exhibit broad, clinically relevant effects on all three components of the disease, establishing clinical proof-of-concept and providing further evidence of its multifactorial
                  mechanism of action and disease-modifying potential.&#160;The open label extension portion of the trial is continuing, with a topline data readout expected early in 2025.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The CM-101 SSc clinical program is Phase 2-ready and we have an open IND in the United States for a Phase 2 clinical trial. However, Chemomab has suspended initiation
                  of this study while we focus our resources on completing the Phase 2 PSC trial.&#160; We believe that CM-101 could have disease-modifying potential in this poorly treated condition. While our primary focus is on these two rare indications,
                  early in the year we reported results from a completed Phase 2a clinical study in patients with liver fibrosis due to metabolic dysfunction-associated steatohepatitis (MASH).&#160; This trial provided safety and pharmacokinetic (&#8220;PK&#8221;) data and
                  information useful for assessing our current subcutaneous formulation of CM-101. Additionally, the trial measured a number of biomarkers that may be relevant to the activity of CM-101 in other fibro-inflammatory conditions. The results
                  showed that the trial met its primary endpoint of safety and tolerability, and that CM-101 demonstrated consistent data trends and positive activity across secondary endpoints that included a range of liver fibrosis biomarkers and
                  physiologic assessments. A secondary analysis, that further confirmed and extended these initial results was reported at the 2023 EASL Congress in June 2023.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Fibrosis is the abnormal and excessive accumulation of collagen and extracellular matrix, the non-cellular component in all tissues and organs, which provides
                  structural and biochemical support to surrounding cells. When present in excessive amounts, collagen and extracellular matrix lead to scarring and thickening of connective tissues, affecting tissue properties and potentially leading to
                  organ dysfunction and failure. Fibrosis can occur in many different tissues, including lung, liver, kidney, muscle, skin, and the gastrointestinal tract, resulting in a wide array of progressive fibrotic conditions. Fibrosis and
                  inflammation are intrinsically linked. While a healthy inflammatory response is necessary for efficient tissue repair; after disease or injury, an excessive, uncontrolled inflammatory response can lead to tissue fibrosis that in turn can
                  further stimulate inflammatory processes in a fibro-inflammatory vicious cycle.</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: 400;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">&#160;
      <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z7ea707a92cf4439499ae4729ffedcf41">

          <tr>
            <td style="width: 100%; border-color: rgb(0, 0, 0); border-style: solid; border-width: 2px;">
              <div>
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Recent Developments</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Private Placement</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; line-height: 1.25; font-style: italic;">Securities Purchase Agreement</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">On July 25, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) with certain investors (the &#8220;Purchasers&#8221;), pursuant to
                  which the Company agreed to sell to the Purchasers: (i) 4,148,867 ADSs, at a purchase price of $1.235 per ADS; and (ii), in lieu of ADSs, Pre-Funded Warrants to purchase up to 3,948,300 ADSs at a purchase price of $ 1.2349 per warrant.
                  The Pre-Funded Warrants will have an exercise price of $0.0001 per ADS, be immediately exercisable and remain exercisable until exercised in full. The Purchasers are named as the Selling Shareholders in this registration statement.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The July 2024 Private Placement closed on July 30, 2024, and the Company received gross proceeds from the July 2024 Private Placement of approximately $10.0 million
                  before deducting any offering expenses payable by the Company.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company intends to use the net proceeds from the July 2024 Private Placement, together with the Company&#8217;s existing cash and cash equivalents, to fund its
                  development programs for CM-101, and for general corporate purposes and working capital. The Company expects that the net proceeds will extend its cash runway to fund its operations through the beginning of 2026, an extension of
                  approximately one year from current projections, which should fund the Company for approximately one year after the completion of two major milestones expected in early 2025.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; line-height: 1.25; font-style: italic;">Registration Rights Agreement</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with the July 2024 Private Placement, the Company also entered into a registration rights agreement, dated July 25, 2024 (the &#8220;Registration Rights
                  Agreement&#8221;) with the Purchasers requiring the Company to file a registration statement with respect to the resale of the securities. The Company is required to prepare and file a registration statement with the SEC as soon as reasonably
                  practicable, but in no event later than 30 days following the closing of the July 2024 Private Placement, and to use its commercial best efforts to have the registration statement declared effective as soon as reasonably practicable. The
                  Company granted the Purchasers customary indemnification rights in connection with the Registration Rights Agreement, and the Purchasers granted the Company customary indemnification rights in connection with the Registration Rights
                  Agreement.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Corporate Information</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We were incorporated on September 22, 2011, under the laws of the State of Israel. In March 2021, we changed our name from Anchiano Therapeutics Ltd. to Chemomab
                  Therapeutics Ltd. Our principal executive offices are located at Kiryat Atidim, Building 7, Tel Aviv, Israel 6158002, and our phone number is +972-77-331-0156. Our website is: <font style="font-style: italic;">www.chemomab.com.</font>&#160;</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information contained on our website is not incorporated by reference into this prospectus, and you should not consider any information contained on, or that can be
                  accessed through, our website as part of this prospectus or in deciding whether to purchase our securities.</div>
                <div style="text-align: left; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Please see the section entitled &#8220;Information on the Company &#8211; History and Development of the Company,&#8221; incorporated by reference from our Annual Report on Form 20-F for
                  the fiscal year ended December 31, 2023, filed with the SEC on March 28, 2024, as well as any amendments thereto reflected in our subsequent filings with the SEC.</div>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-weight: bold;">Implications of Being an Emerging Growth Company</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. We will remain an emerging growth
                  company until the earliest to occur of: the last day of the fiscal year in which we have more than $1.235 billion in annual revenue; the date we qualify as a &#8220;large accelerated filer,&#8221; with at least $700 million of equity securities held
                  by non-affiliates; the issuance, in any three-year period, by us of more than $1.0 billion in non-convertible debt securities; and the last day of the fiscal year ending after the fifth anniversary of our initial public offering. As a
                  result of this status, we have taken advantage of reduced reporting requirements in this prospectus and may elect to take advantage of other reduced reporting requirements in our future filings with the SEC. In particular, in this
                  prospectus, we have provided only two years of audited financial statements and have not included all of the executive compensation related information that would be required if we were not an emerging growth company. In addition, the
                  JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to
                  private companies. We have elected to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date
                  we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply
                  with the new or revised accounting standards as of public company effective dates.</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <br>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z2f7142beddad44a79741f33c1e16213a">

          <tr>
            <td style="width: 100%; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE OFFERING</div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
                </div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="3" border="0" id="z97fcc8bea68a4b08b6ca9f0629fed2bb" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">ADSs currently to be outstanding after this offering</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">18,508,057 ADSs (assuming no exercise of the Pre-Funded Warrants).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">ADSs to be outstanding after this offering assuming exercise of Pre-Funded Warrants</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">22,456,357 ADSs.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">ADSs offered by the Selling Shareholders</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">Up to an aggregate of 8,097,167<font style="font-style: italic;">&#160;</font>ADSs consisting of (i) 4,148,867 ADSs, and (ii) up to 3,948,300 ADSs
              issuable upon the exercise of the Pre-Funded Warrants.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">Use of proceeds</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">We will not receive any proceeds from the sale of the ADSs by the Selling Shareholders. All net proceeds from the sale of the ADSs covered by this
              prospectus will go to the Selling Shareholders. In the event the Selling Shareholders exercise all of the Pre-Funded Warrants in cash at an exercise price of $0.0001 per ADS, we may receive an aggregate of approximately $395 of gross proceeds
              resulting from such exercises.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">Dividend Policy</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">We do not anticipate paying any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance operations
              and expand our business. Our board of directors has sole discretion whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital
              requirements and surplus, general financial condition, contractual restrictions, restrictions under our Credit Facility and other factors that our directors may deem relevant. The Companies Law imposes restrictions on our ability to declare
              and pay dividends.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">Risk factors</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">You should read the &#8220;Risk Factors&#8221; section starting on page 12 of this prospectus, &#8220;Item 3. - Key Information &#8211; D. Risk Factors&#8221; in our Annual
              Report on Form 20-F for the year ended December 31, 2023, filed with the SEC on March 28, 2024 (the &#8220;Annual Report&#8221;), and other information included or incorporated by reference in this prospectus for a discussion of factors to consider
              carefully before deciding to invest in our securities.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">Nasdaq Capital Market symbol for our ADS</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#8220;CMMB&#8221;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">Depositary</div>
          </td>
          <td style="width: 1.92%; vertical-align: top;"><br>
          </td>
          <td style="width: 71.18%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: justify;">The Bank of New York Mellon</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="ze668f01d94b64eb1becfaa4a315cf427">

          <tr>
            <td style="width: 100%; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
                </div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Unless otherwise stated, all information in this prospectus, is based on 287,183,800 ordinary shares (or 14,359,190 ADSs) outstanding as of June 30, 2024 (assuming no
                  exercise of the Pre-Funded Warrants), and does not include the following as of that date:</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z3a1b2eb9d823424db7174fcb3efc4b08">

            <tr>
              <td style="width: 100%; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zb8f4c1ad33774a90b4710d3cc9b3d499">

          <tr>
            <td style="width: 5%; border-left: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
            <td style="width: 5%;">&#8226;</td>
            <td style="width: 90%; border-right: 2px solid rgb(0, 0, 0);">
              <div>1,619,078 ADSs issuable upon the exercise of outstanding options to purchase ADSs, at a weighted average exercise price of $2.95 per ADS;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="ze71d50501e194abc874272bad679bb6e">

            <tr>
              <td style="width: 100%; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 5%; border-left: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 5%;">&#8226;</td>
              <td style="width: 90%; border-right: 2px solid rgb(0, 0, 0);">an aggregate of 783,868 ADSs reserved for future issuance under the 2015 Share Incentive Plan (the &#8220;2015 Plan&#8221;) and the 2017 Equity-Based Incentive Plan (the &#8220;2017 Plan&#8221;, and
                together with the 2015 Plan, the &#8220;Share Incentive Plans&#8221;), as of June 30, 2024, as well as any automatic increases in the number of ADSs reserved for future issuance under the 2017 Plan; and</td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zf98e32eb15014cddadedd5656394a0c6">

            <tr>
              <td style="width: 100%; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 5%; border-left: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 5%;">&#8226;</td>
              <td style="width: 90%; border-right: 2px solid rgb(0, 0, 0);">
                <div>261,929 ADSs issuable upon the exercise of outstanding warrants to purchase ADSs at a weighted average exercise price of $17.35 per share, which warrants are expected to remain outstanding at the consummation of this offering.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zadcaec7f2cd74b2e96d6bc1c14c9c4d8">

          <tr>
            <td style="width: 100%; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="3" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="ze91c3285a14042de8921c72913e9dcb8">

          <tr>
            <td style="width: 100%; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">To the extent that options and warrants outstanding as of June 30, 2024 may be exercised, investors purchasing our securities in this offering may experience further
                  dilution.</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="RISKFACTORS1"><!--Anchor--></a>RISK FACTORS</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">An investment in our securities involves certain risks. Before investing in our securities, you should carefully consider the risk factors in our most recent Annual Report, or any
      updates in our Reports on Form 6-K, together with all of the other information appearing in this prospectus or incorporated by reference into this prospectus. The risks so described are not the only risks facing our company. Additional risks not
      presently known to us or that we currently deem immaterial may also impair our business operations. Any of these risks could materially and adversely affect our business, financial condition, results of operations and cash flows and could result in a
      loss of all or part of your investment. In any case, the value of the securities offered by means of this prospectus could decline due to any of these risks, and you may lose all or part of your investment.<font style="font-style: italic;">&#160;</font>Any

      of the risks described below, and any such additional risks, could materially adversely affect our business, financial condition or results of operations. In such case, you may lose all or part of your original investment.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Risks Related to our Securities and this Offering</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Our management will have broad discretion in the use of the net proceeds we receive in this offering and might not apply the proceeds in ways that increase the value of your
      investment.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our management and board of directors will have broad discretion over the use of our net proceeds from this offering, and you will be relying on their judgment regarding the
      application of these proceeds, which can be different from that contemplated at the time of this offering. Our management and board of directors might not apply our net proceeds in ways that ultimately increase the value of your investment and we
      might not be able to yield a significant return, if any, on any investment of these net proceeds. Our failure to apply these funds effectively could have a material adverse effect on our business, delay the development of our products and cause the
      price of our ADSs to decline.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">You may experience future dilution as a result of future equity offerings.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In order to raise additional capital, we expect to in the future offer additional ADSs or other securities convertible into or exchangeable for ADSs. We cannot assure you that we
      will be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future
      could have rights superior to existing shareholders. The price per share at which we sell additional ADSs or other securities convertible into or exchangeable for the ADSs in future transactions may be higher or lower than the price per share in this
      offering.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Future sales of ADSs, or the perception that such sales could occur, may cause the prevailing market price of the ADSs to decrease.&#160;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We cannot predict the effect, if any, that future issuances or sales of our securities, this offering or the availability of our securities for future issuance or sale, will have
      on the market price of the ADSs. Subject to the completion of this offering, we will have sold a substantial number of ADSs. Any sales of such ADSs in the public market or otherwise, or the perception that such issuances or sales could occur, could
      reduce the prevailing market price for the ADSs, as well as make future sales of equity securities by us less attractive or even not feasible.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">The sale of a substantial number of our ADSs in the public market, including resale of the ADSs issued to the Selling Shareholders, could adversely affect the prevailing market
      price for our ADSs.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are registering for resale up to 8,097,167<font style="font-style: italic;">&#160;</font>of our ADSs issuable to the Selling Shareholders pursuant to the July 2024 Private Placement.
      Sales of substantial amounts of our ADSs in the public market, or the perception that such sales might occur, could adversely affect the market price of our ADS. We cannot predict if and when the Selling Shareholders may sell such shares in the
      public markets. Furthermore, in the future, we may issue additional ADS or other equity or debt securities exercisable for, or convertible into, our ADSs. Any such issuances could result in substantial dilution to our existing shareholders and could
      cause our share price to decline.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Risks Related to Our Incorporation and Location in Israel</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic; font-weight: bold;">Conditions in Israel, including the recent attack by Hamas and other terrorist organizations from the Gaza Strip and elsewhere in the region, and the threat of a wider regional
      conflict and Israel&#8217;s actions to counter these threats, may affect our operations.&#160;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our headquarters, ten of our employees, including our Chief Executive Officer and Chief Financial Officer, and two members of our board of directors (not including our Chief
      Executive Officer) are located in Israel and therefore our business and operations are at risk of being directly affected by economic, political, geopolitical and military conditions in Israel.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Since the establishment of the State of Israel in 1948, a number of armed conflicts have occurred between Israel and its neighboring countries and terrorist organizations active in
      the region. These conflicts have involved missile strikes, hostile infiltrations and terrorism against civilian targets in various parts of Israel, which have negatively affected business conditions in Israel.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In October 2023, Hamas terrorists infiltrated Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched
      extensive rocket attacks on Israeli population and industrial centers located along Israel&#8217;s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians
      and soldiers in the southern part of the country. Following the attack, Israel&#8217;s security cabinet declared war against Hamas and a military campaign against these terrorist organizations commenced in parallel to their continued rocket and terror
      attacks. In addition, since the commencement of these events, there have been continued hostilities along Israel&#8217;s northern border with Lebanon (with the Hezbollah terror organization) and southern border (with the Houthi movement in Yemen, as
      described below). It is possible that hostilities with Hezbollah in Lebanon will escalate, and that other terrorist organizations, including Palestinian military organizations in the West Bank as well as other hostile countries, such as Iran, will
      join the hostilities.&#160; Such clashes may escalate in the future into a greater regional conflict, potentially involving Iran and other countries.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The intensity and duration of Israel&#8217;s current war against Hamas is difficult to predict, as are the war&#8217;s economic implications, that may involve a downgrade in Israel&#8217;s credit
      rating by rating agencies (such as the recent downgrade by Moody&#8217;s of its credit rating of Israel from A1 to A2, as well as the downgrade of its outlook rating from &#8220;stable&#8221; to &#8220;negative&#8221;), for our business and operations and for Israel&#8217;s economy in
      general.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with the war, several hundred thousand Israeli military reservists were called up to service. With the exception of one employee, all of our Israeli personnel
      (including employees, consultants and directors) are exempt from military reserve duty, including our Chief Executive Officer and Chief Financial Officer. The single employee who was called up has since returned to work.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">CM-101 clinical trial supplies for our Phase 2 PSC trial are manufactured by our supplier in Denmark and are not required to be manufactured in Israel under the regulations of the
      Israel Innovation Authority of the Israeli Ministry of Economy and Industry.&#160; CM-101 clinical trial supplies for our Phase 2 PSC trial are packaged and stored in Germany for ongoing importation to an Israeli depot and final distribution to our
      clinical sites in Israel. The current inventory at the Israeli depot and sites is sufficient to support the ongoing open label trial activity. Resupply to the depot and sites is triggered based on product usage. That process is ongoing during the
      study and has been proceeding without any complications at this time.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of the date of this annual report, we have not experienced any impact to patient treatment visits in accordance with our protocol and active patients continue to receive
      treatments as scheduled in the open label extension part of the study.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Depending on the intensity and duration of the current war with Hamas, or any future hostilities that may emerge, PSC patients in the open label part of the study at Israeli
      hospitals may elect to either withdraw from the clinical trial or relocate to a different hospital outside of Israel. Also, the hospital staff at Israeli hospitals available to help with the conduct of the CM-101 trial may become limited due to the
      general call-up of reservists to military service in the war with Hamas, or otherwise related to the ongoing hostilities. We do not anticipate these factors will have any material adverse effect on our ability to complete the open label part of the
      PSC clinical trial on time due to the comparatively low ratio of patients currently being treated at Israeli hospitals relative to the total number of patients enrolled in the clinical trial globally. Even if there were disruptions to Israeli
      clinical operations going forward, we believe that the combination of the relatively advanced stage of the trial (DB part of the study has been completed) and the relatively low number of trial participants remaining in Israel make it unlikely that
      the trial results or timelines would be substantially compromised. In addition, we are establishing contingency strategies to mitigate any future risks if there are breakdowns in communications or normal site operations.&#160; Moreover, the planning,
      management and execution of the CM-101 clinical trial is led primarily from the US, where our Chief Medical Officer, our Senior Vice President of Global Clinical Operations and most of their team members are located.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the
      reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure that such government coverage will be maintained or that it will sufficiently cover our potential damages.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is currently not possible to predict the duration or severity of the ongoing conflict or its effects on our business, operations and financial conditions. The conflict is
      rapidly evolving and could disrupt our operations in Israel and hamper our ability to raise additional funds or sell our securities, among other outcomes.&#160;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, some countries around the world restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business with
      Israel and Israeli companies if hostilities in Israel or political instability in the region continue or increase. These restrictions may limit materially our ability to obtain raw materials from these countries or sell our products and provide our
      services to companies and customers in these countries. In addition, there have been increased efforts by countries, activists and organizations to cause companies and consumers to boycott Israeli goods and services. In addition, in January 2024 the
      International Court of Justice, or ICJ, issued an&#160;interim ruling&#160;in a case&#160;filed by South Africa against Israel in December 2023, making allegations of genocide amid and in connection with the war in Gaza, and ordered Israel, among other things, to&#160;
      take measures to prevent genocidal acts,&#160; prevent and punish incitement to genocide, and take steps to provide basic services and humanitarian aid to civilians in Gaza. There are concerns that companies and businesses will terminate, and may have
      already terminated, certain commercial relationships with Israeli companies following the ICJ decision. The foregoing efforts by countries, activists and organizations, particularly if they become more widespread, as well as the ICJ rulings and
      future rulings and orders of other tribunals against Israel (if handed), may materially and adversely impact our ability to sell and provide our products and services outside of Israel.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Furthermore, following Hamas&#8217; attack on Israel and Israel&#8217;s security cabinet declaration of war against Hamas, the Houthi movement, which controls parts of Yemen, launched a number
      of attacks on marine vessels traversing the Red Sea, which marine vessels were thought to either be in route towards Israel or to be partly owned by Israeli businessmen. The Red Sea is a vital maritime route for international trade traveling to or
      from Israel. As a result of such disruptions, we may experience in the future delays in supplier deliveries, extended lead times, and increased cost of freight, increased insurance costs, purchased materials and manufacturing labor costs.&#160; The risk
      of ongoing supply disruptions may further result in delayed deliveries of our products and may also have adverse impact on economic conditions in Israel.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Finally, political conditions within Israel may affect our operations. Israel has held five general elections between 2019 and 2022, and prior&#160;to October 2023, the Israeli
      government pursued extensive changes to Israel&#8217;s judicial system, which sparked extensive political debate and unrest. In response to such initiative, many individuals, organizations and institutions, both within and outside of Israel, voiced
      concerns that the proposed changes may negatively impact the business environment in Israel including due to reluctance of foreign investors to invest or transact business in Israel, as well as to increased currency fluctuations, downgrades in credit
      rating, increased interest rates, increased volatility in security markets and other changes in macroeconomic conditions. To date, these initiatives have been substantially put on hold. If such changes to Israel&#8217;s judicial system are again pursued by
      the government and approved by the parliament, this may have an adverse effect on our business, our results of operations and our ability to raise additional funds, if deemed necessary by our management and board of directors.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="USEOFPROCEEDS1"><!--Anchor--></a>USE OF PROCEEDS</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will not receive any proceeds from the sale of the ADSs by the Selling Shareholders. All net proceeds from the sale of the ADSs covered by this prospectus will go to the Selling
      Shareholders. We will, however, bear the costs incurred in connection with the registration of these securities. In the event the Selling Shareholders exercise all of the Pre-Funded Warrants in cash at an exercise price of $0.0001 per ADS, we may
      receive an aggregate of approximately $395 of gross proceeds resulting from such exercises. Our management will retain broad discretion over the use of the proceeds from the exercise of the Pre-Funded Warrants. We may ultimately use such proceeds for
      different purposes than what we currently intend. Pending any ultimate use of any portion of the proceeds from this offering, if the anticipated proceeds will not be sufficient to fund all the proposed purposes, our management will determine the
      order of priority for using the proceeds, as well as the amount and sources of other funds needed.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pending our use of the net proceeds from this offering, we may invest the net proceeds in a variety of capital preservation investments, including short-term, investment grade,
      interest bearing instruments and U.S. government securities.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="CAPITALIZATION1"><!--Anchor--></a>CAPITALIZATION</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following table sets forth our cash and cash equivalents and total capitalization on an actual basis as of June 30, 2024. The information in this table should be read in
      conjunction with the financial statements and notes thereto and other financial information included in this prospectus, any prospectus supplement or incorporated by reference in this prospectus. Our historical results do not necessarily indicate our
      expected results for any future periods.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z6cab92c80e85408a8bb0ed4fb5565797" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">As of<br>
              June 30,<br>
              2024</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(in thousands)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%;">
            <div style="line-height: 1.25;">Cash, cash equivalents and short-term deposits</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">12,727</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px;">
            <div style="line-height: 1.25;">Restricted cash</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">74</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="line-height: 1.25;">Ordinary shares, no par value; 4,650,000,000 shares authorized; 287,183,800&#160; issued and outstanding, actual</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%;">
            <div style="line-height: 1.25;">Additional paid-in capital</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">106,162</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Accumulated (deficit)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">(96,177</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Total shareholders&#8217; equity (deficiency)</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">9,985</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="line-height: 1.25;">Total capitalization</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The number of ordinary shares outstanding in the table above is based on 287,183,800 ordinary shares (including in the form of ADSs) outstanding as of June 30, 2024, and does not
      include:&#160;<font style="font-weight: bold;">&#160;</font></div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z826cd8f6373a4d2a8c9ab8409f46fc60" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>1,619,078 ADSs issuable upon the exercise of outstanding options to purchase ADSs, at a weighted average exercise price of $2.95 per ADS;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zdeb7f6cff1f844548d439b3e351a10cf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>an aggregate of 783,868 ADSs reserved for future issuance under the Share Incentive Plans, as of June 30, 2024, as well as any automatic increases in the number of ADSs reserved for future issuance under the 2017 Plan; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z72733b9c2a574a8fa89a5ba42c6ba38f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>261,929 ADSs issuable upon the exercise of outstanding warrants to purchase ADSs at a weighted average exercise price of $17.35 per ADS, which warrants are expected to remain outstanding at the consummation of this offering.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="DESCRIPTIONOFSHARECAPITAL1"><!--Anchor--></a>DESCRIPTION OF SHARE CAPITAL</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following descriptions of our share capital and provisions of our amended and restated articles of association are summaries and are qualified by reference to our amended and
      restated articles of association, a copy of which is filed as Exhibit 3.1 hereto.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Registration Number and Purposes of the Company</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are registered with the Israeli Registrar of Companies. Our registration number is 51-4672625. Our affairs are governed by our amended and restated articles of association,
      applicable Israeli law and the Companies Law. Our purpose as set forth in our amended and restated articles of association is to engage in any lawful act or activity.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Voting Rights</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All ordinary shares will have identical voting and other rights in all respects.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Transfer of Shares</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our fully paid ordinary shares are issued in registered form and may be freely transferred under our amended and restated articles of association, unless the transfer is restricted
      or prohibited by another instrument, applicable law or the rules of the Nasdaq Capital Market. The ownership or voting of our ordinary shares by non-residents of Israel is not restricted in any way by our amended and restated articles of association
      or the laws of the State of Israel, except for ownership by nationals of some countries that are, have been, or will be, in a state of war with Israel.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Election of Directors</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under our amended and restated articles of association, our board of directors must consist of not less than three (3) but no more than 11 (eleven) directors. Pursuant to our
      amended and restated articles of association, each of our directors will be appointed by a simple majority vote of holders of our ordinary shares, participating and voting at an annual general meeting of our shareholders, provided that (i) in the
      event of a contested election, the method of calculation of the votes and the manner in which the resolutions will be presented to our shareholders at the general meeting shall be determined by our board of directors in its discretion, and (ii) in
      the event that our board of directors does not or is unable to make a determination on such matter, then the directors will be elected by a majority of the voting power represented at the general meeting in person or by proxy and voting on the
      election of directors, provided that if the number of such nominees exceeds the number of directors to be elected, then as among such elected nominees the election shall be by a plurality of the votes cast. In addition, our directors are divided into
      three classes, one class being elected each year at the annual general meeting of our shareholders, and shall serve on our board of directors until the third annual general meeting following such election or re-election or until they are removed by a
      vote of 65% of the total voting power of our shareholders at a general meeting of our shareholders or upon the occurrence of certain events, in accordance with the Companies Law and our amended and restated articles of association. In addition, our
      amended and restated articles of association provide that vacancies on our board of directors may be filled by a vote of a simple majority of directors then in office. Any director so appointed will hold office until the next annual general meeting
      of our shareholders for the election of the class of directors in respect of which the vacancy was created, or in the case of a vacancy due to the number of directors being less than the maximum number of directors stated in our amended and restated
      articles of association, until the next annual general meeting of our shareholders for the election of the class of directors to which such director was assigned by our board of directors.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Dividend and Liquidation Rights</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may declare a dividend to be paid to the holders of our ordinary shares in proportion to their respective shareholdings. Under the Companies Law, dividend distributions are
      determined by the board of directors and do not require the approval of the shareholders of a company unless the company&#8217;s articles of association provide otherwise. Our amended and restated articles of association do not require shareholder approval
      of a dividend distribution and provide that dividend distributions may be determined by our board of directors.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the Companies Law, the distribution amount is limited to the greater of retained earnings or earnings generated over the previous two years, according to our then last
      reviewed or audited financial statements (less the amount of previously distributed dividends, if not reduced from the earnings), provided that the end of the period to which the financial statements relate is not more than six months prior to the
      date of the distribution. If we do not meet such criteria, then we may distribute dividends only with court approval; as a company listed on an exchange outside of Israel, however, court approval is not required if the proposed distribution is in the
      form of an equity repurchase, provided that we notify our creditors of the proposed equity repurchase and allow such creditors an opportunity to initiate a court proceeding to review the repurchase. If within 30 days such creditors do not file an
      objection, then we may proceed with the repurchase without obtaining court approval. In each case, we are only permitted to distribute a dividend if our board of directors and, if applicable, the court determines that there is no reasonable concern
      that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they become due.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the event of our liquidation, after satisfaction of liabilities to creditors, our assets will be distributed to the holders of our ordinary shares in proportion to their
      shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a class of shares with preferential rights that may be authorized in the future.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Exchange Controls</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">There are currently no Israeli currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the ordinary shares or interest or other
      payments to non-residents of Israel, except for shareholders who are subjects of countries that are, have been, or will be, in a state of war with Israel.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Shareholder Meetings</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year and no later than 15 months after the date of the previous annual
      general meeting. All meetings other than the annual general meeting of shareholders are referred to in our amended and restated articles of association as special general meetings. Our board of directors may call special general meetings of our
      shareholders whenever it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Companies Law provides that our board of directors is required to convene a special general meeting of our shareholders upon
      the written request of (i) any two or more of our directors, (ii) one-quarter or more of the serving members of our board of directors or (iii) as a company listed on an exchange in the U.S., one or more shareholders holding, in the aggregate, either
      (a) 10% or more of our outstanding issued shares and 1% or more of our outstanding voting power or (b) 10% or more of our outstanding voting power.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under Israeli law, one or more shareholders holding at least 1% of the voting rights at the general meeting of the shareholders may request that the board of directors include a
      matter in the agenda of a general meeting of the shareholders to be convened in the future, provided that it is appropriate to discuss such a matter at the general meeting. Notwithstanding the foregoing, as a company listed on an exchange outside of
      Israel, a matter relating to the appointment or removal of a director may only be requested by one or more shareholders holding at least 5% of the voting rights at the general meeting of the shareholders. Our amended and restated articles of
      association contain procedural guidelines and disclosure items with respect to the submission of shareholder proposals for general meetings.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Subject to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings of shareholders are the
      shareholders of record on a date to be decided by the board of directors, which, as a company listed on an exchange outside Israel, may be between four and 60 days prior to the date of the meeting. Furthermore, the Companies Law requires that
      resolutions regarding the following matters must be passed at a general meeting of shareholders:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z25b7eeceaabe43b0992d8968975437ec" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>amendments to our articles of association;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zc1ccc3d747144eb394907ae1b6aa34d3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>appointment, terms of service or and termination of service of our auditors;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zeaf926e0754f4e36aeff5b64ddd3bdcc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>appointment of directors, including external directors (if applicable);</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb2ceb1c48f1c463d86c444fa6d867d58" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>approval of certain related party transactions;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z53c1fb124ee545a389da06af0b24e0eb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>increases or reductions of our authorized share capital;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4c6a5d58fa3d4284b246cfe384c71d5d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a merger; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zdb00196bd88f4026b6b78e00997f974d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the exercise of our board of directors&#8217; powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Companies Law requires that a notice of any annual general meeting or special general meeting be provided to shareholders at least 21 days prior to the meeting and if the
      agenda of the meeting includes, among other things, the appointment or removal of directors, the approval of transactions with office holders or interested or related parties, or an approval of a merger, notice must be provided at least 35 days prior
      to the meeting. Under the Companies Law and our amended and restated articles of association, shareholders are not permitted to take action by way of written consent in lieu of a meeting.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Quorum</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to our amended and restated articles of association, holders of our ordinary shares have one vote for each ordinary share held on all matters submitted to a vote before
      the shareholders at a general meeting of shareholders. The quorum required for our general meetings of shareholders consists of at least two shareholders present in person or by proxy who hold or represent between them at least 33&#8531;% of the total
      outstanding voting rights, provided, however, that with respect to any general meeting that was convened pursuant to a resolution adopted by the board of directors and which at the time of such general meeting we qualify as a &#8220;foreign private
      issuer,&#8221; the requisite quorum shall consist of two or more shareholders present in person or by proxy who hold or represent between them at least 25% of the total outstanding voting rights. The requisite quorum shall be present within half an hour of
      the time fixed for the commencement of the general meeting. A general meeting adjourned for lack of a quorum shall be adjourned either to the same day in the next week, at the same time and place, to such day and at such time and place as indicated
      in the notice to such meeting, or to such day and at such time and place as the chairperson of the meeting shall determine. At the reconvened meeting, any number of shareholders present in person or by proxy shall constitute a quorum, unless a
      meeting was called pursuant to a request by our shareholders, in which case the quorum required is one or more shareholders, present in person or by proxy and holding the number of shares required to call the meeting as described above.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Vote Requirements</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our amended and restated articles of association provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required by the Companies Law or
      by our amended and restated articles of association. Under the Companies Law, certain actions require the approval of a special majority, including: (i) an extraordinary transaction with a controlling shareholder or in which the controlling
      shareholder has a personal interest, (ii) the terms of employment or other engagement of a controlling shareholder of the company or a controlling shareholder&#8217;s relative (even if such terms are not extraordinary) and (iii) certain
      compensation-related matters described above under &#8220;Management-Compensation Committee-Compensation Policy under the Companies Law.&#8221; Under our amended and restated articles of association, the alteration of the rights, privileges, preferences or
      obligations of any class of our shares (to the extent there are classes other than ordinary shares) requires the approval of a simple majority of the class so affected (or such other percentage of the relevant class that may be set forth in the
      governing documents relevant to such class), in addition to a majority of all classes of shares voting together as a single class at a shareholder meeting.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under our amended and restated articles of association, the approval of the holders of at least 65% of the total voting power of our shareholders is generally required to remove
      any of our directors from office, to amend the provision requiring the approval of at least 65% of the total voting power of our shareholders to remove any of our directors from office, or certain other provisions regarding our staggered board,
      shareholder proposals, the size of our board and plurality voting in contested elections. Another exception to the simple majority vote requirement is a resolution for the voluntary winding up, or an approval of a scheme of arrangement or
      reorganization, of the company pursuant to Section 350 of the Companies Law, which requires the approval of holders holding at least 75% of the voting rights represented at the meeting and voting on the resolution.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Access to Corporate Records</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Companies Law, all shareholders generally have the right to review minutes of our general meetings, our shareholder register (including with respect to material
      shareholders), our articles of association, our financial statements, other documents as provided in the Companies Law and any document we are required by law to file publicly with the Israeli Registrar of Companies or the Israeli Securities
      Authority. Any shareholder who specifies the purpose of its request may request to review any document in our possession that relates to any action or transaction with a related party which requires shareholder approval under the Companies Law. We
      may deny a request to review a document if we determine that the request was not made in good faith, that the document contains a trade secret or a patent or that the document&#8217;s disclosure may otherwise impair our interests.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Acquisitions under Israeli Law</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold;">Full Tender Offer</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">A person wishing to acquire shares of a public Israeli company who would, as a result, hold over 90% of the target company&#8217;s voting rights or the target company&#8217;s issued and
      outstanding share capital (or of a class thereof), is required by the Companies Law to make a tender offer to all of the company&#8217;s shareholders for the purchase of all of the issued and outstanding shares of the company (or the applicable class). If
      (a) the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company (or the applicable class) and the shareholders who accept the offer constitute a majority of the offerees that do not have a
      personal interest in the acceptance of the tender offer or (b) the shareholders who did not accept the tender offer hold less than 2% of the issued and outstanding share capital of the company (or of the applicable class), all of the shares that the
      acquirer offered to purchase will be transferred to the acquirer by operation of law. A shareholder who had its shares so transferred may petition an Israeli court within six months from the date of acceptance of the full tender offer, regardless of
      whether such shareholder agreed to the offer, to determine whether the tender offer was for less than fair value and whether the fair value should be paid as determined by the court. However, an offeror may provide in the offer that a shareholder who
      accepted the offer will not be entitled to petition the court for appraisal rights as described in the preceding sentence, as long as the offeror and the company disclosed the information required by law in connection with the full tender offer. If
      the full tender offer was not accepted in accordance with any of the above alternatives, the acquirer may not acquire shares of the company that will increase its holdings to more than 90% of the company&#8217;s voting rights or the company&#8217;s issued and
      outstanding share capital (or of the applicable class) from shareholders who accepted the tender offer. Shares purchased in contradiction to the full tender offer rules under the Companies Law will have no rights and will become dormant shares.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold;">Special Tender Offer</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if, as a result of the acquisition, the
      purchaser would become a holder of 25% or more of the voting rights in the company. This requirement does not apply if there is already another holder of 25% or more of the voting rights in the company. Similarly, the Companies Law provides that an
      acquisition of shares of an Israeli public company must be made by means of a special tender offer if, as a result of the acquisition, the purchaser would become a holder of more than 45% of the voting rights in the company, if there is no other
      shareholder of the company who holds more than 45% of the voting rights in the company. These requirements do not apply if (i) the acquisition occurs in the context of a private placement by the company that received shareholder approval as a private
      placement whose purpose is to give the purchaser 25% or more of the voting rights in the company, if there is no person who holds 25% or more of the voting rights in the company or as a private placement whose purpose is to give the purchaser 45% of
      the voting rights in the company, if there is no person who holds 45% of the voting rights in the company, (ii) the acquisition was from a shareholder holding 25% or more of the voting rights in the company and resulted in the purchaser becoming a
      holder of 25% or more of the voting rights in the company, or (iii) the acquisition was from a shareholder holding more than 45% of the voting rights in the company and resulted in the purchaser becoming a holder of more than 45% of the voting rights
      in the company. A special tender offer must be extended to all shareholders of a company. A special tender offer may be consummated only if (i) at least 5% of the voting power attached to the company&#8217;s outstanding shares will be acquired by the
      offeror and (ii) the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding the purchaser, its controlling shareholders, holders of 25% or more of the voting rights in the company and any
      person having a personal interest in the acceptance of the tender offer, or anyone on their behalf, including any such person&#8217;s relatives and entities under their control).</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the event that a special tender offer is made, a company&#8217;s board of directors is required to express its opinion on the advisability of the offer, or may abstain from expressing
      any opinion if it is unable to do so, provided that it gives the reasons for its abstention. The board of directors shall also disclose any personal interest that any of the directors has with respect to the special tender offer or in connection
      therewith. An office holder in a target company who, in his or her capacity as an office holder, performs an action the purpose of which is to cause the failure of an existing or foreseeable special tender offer or to impair the chances of its
      acceptance, is liable to the potential purchaser and shareholders for damages, unless such office holder acted in good faith and had reasonable grounds to believe he or she was acting for the benefit of the company. However, office holders of the
      target company may negotiate with the potential purchaser in order to improve the terms of the special tender offer, and may further negotiate with third parties in order to obtain a competing offer.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If a special tender offer is accepted, then shareholders who did not respond to or that had objected the offer may accept the offer within four days of the last day set for the
      acceptance of the offer and they will be considered to have accepted the offer from the first day it was made.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the event that a special tender offer is accepted, then the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling
      person or entity at the time of the offer may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the
      purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer. Shares purchased in contradiction to the special tender offer rules under the Companies Law will have no rights and will become
      dormant shares.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">23</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-style: italic; font-weight: bold;">Merger</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Companies Law permits merger transactions if approved by each party&#8217;s board of directors and, unless certain conditions described under the Companies Law are met, a simple
      majority of the outstanding shares of each party to the merger that are represented and voting on the merger. The board of directors of a merging company is required pursuant to the Companies Law to discuss and determine whether in its opinion there
      exists a reasonable concern that as a result of a proposed merger, the surviving company will not be able to satisfy its obligations towards its creditors, such determination taking into account the financial status of the merging companies. If the
      board of directors determines that such a concern exists, it may not approve a proposed merger. Following the approval of the board of directors of each of the merging companies, the boards of directors must jointly prepare a merger proposal for
      submission to the Israeli Registrar of Companies.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For purposes of the shareholder vote of a merging company whose shares are held by the other merging company, or by a person or entity holding 25% or more of the voting rights at
      the general meeting of shareholders of the other merging company, or by a person or entity holding the right to appoint 25% or more of the directors of the other merging company, unless a court rules otherwise, the merger will not be deemed approved
      if a majority of the shares voted on the matter at the general meeting of shareholders (excluding abstentions) that are held by shareholders other than the other party to the merger, or by any person or entity who holds 25% or more of the voting
      rights of the other party or the right to appoint 25% or more of the directors of the other party, or any one on their behalf including their relatives or corporations controlled by any of them, vote against the merger. In addition, if the
      non-surviving entity of the merger has more than one class of shares, the merger must be approved by each class of shareholders. If the transaction would have been approved but for the separate approval of each class or the exclusion of the votes of
      certain shareholders as provided above, a court may still approve the merger upon the request of holders of at least 25% of the voting rights of a company, if the court holds that the merger is fair and reasonable, taking into account the valuation
      of the merging companies and the consideration offered to the shareholders. If a merger is with a company&#8217;s controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the
      same special majority approval that governs all extraordinary transactions with controlling shareholders.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Companies Law, each merging company must deliver to its secured creditors the merger proposal and inform its unsecured creditors of the merger proposal and its content.
      Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy
      the obligations of the merging company, and may further give instructions to secure the rights of creditors.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, a merger may not be completed unless at least 50 days have passed from the date that a proposal for approval of the merger is filed with the Israeli Registrar of
      Companies and 30 days from the date that shareholder approval of both merging companies is obtained.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">24</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Anti-Takeover Measures</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Companies Law allows us to create and issue shares having rights different from those attached to our ordinary shares, including shares providing certain preferred rights with
      respect to voting, distributions or other matters and shares having preemptive rights. As of this Current Report on Form 8-K, no preferred shares will be authorized under our amended and restated articles of association. In the future, if we do
      authorize, create and issue a specific class of preferred shares, such class of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from
      realizing a potential premium over the market value of their ordinary shares. The authorization and designation of a class of preferred shares will require an amendment to our amended and restated articles of association, which requires the prior
      approval of the holders of a majority of the voting power attached to our issued and outstanding shares at a general meeting of our shareholders. The convening of the meeting, the shareholders entitled to participate and the vote required to be
      obtained at such a meeting will be subject to the requirements set forth in the Companies Law and our amended articles of association, as described above in &#8220;-Shareholder Meetings.&#8221; In addition, as disclosed under &#8220;-Election of Directors,&#8221; we have a
      classified board structure, which effectively limits the ability of any investor or potential investor or group of investors or potential investors to gain control of our board of directors.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Borrowing Powers</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the Companies Law and our amended and restated articles of association, our board of directors may exercise all powers and take all actions that are not required under
      law or under our amended and restated articles of association to be exercised or taken by our shareholders, including the power to borrow money for company purposes.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Changes in Capital</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our amended and restated articles of association enable us to increase or reduce our share capital. Any such changes are subject to Israeli law and must be approved by a resolution
      duly passed by our shareholders at a general meeting of shareholders. In addition, transactions that have the effect of reducing capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings or profits,
      require the approval of both our board of directors and an Israeli court.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Exclusive Forum</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our amended and restated articles of association provide that unless we consent in writing to the selection of an alternative forum, the United States District Court for the
      Southern District of New York shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act and/or the Exchange Act. Our amended and restated articles of association also provide that
      unless we consent in writing to the selection of an alternative forum, the competent courts in Tel Aviv, Israel shall be the exclusive forum for any derivative action or proceeding brought on behalf of the Company, any action asserting a breach of a
      fiduciary duty owed by any of our directors, officers or other employees to the Company or our shareholders or any action asserting a claim arising pursuant to any provision of the Companies Law or the Israeli Securities Law.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Transfer Agent and Registrar</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The transfer agent and registrar for our ordinary shares and ADSs is Computershare Trust Company, N.A. Its address is 1290 Avenue of the Americas, 9th Floor, New York, NY 10104,
      and its telephone number is (212) 805-7100.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 18pt; line-height: 1.25; font-weight: bold;">Listing</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our ordinary shares represented by American Depositary Shares are listed on the Nasdaq Capital Market under the symbol &#8220;CMMB.&#8221;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">25</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="DESCRIPTIONOFAMERICANDEPOSITARYSHARES1"><!--Anchor--></a>DESCRIPTION OF AMERICAN DEPOSITARY SHARES</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">American Depositary Shares</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Bank of New York Mellon, as depositary, will register and deliver the ADSs. Each ADS will represent twenty (20) ordinary shares (or a right to receive twenty (20) ordinary
      shares). Each ADS will also represent any other securities, cash or other property which may be held by the depositary. The depositary&#8217;s office at which the ADSs will be administered and its principal executive office are located at 240 Greenwich
      Street, New York, New York 10286.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You may hold ADSs either (A) directly (i) by having an American Depositary Receipt (&#8220;ADR&#8221;), which is a certificate evidencing a specific number of ADSs, registered in your name or
      (ii) by having uncertificated ADSs registered in your name or (B) indirectly by holding a security entitlement in ADSs through your broker or other financial institution that is a direct or indirect participant in DTC. If you hold ADSs directly, you
      are a registered ADS holder, also referred to as an ADS holder. This description assumes you are an ADS holder. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS
      holders described in this section. You should consult with your broker or financial institution to find out what those procedures are.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Registered holders of uncertificated ADSs will receive statements from the depositary confirming their holdings.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As an ADS holder, we will not treat you as one of our shareholders and you will not have shareholder rights. Israeli law governs shareholder rights. The depositary will be the
      holder of the ordinary shares underlying the ADSs. As a registered holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary, ADS holders and all other persons indirectly or beneficially holding ADSs sets out ADS
      holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of ADR. For
      directions on how to obtain copies of those documents see &#8220;<font style="font-style: italic;">Where You Can Find More Information</font>.&#8221;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Dividends and Other Distributions</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">How will you receive dividends and other distributions on the shares?</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary has agreed to pay or distribute to ADS holders the cash dividends or other distributions it or the custodian receives on ordinary shares or other deposited
      securities, upon payment or deduction of its fees and expenses. You will receive these distributions in proportion to the number of ordinary shares the ADSs represent.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;"><font style="font-weight: bold;">Cash.</font> The depositary will convert any cash dividend or other cash distribution we pay on the ordinary shares into U.S. dollars, if it can do
      so on a reasonable basis and can transfer the U.S. dollars to the United States. If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency
      only to those ADS holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any
      interest.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">26</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Before making a distribution, any withholding taxes or other governmental charges that must be paid will be deducted. See &#8220;Taxation and Government Programs.&#8221; The depositary will
      distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some or all of the value of
      the distribution.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;"><font style="font-weight: bold;">Shares.</font> The depositary may distribute additional ADSs representing any ordinary shares we distribute as a dividend or free distribution. The
      depositary will only distribute whole ADSs. It will sell ordinary shares which would require it to deliver a fraction of an ADS (or ADSs representing those ordinary shares) and distribute the net proceeds in the same way as it does with cash. If the
      depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new shares. The depositary may sell a portion of the distributed ordinary shares (or ADSs representing those ordinary shares) sufficient to pay its fees and
      expenses in connection with that distribution.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;"><font style="font-weight: bold;">Rights to purchase additional shares.</font> If we offer holders of our securities any rights to subscribe for additional ordinary shares or any
      other rights, the depositary may (i) exercise those rights on behalf of ADS holders, (ii) distribute those rights to ADS holders or (iii) sell those rights and distribute the net proceeds to ADS holders, in each case after deduction or upon payment
      of its fees and expenses. To the extent the depositary does not do any of those things, it will allow the rights to lapse. <font style="font-style: italic;">In that case, you will receive no value for them.</font> The depositary will exercise or
      distribute rights only if we ask it to and provide satisfactory assurances to the depositary that it is legal to do so. If the depositary will exercise rights, it will purchase the securities to which the rights relate and distribute those securities
      or, in the case of ordinary shares, new ADSs representing the new ordinary shares, to subscribing ADS holders, but only if ADS holders have paid the exercise price to the depositary. U.S. securities laws may restrict the ability of the depositary to
      distribute rights or ADSs or other securities issued on exercise of rights to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;"><font style="font-weight: bold;">Other Distributions.</font> The depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks is
      legal, fair and practical. If it cannot make the distribution in that way, the depositary will have a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Or, it may decide to hold
      what we distributed, in which case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it
      is legal to make that distribution. The depositary may sell a portion of the distributed securities or property sufficient to pay its fees and expenses in connection with that distribution. U.S. securities laws may restrict the ability of the
      depositary to distribute securities to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs,
      ordinary shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. This means that you may not receive the
      distributions we make on our ordinary shares or any value for them if it is illegal or impractical for us to make them available to you.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">27</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Deposit, Withdrawal and Cancellation</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">How are ADSs issued?</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary will deliver ADSs if you or your broker deposits ordinary shares or evidence of rights to receive ordinary shares with the custodian. Upon payment of its fees and
      expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons
      that made the deposit.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">How can ADS holders withdraw the deposited securities?</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You may surrender the ADSs for the purpose of withdrawal at the depositary&#8217;s office. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock
      transfer taxes or fees, the depositary will deliver the ordinary shares and any other deposited securities underlying the ADSs to the ADS holder or a person the ADS holder designates at the office of the custodian. Or, at your request, risk and
      expense, the depositary will deliver the deposited securities at its office, if feasible. However, the depositary is not required to accept surrender of ADSs to the extent it would require delivery of a fraction of a deposited share or other
      securities. The depositary may charge you a fee and its expenses for instructing the custodian regarding delivery of deposited securities.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">How do ADS holders interchange between certificated ADSs and uncertificated ADSs?</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will send to the ADS holder a
      statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Alternatively, upon receipt by the depositary of a proper instruction from a registered holder of uncertificated ADSs requesting the exchange of uncertificated
      ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those ADSs.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Voting Rights</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">How do you vote?</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">ADS holders may instruct the depositary how to vote the number of deposited ordinary shares their ADSs represent. If we request the depositary to solicit your voting instructions
      (and we are not required to do so), the depositary will notify you of a shareholders&#8217; meeting and send or make voting materials available to you. Those materials will describe the matters to be voted on and explain how ADS holders may instruct the
      depositary how to vote. For instructions to be valid, they must reach the depositary by a date set by the depositary. The depositary will try, as far as practical, subject to the laws of Israel and the provisions of our articles of association or
      similar documents, to vote or to have its agents vote the ordinary shares or other deposited securities as instructed by ADS holders. If we do not request the depositary to solicit your voting instructions, you can still send voting instructions,
      and, in that case, the depositary may try to vote as you instruct, but it is not required to do so.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">28</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25;"><font style="font-style: italic;">Except by instructing the depositary as described above, you won&#8217;t be able to exercise voting rights unless you surrender the ADSs and withdraw
        the ordinary shares.</font> However, you may not know about the meeting enough in advance to withdraw the ordinary shares. In any event, the depositary will not exercise any discretion in voting deposited securities and it will only vote or attempt
      to vote as instructed.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote your shares. In addition, the depositary and its
      agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. This means that you may not be able to exercise your right to vote and there may be nothing you can do if your ordinary
      shares are not voted as you requested.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In order to give you a reasonable opportunity to instruct the Depositary as to the exercise of voting rights relating to Deposited Securities, if we request the Depositary to act,
      we agree to give the Depositary notice of any such meeting and details concerning the matters to be voted upon at least 45 days in advance of the meeting date.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Fees and Expenses</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z53f5e9d3ae0c4b1181a642ade9e18301" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Persons depositing or withdrawing ordinary shares or<br>
              ADS holders must pay</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25; font-weight: bold;">For</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Issuance of ADSs, including issuances resulting from a distribution of ordinary shares or rights or other property Cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">$.05 (or less) per ADS</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Any cash distribution to ADS holders</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">A fee equivalent to the fee that would be payable if securities distributed to you had been ordinary shares and the ordinary shares had been deposited for issuance of ADSs</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Distribution of securities distributed to holders of deposited securities (including rights) that are distributed by the depositary to ADS holders</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">$.05 (or less) per ADS per calendar year</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Depositary services</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">Registration or transfer fees</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Transfer and registration of ordinary shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw ordinary shares</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">Expenses of the depositary</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Cable, telex and facsimile transmissions (when expressly provided in the deposit agreement)</div>
            <div style="line-height: 1.25;">&#160;</div>
            <div style="line-height: 1.25;">Converting foreign currency to U.S. dollars</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or ordinary shares underlying ADSs, such as stock transfer taxes, stamp duty or withholding taxes</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">As necessary</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="line-height: 1.25;">Any charges incurred by the depositary or its agents for servicing the deposited securities</div>
          </td>
          <td style="width: 1%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">As necessary</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">29</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary collects its fees for delivery and surrender of ADSs directly from investors depositing ordinary shares or surrendering ADSs for the purpose of withdrawal or from
      intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its
      annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The depositary may collect any of its fees by deduction from any
      cash distribution payable (or by selling a portion of securities or other property distributable) to ADS holders that are obligated to pay those fees. The depositary may generally refuse to provide fee-attracting services until its fees for those
      services are paid.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">From time to time, the depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance of the ADS program, waive
      fees and expenses for services provided to us by the depositary or share revenue from the fees collected from ADS holders. In performing its duties under the deposit agreement, the depositary may use brokers, dealers, foreign currency or other
      service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads or commissions.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary may convert foreign currency itself or through any of its affiliates and, in those cases, acts as principal for its own account and not as an agent, fiduciary or
      broker on behalf of any other person and earns revenue, including, without limitation, fees and spreads that it will retain for its own account. The revenue is based on, among other things, the difference between the exchange rate assigned to the
      currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives when buying or selling foreign currency for its own account. The depositary makes no representation that the exchange rate used or
      obtained in any currency conversion under the deposit agreement will be the most favorable rate that could be obtained at the time or that the method by which that rate will be determined will be most favorable to ADS holders, subject to its
      obligations under the deposit agreement. The methodology used to determine exchange rates used in currency conversions is available upon request.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">30</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Payment of Taxes</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You will be responsible for any taxes or other governmental charges payable on the ADSs or on the deposited securities represented by any of the ADSs. The depositary may refuse to
      register any transfer of the ADSs or allow you to withdraw the deposited securities represented by the ADSs until such taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by the ADSs to pay any
      taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds, or send to ADS holders any property,
      remaining after it has paid the taxes.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary will not tender deposited securities in any voluntary tender or exchange offer unless instructed to do by an ADS holder surrendering ADSs and subject to any
      conditions or procedures the depositary may establish.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If deposited securities are redeemed for cash in a transaction that is mandatory for the depositary as a holder of deposited securities, the depositary will call for surrender of a
      corresponding number of ADSs and distribute the net redemption money to the holders of called ADSs upon surrender of those ADSs.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If there is any change in the deposited securities such as a subdivision, combination or other reclassification, or any merger, consolidation, recapitalization or reorganization
      affecting the issuer of deposited securities in which the depositary receives new securities in exchange for or in lieu of the old deposited securities, the depositary will hold those replacement securities as deposited securities under the deposit
      agreement. However, if the depositary decides it would not be lawful and practical to hold the replacement securities because those securities could not be distributed to ADS holders or for any other reason, the depositary may instead sell the
      replacement securities and distribute the net proceeds upon surrender of the ADSs.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If there is a replacement of the deposited securities and the depositary will continue to hold the replacement securities, the depositary may distribute new ADSs representing the
      new deposited securities or ask you to surrender your outstanding ADRs in exchange for new ADRs identifying the new deposited securities.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If there are no deposited securities underlying ADSs, including if the deposited securities are cancelled, or if the deposited securities underlying ADSs have become apparently
      worthless, the depositary may call for surrender or of those ADSs or cancel those ADSs upon notice to the ADS holders.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Amendment and Termination</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">How may the deposit agreement be amended?</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We may agree with the depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees or charges, except for
      taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADS holders, it will not become effective for outstanding ADSs until 30
      days after the depositary notifies ADS holders of the amendment. At the time an amendment becomes effective, you are considered, by continuing to hold the ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as
      amended.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">31</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-style: italic;">How may the deposit agreement be terminated?</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary will initiate termination of the deposit agreement if we instruct it to do so. The depositary may initiate termination of the deposit agreement if:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2ffffea500f34686a8bdc3de597fb8cd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>90 days have passed since the depositary told us it wants to resign but a successor depositary has not been appointed and accepted its appointment;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4e8d2c5324374e2782e1b50e71d5194c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we delist the ADSs from an exchange on which they were listed and do not list the ADSs on another exchange within a reasonable time;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfa9c0d5a7426417889863e4a90b23366" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>we appear to be insolvent or enter insolvency proceedings;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z28312ce8c02b4987a6095a137960fee8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>all or substantially all the value of the deposited securities has been distributed either in cash or in the form of securities;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z77b5e8f9432644a3bac7b72a05836b8a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>there are no deposited securities underlying the ADSs or the underlying deposited securities have become apparently worthless; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2841459f9f6b49928c91c4e4f0d1efe5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>there has been a replacement of deposited securities.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the deposit agreement will terminate, the depositary will notify ADS holders at least 90 days before the termination date. At any time after the termination date, the depositary
      may sell the deposited securities. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement, unsegregated and without liability for interest, for the pro rata benefit
      of the ADS holders that have not surrendered their ADSs. Normally, the depositary will sell as soon as practicable after the termination date.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">After the termination date and before the depositary sells, ADS holders can still surrender their ADSs and receive delivery of deposited securities, except that the depositary may
      refuse to accept a surrender for the purpose of withdrawing deposited securities or reverse previously accepted surrenders of that kind if it would interfere with the selling process. The depositary may refuse to accept a surrender for the purpose of
      withdrawing sale proceeds until all the deposited securities have been sold. The depositary will continue to collect distributions on deposited securities, but, after the termination date, the depositary is not required to register any transfer of
      ADSs or distribute any dividends or other distributions on deposited securities to the ADSs holder (until they surrender their ADSs) or give any notices or perform any other duties under the deposit agreement except as described in this paragraph.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">32</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Limitations on Obligations and Liability</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-style: italic;">Limits on our obligations and the obligations of the depositary; Limits on liability to holders of ADSs</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary. We and the
      depositary:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za2a5a8d3fa3f4391a073238d85b7c1be" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith and the depositary will not be a fiduciary or have any fiduciary duty to holders of ADSs;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z47144ff1b6524b46a868d044193552c3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are not liable if we are or it is prevented or delayed by law or circumstances beyond our or its control from performing our or its obligations under the deposit agreement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z2aa01970c96c4ee3b50023b14b346aeb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are not liable if we exercise or it exercises discretion permitted under the deposit agreement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4389c9e4e18a433aa73a67b5c1091b38" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential or
              punitive damages for any breach of the terms of the deposit agreement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze09abcfdc0d948ffa9f4b4466227eedd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5dad8a618aec4c93a4da1d8f41f2aa2a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>are not liable for the acts or omissions of any securities depository, clearing agency or settlement system;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8d4cd1b4055a462fbfc874cd8ce5b157" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or presented by the proper person; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z6ffa7e2e2182473d9d2fed5e4bbc52f4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the depositary has no duty to make any determinations or provide any information as to our status, or any liability for any tax consequences that may be incurred by ADS holders as a result of owning or holding ADSs or any liability for the
              inability or failure of an ADS holder to obtain the benefit of a foreign tax credit, reduced rate of withholding or a refund of amounts withheld in respect of tax or any other tax benefit.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">33</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Requirements for Depositary Actions</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Before the depositary will deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of shares, the depositary may require:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfeeb0579963a4b0f88711fead29cf734" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any ordinary shares or other deposited securities;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf5f08cae13d64230a87b49280a066599" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze594b96b418b48b391ad28ed95e9d32a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary may refuse to deliver ADSs or register transfers of ADSs when the transfer books of the depositary or our transfer books are closed or at any time if the depositary
      or we think it advisable to do so.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Your Right to Receive the Ordinary Shares Underlying the ADSs</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">ADS holders have the right to cancel their ADSs and withdraw the underlying ordinary shares at any time except:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7d6bb50048d8441b918561b25d40d86e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>when temporary delays arise because: (i) the depositary has closed its transfer books or we have closed our transfer books; (ii) the transfer of ordinary shares is blocked to permit voting at a shareholders&#8217; meeting; or (iii) we are paying
              a dividend on our shares;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z950786c2dd0c4feb842809f3a5af7a6f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>when you owe money to pay fees, taxes and similar charges; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze787f51e9d2f491f9b75d4342301a92f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of ordinary shares or other deposited securities.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This right of withdrawal may not be limited by any other provision of the deposit agreement.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Direct Registration System</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In the deposit agreement, all parties to the deposit agreement acknowledge that the Direct Registration System, or DRS, and Profile Modification System, or Profile, will apply to
      the ADSs. DRS is a system administered by DTC that facilitates interchange between registered holding of uncertificated ADSs and holding of security entitlements in ADSs through DTC and a DTC participant. Profile is a feature of DRS that allows a DTC
      participant, claiming to act on behalf of a registered holder of uncertificated ADSs, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without
      receipt by the depositary of prior authorization from the ADS holder to register that transfer.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the deposit agreement understand that the depositary will not
      determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and delivery as described in the paragraph above has the actual authority to act on behalf of the ADS holder
      (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree that the depositary&#8217;s reliance on and compliance with instructions received by the depositary through the DRS/Profile system and in
      accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Shareholder Communications; Inspection of Register of Holders of ADSs</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally
      available to holders of deposited securities. The depositary will send you copies of those communications or otherwise make those communications available to you if we ask it to. You have a right to inspect the register of holders of ADSs, but not
      for the purpose of contacting those holders about a matter unrelated to our business or the ADSs.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">Jury Trial Waiver</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The deposit agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary arising out
      of or relating to our shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was
      enforceable in the facts and circumstances of that case in accordance with applicable case law.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">34</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="SELLINGSHAREHOLDERS1"><!--Anchor--></a>SELLING SHAREHOLDERS</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The securities being offered by the Selling Shareholders are those acquired pursuant to the July 2024 Private Placement, which includes (1) 4,148,867 ADSs and (2) 3,948,300 ADSs
      issuable to the Selling Shareholders upon the exercise of the Pre-Funded Warrants. For additional information regarding the ADSs and the issuance of the Pre-Funded Warrants, see &#8220;Our Company &#8212; Recent Financings&#8221; above. We are registering the ADSs in
      order to permit the Selling Shareholders to offer the ADSs and ADSs issuable upon exercise of the Pre-Funded Warrants for resale from time to time.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The table below lists the Selling Shareholders and other information regarding the beneficial ownership of the ADSs by the Selling Shareholders. The second column lists the number
      of ADSs beneficially owned by the Selling Shareholders, based on each Selling Shareholder&#8217;s ownership of the ADSs and ADSs issuable upon the exercise of the Pre-Funded Warrants, as of August 22 , 2024, assuming exercise of the Pre-Funded Warrants
      held by the Selling Shareholders on that date. The third column lists the ADSs and ADSs issuable upon exercise of the Pre-Funded Warrants being offered by this prospectus by the Selling Shareholders.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This prospectus generally covers the resale of the maximum number of ADSs issuable upon the exercise of the Pre-Funded Warrants, determined as if the outstanding Pre-Funded
      Warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject
      to adjustment, without regard to any limitations on the exercise of the Pre-Funded Warrants.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the terms of the Securities Purchase Agreement covering the ADSs and Securities Purchase Agreement covering the Pre-Funded Warrants, each Selling Shareholder may not sell, if
      so elected by such Selling Shareholder, ADSs or exercise Pre-Funded Warrants to the extent that such exercise would cause such Selling Shareholder(s), together with its affiliates, to beneficially own a number of ADSs which would exceed 4.99% (or if
      applicable, 9.99%) of our then outstanding ADSs following such exercise, excluding for purposes of such determination ADSs not yet issuable upon exercise of the warrants which have not been exercised. The fourth and fifth columns list the amount of
      ADSs owned after the offering, by number of ADSs and percentage of outstanding ADSs, assuming in both cases the sale of all of the ADSs offered by the Selling Shareholders pursuant to this prospectus, giving effect to the beneficial ownership
      limitation provision described above. The Selling Shareholders may sell all, some or none of its ADSs in this offering. See &#8220;Plan of Distribution.&#8221;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Except as otherwise indicated in the table below, addresses of the selling securityholder are care of Chemomab Therapeutics Ltd., Kiryat Atidim, Building 7, Tel Aviv 6158002,
      Israel +972 77-331-0156.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">35</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z040705c84c2d42c7acbb9d3410e25a8d" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">Name of Selling Shareholder</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Number of<br>
              ADSs<br>
              Beneficially Owned<br>
              Prior to Offering (1)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Maximum<br>
              Number of<br>
              ADSs to be<br>
              Sold Pursuant to<br>
              this Prospectus</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Number of<br>
              ADSs<br>
              Beneficially Owned<br>
              After Offering</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Percentage of ADSs<br>
              Owned<br>
              After the<br>
              Offering (1)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
            <div style="line-height: 1.25;">HBM Healthcare Investments (Cayman) Ltd.</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,048,583</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(2)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4,048,583</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4.9</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="line-height: 1.25;">OrbiMed Israel Partners Limited Partnership</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,270,090</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(3)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">809,717</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(4)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3,079,807</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">12.2</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
            <div style="line-height: 1.25;">Yelin Lapidot Provident Funds Management Ltd.</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">809,717</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(5)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">809,717</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4.4</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="line-height: 1.25;">Sphera Biotech Master Fund LP</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,214,575</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(6)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,214,575</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">6.6</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
            <div style="line-height: 1.25;">Hazavim BOND LP</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">121,457</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(7)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">121,457</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">0.7</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="line-height: 1.25;">Hazavim Limited Partnership</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">283,401</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(8)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">283,401</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1.5</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
            <div style="line-height: 1.25;">Apeiron Presight Capital Fund II, L.P.</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">316,987</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">404,858</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(9)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">721,845</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3.9</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="line-height: 1.25;">The Centillion Fund</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">661,370</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">242,915</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(10)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">904,285</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">4.9</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
            <div style="line-height: 1.25;">Rosario Capital Ltd.</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">80,972</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(11)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">80,972</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="line-height: 1.25;">Sean Ellis</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">40,486</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(12)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">40,486</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 52%;">
            <div style="line-height: 1.25;">Ronen Bezalel Law Firm</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">40,486</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;(13)</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">40,486</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br>
    </div>
    <div style="line-height: 1.25;">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less than 1%.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z05d2ca63cd644783a7e9b3c86a8ff524" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(1)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Beneficial ownership is determined in accordance with SEC rules and generally includes voting or investment power with respect to securities. ADSs subject to options or warrants currently exercisable, or exercisable within 60 days of
              August 22, 2024, are counted as outstanding for computing the percentage of the selling shareholder holding such options or warrants but are not counted as outstanding for computing the percentage of any other selling shareholder. The
              calculation of % of Percentage of ADSs Owned After the Offering does not include the Pre- Funded Warrants.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z8038627413f848d8b07a3306c9e80279" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(2)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 910,000 ADSs and 3,138,583 ADSs issuable upon the exercise of the Pre-Funded Warrants.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 27pt; vertical-align: top;"><br>
            </td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Pre-Funded Warrants have a blocker provision that subjects the exercise of such warrants to a 4.99% or 9.99%, as applicable and if so elected, beneficial ownership limitation. If the foregoing warrants did not contain the block
                provision, the Selling Shareholder would have beneficially owned approximately 18.7% of our outstanding ADSs following the offering.</div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" id="za225f5b383e64b70b04b86b5965b24f4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(3)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of (i) 2,241,273 ADSs and (ii) 28,817 ADSs issuable upon the exercise of warrants to purchase ADSs held by OrbiMed Israel Partners Limited Partnership (&#8220;OIP&#8221;). OrbiMed Israel BioFund GP Limited Partnership (&#8220;Israel BioFund&#8221;) is
              the general partner of OIP. OrbiMed Israel GP Ltd. (&#8220;Israel GP&#8221;) is the general partner of Israel BioFund. By virtue of such relationships, Israel GP and Israel BioFund may be deemed to have voting power and investment power over the
              securities held by OIP and as a result, may be deemed to have beneficial ownership over such securities. Israel GP exercises voting power and investment power through a management committee comprised of Carl L. Gordon and Erez Chimovits, each
              of whom disclaims beneficial ownership of the shares held by OIP.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z3bd74d642a864c7d9e3a568bfcdd36c2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(4)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 809,717 ADSs issuable upon the exercise of the Pre-Funded Warrants. The Pre-Funded Warrants have a blocker provision that subjects the exercise of such warrants to a 4.99%
              or 9.99%, as applicable, and if so elected, beneficial ownership limitation. If the foregoing warrants did not contain the blocker provision, the Selling Shareholder would have beneficially owned approximately 15.9% of our outstanding ADSs
              following this offering.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="za0688e46c9b64fb98606d0c84b76c1ce" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(5)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 809,717 ADSs.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z22d7fb7319904e5d89299037beb5618c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(6)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 1,214,575 ADSs.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zb04c6729a35e4a6891edca6304940ab6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(7)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 121,457 ADSs.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zda383794a7444a72a6d333795581add1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(8)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 283,401 ADSs.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zf60ff7f2f9d848b1ab43ca8e1a73aead" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(9)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 404,858 ADSs.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zd9a04db936c34a9bb0ff7a51b69a148b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(10)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 242,915 ADSs.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zb4c3d59ef8754b58a9add6014430660c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(11)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 80,972 ADSs.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z46d4c893493c4c40a54ab088690d8f11" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(12)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 40,486 ADSs.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze6599010aeba466da3a86f8823b25a45" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">(13)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Consists of, in connection with the Securities Purchase Agreement, 40,486 ADSs.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">36</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="PLANOFDISTRIBUTION1"><!--Anchor--></a>PLAN OF DISTRIBUTION</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Selling Shareholders of the securities and any of their donees, pledgees, transferees, distributees, assignees and other successors-in-interest may, from time to time, sell any
      or all of their securities covered hereby on the principal trading market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A
      Selling Shareholder may use any one or more of the following methods when selling securities:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8a17c33f2569461fa1d1bb6bd615f910" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb07c15d160204d65b2f1cbb61e0f84be" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z763628b64fdf4142a610959bb2e48f62" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z21544560e2214fed8f3782ab7e3d015e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>an exchange distribution in accordance with the rules of the applicable exchange;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf94a54a8c14f4f4cb6d38a7963c96e10" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>privately negotiated transactions;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z43ad39ad930444fa86c2dfd856cf7fbf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>settlement of short sales;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1aeae73d21c9462e9200666bdefb604c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>in transactions through broker-dealers that agree with the selling shareholders to sell a specified number of such securities at a stipulated price per security;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1ebed6fdbe244d90bf2831ee86b6a86a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd61a79f0cf464043a78936c063db426b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>a combination of any such methods of sale; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z53a6d4978d5b4a31a3567b8164fbdc32" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>any other method permitted pursuant to applicable law.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Selling Shareholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under this prospectus.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Broker-dealers engaged by a Selling Shareholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from a Selling
      Shareholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a
      customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In connection with the sale of the securities or interests therein, the Selling Shareholders may enter into hedging transactions with broker-dealers or other financial
      institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Shareholders may also sell securities short and deliver these securities to close out their short positions, or
      loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Shareholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative
      securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as
      supplemented or amended to reflect such transaction).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">37</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Selling Shareholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in
      connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.
      Each Selling Shareholder has informed us that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are required to pay certain fees and expenses incurred by us incident to the registration of the securities. We have agreed to indemnify the Selling Shareholders against certain
      losses, claims, damages and liabilities, including liabilities under the Securities Act.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Shareholders without registration and without
      regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for us to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all
      of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under
      applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or
      qualification requirement is available and is complied with.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making
      activities with respect to the ADSs for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Shareholders will be subject to applicable provisions of the Exchange Act
      and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the ADSs by the Selling Shareholders or any other person. We will make copies of this prospectus available to the Selling
      Shareholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">38</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="ENFORCEMENTOFCIVILLIABILITIES1"><!--Anchor--></a>ENFORCEMENT OF CIVIL LIABILITIES</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are incorporated under the laws of the State of Israel. Service of process upon us and upon our directors and officers and the Israeli experts named in this prospectus,
      substantially all of whom reside outside the United States, may be difficult to obtain within the United States. Furthermore, because substantially all of our assets and substantially all of our directors and officers are located outside the United
      States, any judgment obtained in the United States against us or any of our directors and officers may not be collectible within the United States.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have irrevocably appointed Chemomab Therapeutics, Inc. as our agent to receive service of process in any action against us in any U.S. federal or state court arising out of this
      offering or any purchase or sale of securities in connection with this offering. The address of our agent is One Kendall Square, Building 1400E, Suite 14-105, Cambridge, MA 02139.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have been informed by our legal counsel in Israel, Meitar | Law Offices, that it may be difficult to initiate an action with respect to U.S. securities law in original actions
      instituted in Israel or obtain a judgement based on the civil liability provisions of the U.S. federal securities laws. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws reasoning that Israel is not the
      most appropriate forum to hear such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable
      U.S. law must be proved as a fact which can be a time-consuming and costly process. Certain matters of procedure may also be governed by Israeli law.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Subject to specified time limitations and legal procedures, Israeli courts may enforce a United States judgment in a civil matter which, subject to certain exceptions, is
      non-appealable, including a judgment based upon the civil liability provisions of the Securities Act or the Exchange Act and including a monetary or compensatory judgment in a non-civil matter, provided that, among other things:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0c437a4a7bc3413ca0ccd984d1745b1d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the judgment is obtained after due process before a court of competent jurisdiction, according to the laws of the state in which the judgment is given and the rules of private international law prevailing in Israel;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfbe0f13a179345ae8e02e505aa4ca2c9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the prevailing law of the foreign state in which the judgment is rendered allows for the enforcement of judgments of Israeli courts;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z677182be2a40475e9a2c7ba785fae9c7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>adequate service of process has been effected and the defendant has had a reasonable opportunity to be heard and to present his or her evidence;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5568175421404bc08e44d0675e723ccf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the judgment is not contrary to public policy of Israel, and the enforcement of the civil liabilities set forth in the judgment is not likely to impair the security or sovereignty of Israel;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7eac62e802d94dca9b2f8c5c487d2f10" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the judgment was not obtained by fraud and does not conflict with any other valid judgment in the same matter between the same parties;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z704c9fe16cd845ff85d822a59ba29b07" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>an action between the same parties in the same matter was not pending in any Israeli court at the time at which the lawsuit was instituted in the foreign court; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z702d804f69b641d69eca053c6a399875" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the judgment is enforceable according to the laws of Israel and according to the law of the foreign state in which the relief was granted.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">If a foreign judgment is enforced by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred out of Israel. The usual
      practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on the date of the judgment, but
      the judgment debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index plus interest at the annual
      statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">39</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="EXPENSESASSOCIATEDWITHTHEREGISTRATION1"><!--Anchor--></a>EXPENSES ASSOCIATED WITH THE REGISTRATION</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following are the estimated expenses related to the filing of the registration statement of which this prospectus forms a part, all of which will be paid by us. With the
      exception of the SEC registration fee, all amounts are estimates and may change:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z5b6a438e867540e1862c08f0558bac33" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%;">
            <div style="line-height: 1.25;">SEC registration fee</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">1,410</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="line-height: 1.25;">FINRA filing fee</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%;">
            <div style="line-height: 1.25;">Depositary and Transfer agent&#8217;s fees</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">80,971</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="line-height: 1.25;">Printing and engraving expenses</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%;">
            <div style="line-height: 1.25;">Legal fees and expenses</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="line-height: 1.25;">Accounting fees and expenses</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Miscellaneous</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 88%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF; width: 88%; padding-bottom: 4px;">
            <div style="line-height: 1.25;">Total</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1" class="cftcurrcell">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="background-color: #CCEEFF; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">*</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="background-color: #CCEEFF; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z8892e1902e2647d38295662bfa0e90c8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">*</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Estimated fees and expenses are not presently known. If required, to be provided by a prospectus supplement or as an exhibit to a Report on Form 6-K that is incorporated by reference into this prospectus.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">40</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="LEGALMATTERS1"><!--Anchor--></a>LEGAL MATTERS</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The validity of the securities offered by this prospectus will be passed upon by Meitar | Law Offices, Ramat Gan, Israel. Cooley LLP, Boston, Massachusetts, will pass upon certain
      matters of U.S. federal law. Additional legal matters may be passed upon for us or any underwriters, dealers or agents, by counsel that we will name in any applicable prospectus supplement. A partner at Meitar | Law Offices owns ADSs, which
      represent, in the aggregate, less than 1% of the Company&#8217;s issued and outstanding share capital.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">41</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="EXPERTS1"><!--Anchor--></a>EXPERTS</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The consolidated financial statements of Chemomab Therapeutics Ltd. as of December 31, 2023 and 2022, and for each of the years in the three-year period ended December 31, 2023,
      December 31, 2022 and December 31, 2021 have been incorporated by reference herein in reliance upon the report of Somekh Chaikin, a member firm of KPMG International, independent registered public accounting firm incorporated by reference herein, and
      upon the authority of said firm as experts in accounting and auditing.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">42</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><a name="WHEREYOUCANFINDMOREINFORMATIONINCORPORATIONOFINFORMATIONBYREFERENCE1"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION OF INFORMATION BY REFERENCE</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The SEC allows us to incorporate by reference the information we file with them, which means that we can disclose important information to you by referring you to those documents.
      The information incorporated by reference is considered to be part of this registration statement, and later information filed with the SEC will update and supersede this information. We hereby incorporate by reference into this registration
      statement the following documents previously filed with the SEC:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>
                <div style="text-align: left; line-height: 1.25;">the Company&#8217;s annual report on Form 20-F for the year ended December 31, 2023, as filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324001124/0001178913-24-001124-index.htm">March 28, 2024</a>;</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>
                <div style="text-align: left; line-height: 1.25;">the Company&#8217;s Reports on Form 6-K as furnished to the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324002717/0001178913-24-002717-index.htm">August 21, 2024</a>
                  (including Exhibits 99.1 (containing our financial results for the three and six months ended June 30, 2024 thereto) and 99.2 thereto), <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324002290/0001178913-24-002290-index.htm">July 25, 2024</a> (including Exhibits 99.1, 99.2, 99.3, 99.4, 99.5 and 99.6 thereto), <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324001986/0001178913-24-001986-index.htm">June 12, 2024</a>, <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324001657/0001178913-24-001657-index.htm">May
                    9, 2024</a> (including Exhibit 99.1 thereto (containing our financial results for the three months ended March 31, 2024)), <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324001621/0001178913-24-001621-index.htm">May
                    8, 2024</a>, <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324001564/0001178913-24-001564-index.htm">May 3, 2024</a>, <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324000856/0001178913-24-000856-index.htm">March 7, 2024</a> and <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324000033/0001178913-24-000033-index.htm">January

                    3, 2024</a>; and</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z9969b7e166dc40b08867710f40d5a0f5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 20.25pt;"><br>
          </td>
          <td style="width: 27pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the description of our share capital, which is set forth in <a href="https://www.sec.gov/Archives/edgar/data/1534248/000117891324001124/exhibit_2-1.htm">Exhibit 2.1</a> of our Annual Report, and as may be further updated or amended in any
              amendment or report filed for such purpose.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All subsequent annual reports filed by us pursuant to the Exchange Act on Form 20-F prior to the termination of an offering shall be deemed to be incorporated by reference to this
      prospectus and to be a part hereof from the date of filing of such documents. We may also incorporate part or all of any Form 6-K subsequently submitted by us to the SEC prior to the termination of an offering by identifying in such Forms 6-K that
      they, or certain parts of their contents, are being incorporated by reference herein, and any Forms 6-K so identified shall be deemed to be incorporated by reference in this prospectus and to be a part hereof from the date of submission of such
      documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in any
      other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or
      superseded, to constitute a part of this prospectus.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The information we incorporate by reference is an important part of this prospectus, and later information that we file with the SEC will automatically update and supersede the
      information contained in this prospectus.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Information and statements contained in this prospectus or any annex to this prospectus are qualified in all respects by reference to the copy of the relevant contract or other
      annex filed as an exhibit to the registration statement of which this prospectus forms a part.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Statements made in this prospectus concerning the contents of any contract, agreement or other document are not complete descriptions of all terms of these documents. If a document
      has been filed as an exhibit to the registration statement, we refer you to the copy of the document that has been filed for a complete description of its terms. Each statement in this prospectus relating to a document filed as an exhibit is
      qualified in all respects by the filed exhibit. You should read this prospectus and the documents that we have filed as exhibits to the registration statement of which this prospectus is a part in their entirety.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">43</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are subject to the informational requirements of the Exchange Act. Accordingly, we will be required to file reports and other information with the SEC, including annual reports
      on Form 20-F and reports on Form 6-K. The SEC maintains an internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are a &#8220;foreign private issuer&#8221; as defined in Rule 3b-4 under the Securities Exchange Act of 1934, or the Exchange Act. As a result, our proxy solicitations are not subject to
      the disclosure and procedural requirements of Regulation 14A under the Exchange Act and transactions in our equity securities by our officers and directors are exempt from Section 16 of the Exchange Act. In addition, we are not required under the
      Exchange Act to file periodic reports and financial statements as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. We publish annually an annual report filed on Form 20-F containing financial
      statements that have been examined and reported on, with an opinion expressed by, a registered public accounting firm. We prepare our annual financial statements in United States dollars and in accordance with accounting principles generally accepted
      in the United States, or U.S. GAAP. If there is any inconsistency between the information in this prospectus and in any post-effective amendment to the Form F-3 of which this prospectus is a part, or in any prospectus supplement, you should rely on
      the information in the post-effective amendment or prospectus supplement, as relevant. You should read this prospectus and any post-effective amendment or prospectus supplement together with the additional information contained in documents listed
      above under the heading &#8220;Where You Can Find More Information; Incorporation of Information by Reference.&#8221; The registration statement containing this prospectus, including the exhibits to the registration statement, provides additional information
      about us, the securities offered under this prospectus, and our other outstanding securities. The registration statement, including the exhibits, can be read at the SEC&#8217;s website mentioned above under &#8220;Where You Can Find More Information;
      Incorporation of Information by Reference.&#8221;</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will provide to each person, including any beneficial owner, to whom this prospectus is delivered, a copy of any or all the information that has been incorporated by reference
      in this prospectus but not delivered with this prospectus (and any exhibits specifically incorporated in such information), at no cost, upon written or oral request to us at the following address:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">Chemomab Therapeutics Ltd.</div>
    <div style="text-align: center; line-height: 1.25;">Attention: Sigal Fattal, Chief Financial Officer</div>
    <div style="text-align: center; line-height: 1.25;">Kiryat Atidim, Building 7</div>
    <div style="text-align: center; line-height: 1.25;">Tel Aviv</div>
    <div style="text-align: center; line-height: 1.25;">6158002</div>
    <div style="text-align: center; line-height: 1.25;">Israel</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">44</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You may also obtain information about us by visiting our website at <font style="font-style: italic;">www.chemomab.com</font>. Information contained in our website is not part of
      this prospectus.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We have not authorized anyone to give any information or make any representation about their companies that is different from, or in addition to, that contained in this prospectus
      or in any of the materials that have been incorporated in this prospectus. Therefore, if anyone does give you information of this sort, you should not rely on it. If you are in a jurisdiction where offers to exchange or sell, or solicitations of
      offers to exchange or purchase, the securities offered by this prospectus or the solicitation of proxies is unlawful, or if you are a person to whom it is unlawful to direct these types of activities, then the offer presented in this prospectus does
      not extend to you. The information contained in this prospectus speaks only as of the date of this prospectus unless the information specifically indicates that another date applies. You should read all information supplementing this prospectus.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will provide you without charge, upon your written or oral request, a copy of any of the documents incorporated by reference in this prospectus, other than exhibits to such
      documents which are not specifically incorporated by reference into such documents. Please direct your written or telephone requests to us at: Chemomab Therapeutics Ltd., Kiryat Atidim, Building 7, Tel Aviv, Israel 6158002. Attention: Sigal Fattal,
      Chief Financial Officer, telephone number: + +972 77-331-0156.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">45</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">8,097,167</font><font style="font-style: italic;">&#160;</font><font style="font-weight: bold;">ADSs Offered by the Selling Shareholders</font></div>
    <div style="text-align: center; line-height: 1.25;"><img width="224" height="117" src="image1.jpg"></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Chemomab Therapeutics Ltd.</div>
    <div style="line-height: 1.25;"><br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 1pt;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">PROSPECTUS</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 1pt;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">SEPTEMBER 6, 2024</div>
    <div style="line-height: 1.25;">
      <div>
        <div style="line-height: 1.25">
          <div><br>
          </div>
          <div style="text-align: center;">&#160;<font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;">46</font></div>
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0O!W<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ***:[K&CR,<*BL['T506)_ "@!U5[FYCM8GFE8*B*6);@ *"23^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:-?+090X/)7[H]^>!Q5^YC\],;<;>0<=< \\#O\ 6JD4C9$-P-D2?=;ID@C
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MDFI'DJ5(+:,Y17I&37Z'ZPG=)]T@HHHJ!A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *0G )/0#)_"EKPSX]_%6+X2^
M"[WQ'+C$4$I&6"\X(')KIPF%K8W$T<)AX.=:O4C3IQ6\I2=DD9U:D:-.=6;M
M"$7*3[)$/Q7^,_ACP)I=^UUJ]E;WL%K+,D4EW#&Y9!Q\K.&Z]\#-?RG_ +:7
M[9GBWXW>*M8\"F]DMM(L;F=+>YM+EOG2)VC4@A0IRIS][TQ7*_M:_M3^+/BO
MX_U!]+U>YL[ 1&,)',VQOW\NX?*RKR,#Z]?6OAXQSWUPT]RY-R3N>Y;[SDG)
M)/4DGG[W7/-?Z.^!/T9>6C@>(,[I4ZTZE&EB*<*L/X,Y6;2UU:V?YGY5GW%$
MW6DL%7E&[Y6EU2LK^CW_ .#8JVEGJD)FAN=8O[B-&(033,RN,#WY[_G[FHT5
M;>1BT*OSD,R\GZG.#[UM!3-\ARGD';N/_+3OD?GC\,8I'1;M2K#9LXY'WO;Z
M_G7^@G#V099DU*A0AAJ,(TX*%XTXI;+HE=]WOTZ'PV.QV)Q]U5G)Q:5HO76-
MK^>_GMWV(%FBFA?$4:D 84#DGCL/Z ].E.MX(O)>1XE#J3A2N"?3C'.?U^M0
M6\#12ESD!,X'][\,<GGV_2GRW+F57$9"+C(P?J<<5])7RS#UJBY*<.5)-^[%
M;V:2?7F>_GNCR(QI\]24KN?-%:_9TBE9WO\ CU>_6K<VEQ<0R2P3S6DJ@[/*
M.QN.F !GCK^HKIO@M\1?%OP3\9VOCNRUC4+JZ@G606\UP^SG@C !['^[T[9K
M!>\+R*Z+\B]0"1T]1Q_*E<1W$OFLHV'^# ('Y\8!P><'W'6OSWB_PNR7BG!U
M:&-P.'J*K"7,ITU)W:7N:;7UVVV70][ YEC:,XJA5FN2W+K96TVOH]N^N^Q_
M4!^R'_P4+/Q'?1[7QGJ5E8"5[:!_/O(X^"4CR?-V=![#'UYK]H-)U:QUJSBO
M]/GCN+:90R2Q.LB,&&00R$J<CT-?YZ4]_P"*=+G2Y\/ZM<V!A=)4$#N,;&#X
M&QP,\<^E?TH_\$V_V_G^(<>G_#/Q#(RW&FPQ6[74\N6D:+;$<[@#R<]SC%?Y
MA?2,^C]B.#J]/.,@P$:>70I26)H4(.U)1::J[N[ES6MTMLKZ_J_#>?2Q,/88
MV359M*#DU>6B7D]-N_S/WOHJO;74%W$LUO(LL3 %74@@@C(.1D<BK%?QBTTV
MFFFG9IIII]FGLS[0***C:0JV,$].<>OOVH2;V)E)05Y.RNEL]V24444B@HHH
MH ***,XZT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &3K.LV&B6
M4][J%PEO%%%)(7<A1\B%NI([C%?S7?\ !17_ (*!+J>J:M\(=*3S8"7@%W%)
ME3@;N-H([8Z_TK]8/^"B_C[4/A_\$-6U?3II(9EMW&Z-F4\MM[$'H?\ ]>,5
M_&GKGBB[^(.M7?B'4C)+<O<3DRR$LW$C+U;/T//O7]@?1;\)\!QGG"SO-:?U
MC#8*K:A1>B5>G*,E/F6_IZGS&?YJL)&6'VYZ;;?=.WNM6=O7_,>9)-0GD><L
M'9VD\T]6WLS8[],CO@'TI+FX,8$2H1L/WP.N,CGZ]14L.;A?(50IC .\<9_V
M<X[>F>,U(5$^8&7;LXW==V..N._:O]>,FPE'+*.$P=.$84</&,(PC9<L4DNF
M^RW^_M^'8J3J5ZTHOXINVSW::6MOOV(EE\](^J%!CI][OGGZ_ET/6G2,9L8S
M'Y;<_P"U_P#7_P :J3LT4BQJA"H<9 Z\YYQWY_+N>[[FX9E3:A7'L>>GZ_G7
MT4J"J<B4%RMN47=>YU?K??R\CSU[5J;<N5W5HVO:W_R7D6&E$A5MI'E$G:.=
MV..<?KUJ&XO1*NSRMK8( Q@\C'&?UQ202M-B1@R>7EL?W_;^1J8E9767;@K_
M  XZX.>/K_/K2Y.6I"Z?)33T3>CT:5]W??LGHS&%6%2,I5'JYQ7*E9IJR7K=
MH@ACVQLS@!N2HZG(Z=NWX_X,"'9YO\9Y*\Y_EC';IR>*?-=$RHVP@#'&#@XQ
M_GI4IGS(9U7(Y.P<^W^>,_T*OMDI5&^6+BVUHTGI:/7?OH=T'7DE&%32G)3C
MHDU'32^E^]NHJ2JB&1U)8 Y4^N/S_0G/T%=;\$/B7J7PB\=6.M6'F1"XOHUD
M9&*@*\@8YYQCUS^=<+).[7'F",XR/DP<$=#_ /K]:U;F2!8 R1*9B/EQU1CS
MGIU'L>*_/N.^'J'$N25\OQ5*$IXBC.$92C&7Q1TTL[6=GZH[,%C,33QD:DZL
ME&#BU-*UE=:6T^_\3^V7]DWXV>'/B+\-- ECUFWN=7DL[5I[82JTJ,8AN! <
MM]XXY%?7JN&Z'G_/^<&OX;?V6OVK_%W[-?C*TU6XO[K4=-O;E(5LVE<I"DD@
M.,$L!M QT'&/6OZX/@=^T]\/_B'X#\+^)K[Q#8VFIZ_:&=[!YXQ)&YFDC"D,
MZG)V ]!P<U_B[XR^$&<^'^>XF4J-7$Y=BZ\ZF'Q-.E+EYYMS=*T5[L8I.S>E
MU9'[ME&;X?&TZ<56CS^SC[FEVTE=W\^WF?6M&/;]*KVMU!>P1W-M()890&1U
M.0P(SD$58K\*::=FFFMTU9GO!12$X!->9>.OBAX7\$6$T^KZK:V<J+(5261$
M+;(V;&&<'T]^>V*WPN$Q&,K0H8:E.K4J248QA%R=WY*[,JM:G25ZDE%6;UT6
MGGL==KOB;2/#=H]]K-Y%96B L99F"J ./O,5'7MD?UK\_/VF/V]?!_P?\*:G
MK>@ZE::O<65O/*D,$\99FB5B%&UG[KCH>HK\G_V_O^"BVH>)/[4^&/A&:2,,
M6A34+68]/O9!3&?SYSGZ_BI;^)O&>MJ]EXAUF[U"WG>0ND\DC@K(Y)4[F88P
M<=.*_K[PE^B_GO$OU?-,_P '*E@IN%189[UJ#2=V]'%R3>FEM.Q\EG'%%' 0
ME&G4C.4XODE=)QET6E_Z=S]RK3_@M_?R,?.T*6-><$R=?3&8L'^>.:^MOV4O
M^"I6D?&_QC_8/B/R]%L_](/VBYG54/E1.X^\(QU4#KR3]*_E]N(;&]7[*MJD
M7E8^<*.=N1Z <]>I'IP.:T5SJU@&B\-7TNEWD:D">W<HYV@[N593R!Z]_<U_
M1^>_0^X7_L;%K+\&\/F%6A+ZO5YI35&=E9V^%V=N^WR/D:''&)JR]^=X)I-/
M3GU5UTM^3/\ 0"\*_$/PEXS3/A[6+74B -WD2(^,_P"Z[>G7O]:[4N%ZU_&)
M^Q!^W#XQ^ /B2WTCQ/?WFKP:C<11&6YFDVHN_:6^<OQ\V?KWK^L'X._&'0?B
M[X?T[5M*U"&>:X@CEEBBE5V0NH;!VGJ,D#(^M?P!XC>$_$'AYF-2AF-"H\%S
M/V.+Y?=FE:]TOAM>VO\ P#]+RO-L+F,::]HH5)+WH[VT3_'<]\HIJ<*!G.!C
M_/\ GI3J_*3U0HHHH **** "D)QC@G)_S^-+5#4M2M=*M9KZ^F2WM;=#)--(
M<*B@$DDD@# ![TFI25HOE=UK:^B=WOW0FU%7>R_SL9GB+Q'IWAFPGU;5[A+/
M3;-?,NKJ5@D<4>0NYF8A<9(Y) _6OA3]H[_@H5\#OA#\-?$7BW2_'.C:AJ>C
MVMU*ME'>6_F-)!"7V8$K')(P.,^W>OQ<_P""[G_!7KP_\!/A=K/PG^'6L0:G
MK/C61=">ZT^Z4S:<P$ERTK"(NPP;;9U4_-U&,5_GN>*?VBOCKXKU#5Y=4\>:
MW=Z7JEW/.]I+=7#Q^7,>4VM*PP%XZ<>F.GZ)P=P+C^*)0K4Z<H86E4C"K5M\
M;]UM+IK>UU?[SQLVSBAEU*2<E[64&X1\^E]K?GY=_P"S'QQ_P=8R^'/$.I:9
M:^'O/M[.\F@25+@[66-L C$9'(QWQ72?"3_@Z9'CWQ7:Z+>Z']EMIYXXVF>X
M 50Q )R8P./\:_A:\W^TB_VF(S32L6>5@22S=3R.23Z^@XK3T:YDT&=?L2F&
MX3&)5R&W#H>QR#T&:_;X>#.4<J]I%QG&*J."3]Y144Z=T].9VUZ6?2Q\.^-J
MT(.,H>_R2]ZZ\ES+S6EDG^)_L"?LM?M_?"'X[>$-/UBX\7:5:ZK>11M]B:[@
M,H9\<8\P'//]T=?3FOO?2=9L-;MUO-,N([JT?A)8R&4G&[J,]B/S_/\ QJO@
MI^U[\8?@=XIL_$=MXNU9M+M)8Y18BZG6/:A'R[1*1VZ[>*_N*_X(A_\ !:&;
M]J36[OX+^((S'<Z&FG3&[GN"[/\ ;5DAQ\R@\&UR?FP23Z5^-\5>'F89-]:Q
M=*C)X:-5N$%?W*+LHM/5NW;\K'U>59]3S".&BI+6,>>?>I9)PMTZN_IY(_K@
MHJ&"XAN8Q+ XDC8 AEY!!Z5-7YBTU=.Z?FM4_0^G$!SG@C!_S^-+114Q4DDI
M/F?5VL 44450!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR'*#R]@3&<C[V._;/U]:G.9@JA"HAXSC[W?CIS[<TV5Q<#!784X^8<G'Y?\
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MR;BC#2HYKA*-:G-N*YXQ;7-&TK:-JR;M+KJ=F%QN*P5ITJLI58OW=6E]GO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M78T45_.\YRJ3E.6LI-RD^[>Y^A1BHQ45M%)+T04445 PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7Z'XOGN15,-C)-IV=DVH-^XDK2;6NME_EU.!NIU#)&$SY0QNQG=WS]??FKJ
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MBYQ<)XFO*$M)1E5FXM>:;LQ<D+WY(W[\JO\ D%%%%<Q04444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>
M#_M&_&[2?V?OA?K_ ,2=:7=8:'9W-W,, _+;PF5OO$#H* />**_DKU7_ (.E
M?V?=,UK5-(>P9I--O)K20B*WQNB;:<_O,_Y]C5,_\'4/[/8/.G/C_KE;8_\
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M\,,VRBI*>%A+&4&_==.+T71/KU_4^]P'$6%QT8Q4E1K2M:$FNEKJ^US_ $G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *0D @>M+14RYFO=:3NMU?3J 44450!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7YA_\ !709_8L^*(_Z
M@&L=O^G%A_6OT\K\Q_\ @K@N[]B_XH#_ *@&L?\ I"U=.#BIXK#P:NI58)KR
M;%)VBWMHS_(.U+3M/O/&?CF*2 -.?$-X5=E':5\_-R><C_(J"70]."M;_9U\
MW!^;;^(YQ],9SGWS6Y=M%%XZ\<1;?WC>(+TA@/20Y&3SZ59>2$2E2@\S!^;
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MY+UU/QOB+BC$5Y?NY+D@VE)+W6Y6LY=[?KH5[:S2P(M[4!-^/NC!Y],=^/\
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M;^M35_##T;79M'Z'&_*KZNRN_.VH4444AA1110 4444 %%%% !1110 4444
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M^"AXU\/6][H]LS7*>3=I<0/_ *--) WRJK#),?<\^U?Z"_PA_P""/W[)NA>
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M%_P=@#/[)/@ ]AJ7B3/XQ:57^<9X5>!M,A5$PX1<G:/09&>N,\_T[U_HY?\
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M3GIZ^_?\_P#/:G5C#VO-:5K1TO;XM$[K7Y?+8 HHHK8 HHHH **** "BBB@
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M' Z9/)_9_P#9F_X)4^*]*^*&@>,?&<:WOAN33F>:UG$DB[Y9;>1<I(FW(1'
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MX2>/:K13^6P(P00#G.*_N'\/Z!IOAG2;/1=)@2WL+&)8;>%%"JB*H4*%' &
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MSDKOIU?HC^?K_@@Y_P $^_'/[!GP1F\"^-I#)?&]UF4DF4DB[U"ZG4DR*O\
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M3B,+/VN'K5*-2UE.G)QDEY-:HU:4E9I-/=-73]4?'9_88_9\*",^#-+*JRL
M;"VX*]/X1S[U]&^!?A]X:^'6D1Z)X8L8;"PB&U(88DB4#.>%3 '-=O16V)S'
M'XR*ABL7B,1&+NHU:DII-=DVR(4:5/\ ATX0TM[L4M/D(3@9-+G/2BFJ",\\
M=A_G_)KSFZBFM+P?;>+TU>NWR-!U%%%: %%%% !1110 4444 %%%% !1110
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M6Q@FNKR>.VMX1NEGE8)'&N<$LQZ#)%?G#^U=_P %(_A)^S-I6HZCJ6M:9?\
MV"&65XX+B&1LQ DKM+CGM7P=_P %K?\ @JMX,_9(^#/B/P1H.L02>,O%Z+HV
MCW-A.C3VEV";EGW*PDCQ';."0.^,&O\ . ^*_P"V)^T)\:M:UL>+?&&J:CI6
MHWD[QP7%]<R*+>5^$V.2,8)XQ]>U?@G!W!>/XFQ?N86K+"+W9UK-*,FDU=MI
MO=/JO4^\S#,:67T4JE6"J6OR[72>MEJ^_3R/[4/VD/\ @YR^$WB?P'XG\+>#
M(Y;37VBN[6TN8EB1EE,91&#I)N'S8(_R*_DQ\;_\%2OVQ]9UR\U;2?B5KL%A
M-<SRQ1#5;Y L;R,4  ; P#[<?3%?G%-I-A:7?VB[CC:65_,D8@99BW)R>_'K
M_A6M)JMBJB./8(^@ QCMC ';'T]<5_0V4^$^59;AH>WC&M-3A5J*3BW>-N_V
M==4?"9IQ9B).$L'";33B[+1JZ>FVKWTV/MAO^"FO[;.PW(^*&OE1SC^U[_.!
M^)[\#K5K2O\ @IQ^VM8ZOINH77Q/UY[2*[AEFC_M>^YC5LLI&['UKXLCO;-+
M8N[H8P"2G!S^!_\ U\].M5UE7)DD >!_NKCH#TX '3\:]_\ U!X;Q5E["C"4
M9.45%13;:2Z=-+)>NCU/+I\5YG&TJC<.9\O*TTY+33??S>OI<_M+_8\_X./_
M  W\+/ >BZ7\3[F\U;5K2TMX[J69EF9Y4C4.2\TF3ENY'7KTK^BS_@G9_P %
MB/@[^WG<:S;:!>6FDRZ5J)T\QW<D$#2.(()LJ%8[@?. ^HK_ "AKNRTN6/?)
M;*V\ ?ZM21D>YZ_H<5])_LI?M'?$G]EKQYI7B+P#KMYHNBMJ<6H:K!:7$ENL
MX5HE?<L1VL3'$ =W7&37YAQAX5IT*^.RZ'-64N6%.FK)J.^B5M$M]]3Z/)>+
M*$OW-=N*;;]I)W7,[6CU>C=K)_Y'^T#;W,%U&LUO*DT3@%7C.Y6!Z$'N*GK^
M9+_@GK_P7-^&?QNT#PQX*U&Y5?$$,%K9W4MRT.^6<JD9.XR;B2V[DC//KQ7]
M)?AOQ#:^(]%T_6;1@\%_"DJ,I!!5E# C&1W'M_3^?L=E>+R^?)B*4H7;46]+
MM;_=]Y]KAL=2Q$;W49JW-&][<WP_^!=#HJ***\X[0HHHH ***8[[11J]!-J*
M;;LENQ]1330VT;S3R)#$@+/(YVJH[DFO-?B=\4_#/PO\+ZIXC\0ZG96":?:R
M70CN9EC:545C\JL>?NG\J_F%_:V_X.,OA!X2TKQKX!T;Y==2*ZL;.[@,'$P6
M6-65UD##YL$8S[UZV69'F6;SE' X6==TVE-Q5^52:ZZ[_H8SQ-"FE*=1)--I
MORW/Z&?VA_VM?AE\!_A_KWC;4/$FCW2Z';W,TUK%=Q/-NMXR[IL+ ;A@C!/4
M&OYQ?&__  =#_ FV;6='M;)_M-E<3VHD6*WP7CXR&\WIGVY_2OXIOC9_P44_
M:;^*'B'QQ9:UXZUB\\)^(M>UJZM;"34KMXAIM_=S201>4S>7M6"5%VCC QVS
M7PY,NEW4\UU=6X:XN':69BBDL[\L2<GDG//?KZ5^T\-^#M?$QH8G'R?*X*<J
M>SC/1V?^74^+QW%E.E.K3IKVT)2M&4.D=GM>_P!]O5G[J?M^?\%F_CQ\=/B3
MI_B#X+>-=6T'0K9;])[:"_N+96,SP-%E8)"ORA' /J?K7P:__!2_]MNWC#M\
M4=>8_P#88U#]/F_R.@Q7Q19V]O$X>V*0Q <Q_<R>QP.X /7IP!P13EOX;>[S
M<R*\.?N[@?7L3@?YYZFOU; ^&^0T)4U7A1E.E32E=1LFFG[VFK=[/U3V/F*G
M$N9RJ2AAU+V,8\\4U>5E;1OJ[_=I\OM!_P#@IO\ MLK"LQ^*&O\ SDKC^V-0
MSQ@_W^W&#C/0=J[/P-_P5+_;%\/:Q8ZGK?Q+UZ>R2YCEEC?5KX@QA@Q&&..G
M7_\ 77Y\_;[6\OF\ME%N%78G&,\[N/RZ<XZU)K+6[6RQAT*] !C]1_/'?H<U
MT8KP\X<;IR5*ES2=TTERJ]FI2OT=UI^5C.EQ1F?M/92NO=BY:?9LGR]DU>WZ
MV/[6OV2?^#E+P=\./"VDV'Q&GNM4U"UM$CN9)F28M(L)5B3+)DY;G]:_H*_8
M2_X+-?!;]L^6XBTF^LM(,!0'[7)!!]_('W6;.,'TK_*"L?#]A*CR2PHWF(V.
M >2O'4'&.I/\Z]=^%GQU^+OP!FE/PP\0WVA-.QR;2YFM\XR03Y/I[U\!Q-X2
M8>M-XC+4JM3D=Z5+12MK'E2[7U_I+V\-QE"<%AHR5.JY+]Y4U6ZY[]=K^G5/
M<_VK=#\8^&_$<2R:)K&GZD",D6=PLVWOSMS72*VX<?G_ /KK_-N_X)6_\%V/
M%W[/,UQ!^T%X@U'Q$MTT2V_VNYDN@F"V?^/F08^\.G_US_;U^PU_P4.^%O[9
M?@RW\4^'=6T^T>Y,P2TEFBCF)CE>+ 168G)3C_.?P/.>&,UR=UEC,'5I4X3Y
M/:232]Z_*O6W_#]#[G"8^ABE1=.O":J0NE'=M63>E^OYGZ,C(')S2TU'5U5T
M8,K#*L.00>A!IU?.1BHI15[+N[L](****8!7YH?\%&_^"BO@C_@G[\/5\>>,
MX?-M&GL80-L;<WMS#;I_K&4?>F'>OTOK^/'_ (.V(DE_9:M?, *_VOX8R".W
M]LZ<3^8KT,JP7]HYAA<'S*/MZL(<SV2E))WVZ,RK5/8TIU&KJ$>:W>QUL'_!
MU#^SW,I;^SF'UCM?T_>C)[U#+_P=2_L^Q*S-ILFU1G/DVV,?]_*_SJ([#2YH
M+80VJJ=HW?*!G@=\5N:IH^B1^'=0/V5//\CY3L7.[<O?&>Q'/\C7]&5_!_)Z
M>2O&0K-XCV$I1?-=2GR)K3REI]_<^'EQ@H8R.'E2=JE2,(]+7DDW>RM\_,_V
M!/\ @GS_ ,%!O!?[=_@N7Q?X/B\JVBW9&U!T17Z(Q[&OT,OM8TO3(VEU"_MK
M.-02SSRK&H Y))/2OXR_^#<'XHZ3\%_V0/%/C75MJ66DPWEPZMM'R0V*2'@D
M < =<?G7F/\ P4<_X+Z:3>:7XF\(?#?4Y]/UE!=V<$UK*D9690T:D-%*6&#S
MQ7XC@N#\SS#,,1@\-3<HT*CA*JE[JETB_-GUN(S&CAZ,*LK2YK/E35TG:[?H
MGW^9^L'[9G_!P+\#?V4_BQK_ ,+-0:#5+S2;V]T\W%H;>9&>W>2+<',@SDKD
M<?KQ7\R'[?/_  7H\8?%\:D_P?U_4M$%QN\C[/<R0;<].()#C'TQ7\TOCOQ]
MXO\ C!XKOO'?Q)OY]9UC4+N>\GNKJ5KB1WGD=R2TN2<[\DY_E6,\>D1H)HUC
M1 ,!2J@^@X&,]/SY]:_;N'/"C#X.G"KF+C.M**<E*W*DUM9O>_7Y'PN:<83E
M65' TVXPG9U5JKJW_#GV4?\ @IQ^VT(6G_X6?K^))9-H_M?4!@;L@?>'08'?
MGCTS&W_!3C]MM4#_ /"S_$!!_P"HQJ''_C]?( DLYX5*NFP$X7CKWZ^OZ]<$
MFD:>S@0>88W7'RCY3CT/3W/IT]Z^[I^'F058P;PU/]T[RE%1M;2R>[;T^^W0
M^<GQ9FWUA4E>+<^J=I+2UK;??^A^RG[('_!9']H7X3^)(-2^)_CC6-7T]]06
MX,4VH74X\@>4K+B5\'E6]N>/2OZH/@?_ ,'-7P0\1W?A#P1?6Y&I:@UO92W,
MBP8$C&*,LSF3/4DY//7-?YW*+;W,I%Q&)(F;$8V@A5QVSC'0_AG/K6C:11>'
M-0M-7TE3!J-LXFM9HQM:.0$%2" """HY%?(\2>$U/,:=\MIQI2BY.DU&RMH[
M227VNB/H<#Q54PU1+%1E.51Q4W?W4K*S2VT6[_X#/]J3X8?'CX??$KPMH'B#
M3?$VCM)KMK%<06BW<?G'S(UD"A 3SAN@]#7M:.KJKHP96&58<@@]"#7^0G^R
M]_P5)_:;^"?Q;^'.L>)?'FLW/@+P[J(:^TTZC=M"]F+:2-4,3,(RH;9UXX'N
M*_TFO^"</_!1[X;_ +:'PWTK5=*U6RM;ZVLH8)H9YHDFDG2)6?"JS%B2V,_K
MFOP3B?@_,N%ZM*GC82O5C*:?*[)*3CKII>U]_O/O,!F6&S"#GAYJ232T:W:3
MMZZ_U8_52LV_U?3M+C,^H7<%G O66=Q&@'J2>/ZU!K.M:;HVESZIJ%[;VEG#
M$\IN)Y D1VQM(!N/!R%) [XK^1+_ (+$_P#!;?PY\-H/$'P7^'FJF'Q7");>
M+4K"9 !(/F!\Z)M_M^5?/8#!5,?B:.%I)NI7J1I1LF[.75_U]YKB\3]6IRJN
MRA3BYS;>Z36B\W?J?T&_MH?MZ_"O]DCX3ZY\3-6UW2]2@T?3[N]>UMKF&:5A
M:QNY4(6&2=F/K7\TGQF_X.=?A/XV\+ZAI_A))K'49K21(9$$,9$C(0""LFX<
MX.1G^M?QU?&#]N7]HKX[C4?"WCOQIJNL>%]2>XAFLKG4+J>%K:X9LH4D8J04
M<\'^0KXS30+$73K!$L84D?= R ?4$^OI[=J_>.%O!VO.O&KFDXNFN5J"7*T]
M_>O^6FF_<^5Q_%>']C*.';YY4^:_:[6CMUM]Y^H'QP_X*M?M<>-_B3KFK^#_
M (C:[9:)<75Q+:01ZK>1HL;2LR +&Q48'IP.F:\KM_\ @IK^VW(TD1^)^O@P
MG:<ZO?\ H#W?W]L^M?'%K<V%B/*.T.!@DA>W!Z_3TR/SJ:&YL[EW,3(C;OF.
M0"3QS^'\@*_5_P#B%N382BI*C3<WW47%JR::3ZJU_P /)_)UN*,U<'.*ERJW
M)9-W>FM^JM_PY]?3?\%+_P!MZ0X3XHZ^.>?^)Q?_ /Q?J/3/YU^RO_!.K_@O
M#XW^ >AVMC\<_$FHZ_>I<SR2/<W3W+&-[F61!^_?/",H'0U_-FD2#+AU..<
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M 1]TD=_6O9:_)*L)4JDZ<XN,H2:E%[IKHSZ.#YHQ=[W2U770****S*"BBB@
MHHJG>7]II\33WL\=M @R\LKA$4 9))/' II-Z)7$Y**O)V5TK^NQ,88]QD(&
M>6)Q^)/_ -?&?>N1UCXA^"M"\^/5/$VD64\$4DC0W%VD<@\M"Y!4\]J_.7]L
MS_@IQ\)?V6?#&M:K?ZQINHM90W406VGAF;S%#Q@@%QR&QC_]6?\ /6_;O_X+
M&?M"?&KXT:QK_P (?&^L:+X6GNITBM(-0N;>/RBIC("PMLY]/P%?49-PGG&=
MXBE1HX>IRSA&?.XNRINWO/R_JYPU\SP>'A.<ZT4H-Q>OVET[Z71_9]^UQ_P<
M'? O]E[XLZC\,=1\G4;BPM8[EKJV-M-&RR3SP@!BXR<PYX'0COD5^1G[7G_!
MR1X-^*7A&?2_AE-<Z3J9A94FA>. [RC 8:*7/4\8[Y-?Q9_$KQ[XI^*^NOXF
M^(%]-K'B&=!'/>W#M/(\8+.H,DAW'#,Y()QD]\FN.CL; PHMM L<BX+-M R
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M;>_K^.UO]IW2O&7A?6EB.F:[IMZTB(P6WN4D8[E!Z*?>NFX(]0:_S&?V!?\
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ME5JPE15;EG&4HNT(.S3?^):KM?[_ )C-,_IX&HTI1M33O!_%5=E\/^%Z/?\
MS^B/CW_P4@_:A^*6O>,;&[\>ZQ/X)\47$R/ICZE>- UHTS3(ABW>7@83CH"
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M^K=_S\C\&S3,L3B,35;G.4:D93:O=1>B]%%=MKE::6:=C%&2NT\G)YQQV/\
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M'^%2/XOY>^/U,'_!KE^TDZJ?[0;YE##]Y=9Y7/3RO>O] _X1_L<_ SX,(B^
MO">G:0L;!E^S64$&",=/+ ]*^JP H '0  ?0<"ORK-/%WB#$./U6:HIQ:JJ2
MO=MQ::MTM<^DPG#^ HTU'V<9Q5N1V5[:/73U5]^M^_\ F@R?\&O7[35O%*[Z
MDYAAB>4KYUT3B-"Y 'E\\+_D<5^!/QK^!?Q ^!_Q!UKX=ZMX6UJZFT.YN+>6
MY2SE>(_9Y?*)WG''X?\ UO\ :S=%D1XV&5=61AZJP*D?D:_-/XS?\$R/V6?B
M-_PD>O:O\/M&N_$6L6UUB\ETNT>3[3/\V_S"N_.XYS_+FN/)O$[/,+C(5<34
M=:FI)N$=&]DUJ]O78,=PUE^,A&/LU"4?A<=$GIKHM]/N/\A62Y\M_L]S;203
M*<&"9<.A'4%.N0>/3-:.0\*J0-C @K@=.1C'3_&OWL_X*S_\$D?&W[+7CCQ!
M\4-'TB>;P=J-]=36%C8P2,D$$LCRQ_NE4(H6-0..F<5^"-W,;<1K+ \,S#Y[
M=UVRQ'/W67J.WO@CM7]*\*\;Y;Q/E[I0M#%-/GHS?OPLUS/7O?2W3\/ROB#A
MNOE515,/[25/FYKI^[???NG_ )'J?P.^,'B#X&_$CPWXIT.\GL[#3]0AN+Y(
M7:,21QRQN00N > P&>F>:_TW_P#@CQ_P4W^'O[9'P^LO"=K?VUKK7A;0(I+A
M+F2))9Y(VM;=@N'9F),A.#CH3TK_ "Q+F2(P.LL9;>N.0".G4Y],].>_7%?I
M-_P2'_:-\??!G]L?X1>$_"NM7.F:-XN\0/INJV\-Q)!%/;&TGN-CJC!6420H
MV&[C-?"^)? M/&Y;+-L+4A0^K0G4J*VKT3LDKZO;J?2\(YS*<:>'KTW.HVDJ
MFFMFOBOV6W;<_P!>I75U#H0RL,JPY!![BG5Q'PXU+^U? _A>^>83S76C6<TK
MAMQ9WCR23W/O7;U_*LHN,G%IJS:U5GHS]03ND^^H4445(!7$^-?&>A>#=$U+
M6=;U&UL(+"TEN2;F18PXC4MM&[@DC/\ ]?!KL+B9+>&6:0A4B0NQ/   Y))]
M*_DV_P"#B3]LOQ)\.OA0VD_"[Q9_9^JDFWO8K&]:*4IY,BR*RQ,&^\.0>_KC
MGTLLRW%9G75#"TW4FVEIM&^EV<>,KTZ$(NK.,(2=G>_O6Z76W]=C\C?^"Z__
M  6+UWXF?$74OA#\$_$-SI,'@^!=$UR2RNC##>SEI+AGS Q\S,-RB$L.WI7\
MGWB+4[WQI?2:QK4S76H22-+<32,9'DD))8DMDG))Z\\?05#X@\3ZGX\U"Z\4
MZM*UQXAU5_/U:[D8O+<3X";V=LNQ$:*,GG&/0"L2UBN]Q$99FR/W:]7//"CO
MD_B:_L#PYX,I\.9-]=QD$Z]2"J5ZDK<NW,DT^R=NQ^6YMG]3&XFKAZ#4:<9>
MSIQ5^:*NHN[2U4_B7Z:WL3B"8K.2L:6X6,J_&?+&,\=.GK]:@^PZWJ)$VC^'
MM1U.&,89[.U:9<@9Y(S_ )QT/3])?V2O^"8/QD_;0TN#5?"5A?Z5:W$LL \V
M.>$/Y4K0&0;$8$.4)SW')'-?VR_\$O/^"%/PW^#WPW>P^/OA33?$.L3H76:[
MLHKEANB0 ;KF,-PP)_ES7C<7>)N%RBG[/!2C4J23C!4FDKII7M==;7T_4]#*
M.&E6YJE>=U'24'O%2LW?1:_DS^0G]B/_ ((L_'C]MSP/J/CKPQ#>:)9Z9):1
M26]V+BW=S=K,RD*B,/E\@C\1]*^UI?\ @UU_:6F.6U(GZS77_P 9K_1&^!O[
M/_PT_9^T&Z\._#30[30],NWA>>"TMXK=&: .(\K$%'R^8W;C/O7N5?A^(\4.
M)JE2IRUXQC*?-:WO6:6C?HC[.AD>74Z5.,:2:C%+FLKM73U=KWW5_P#(_P T
M:+_@UT_:5A)*ZD0>/^6UWV_[95GZS_P;&_M+:1IFHZM<Z@TL6G6LMTR"6[.Y
M8@6P 8\'/^>U?Z9-5;VS@U"TN+*Y0/!=1-#*A&0R.,,"#P<BLUXG\4)13Q,6
MHO2Z;=M-->B2LMOSOI_8>7>]^XC>2Y7*RO;3K;R?W^1_BI_&CX'?$+X%?$36
M?A[JWAC69WT2ZN+::Z6SE>(""0Q,Y<C[H )/&.<UY'<3QPL//C*R@_-&P 9"
M.NX<8/'XXYK_ %U/C_\ \$NOV8_BIH?CW5;KP#H\_B_7M UR&SOY--M&E34;
MRTF6"42E"X*SNC;AR,9'(%?P1_MJ?\$0/BY\"/$_BWQ:;>:?0'N;FZLK>!)F
M6.%7=U4)L"@!2HXXZ=J_3N!/%2I5Q]#!YC2E5E6;_><R45HKWO;2_;I]Q\-G
M_".%HTI8C"73I2YI03]Z7M&K;):7_/YGX W<]G=;-T69!]PE1D'\1P?\\5]]
M_L+?MW_%O]DGXC^&[^V\3WUMX#T^^@N+O3HKN9(FA^T>=,IA#"/E6/4]^M?"
MGB/3KCP]K=[HE]83VT]G,T),L6S!1BIZX/;MC\ZR;R-Y;-K.4EVE!VD\X#CC
MGMP1T]/7I^N\1Y-E7%V6U84X)*JE./=S4='ITBW9ZZ_.Y\]EN-QF58J.]-0<
M4U-N2Y)<K;CV=E=V\S_77_X)M_\ !0SP-^VM\,M,UK1+J".YL[**"X5WC$DD
MT<2LQPK$DG=U/6OU'K_+O_X(D?MS7OP(^)_A;X63:M)8Z?K&IV<4NZ8QP!9Y
MHX27R0 , ]OY5_IZ^'];TW7M+LM0TN^M[^WGM+>59K:02QL)(D;(9>#G-?QI
MQ1D,^'LRG@YSY]9;)JUFM'?KK^!^PY=CECZ"K1@XQ]WE;^UIJU\S;HHHKYH]
M *_CU_X.T_\ DURS!Z'6/"^1ZC^VM-'\B:_L*K^/O_@[/@,O[+=J0<;-5\,N
M><?=UC3SC\<?YXKZ#A:[S[+DE=O$4[?^!Q./,)*&#Q$GHE3D[O;377[C_/UT
M^WM!80N$4$1CJ!DG _/ZGI]>3'<&*^@FB4?*J_,O3=\PR.?0X...E5]+E-Q:
M1!<JJ+@YX!P,<<X['\ZL!5=B\9V)%S(HS\XZ?SY_K7]RX3+Y5,!A(3;=.I%<
MT-6H126]WUZ6\S\.K^]6E.3]_GYM-'&TE:U^^WD?MW^RK_P4H\)_ ;]DWQC\
M$VC>+6-<L;^VA= @ >XLE@4YW @AAV'^-?B!XJUR[\5^*=8U[49'E2\U&>YC
M,AW821]PZ^_TZ 8J.2SL9Y%NWB4+']XLHXV\]<8Y[C_&O7?@O\&_$W[0?C[1
MOAYX0TB]EFUBZM[-+N"!VB1IY!$"70'&W.20/R KQ<?A^'N$J>)S&=2G#VS]
MI5IW2DZEM+?\,_+0][#5,1C8PHT%5J<UH5$Y-N-[*]WLDM?TL>5MIWB'5(H(
MM'\,ZI?6\[QQI<6MFTL1$CA%8,HP1R#P.GYU^V7[*'_!!?\ :#_:K^'5E\0=
M'-UIME>Q"5+:?[5"X#-MQM"<<\\'_&O[)_\ @G-_P1+^"GPL^ WA+0?C3X*T
MK7/&%MI&E_:[VZT^"XE>Y6"%W<R3H'+%P3D_7@\5^\_PI^#_ ()^#/AV'POX
M&TJWTG28%"1V]O#'"@4'( 2,!>M?@'$?BYF.*J2I98O84X3?+*6KE%-).ZUU
M2VZ?@?;9;PS@L+!\T54E+23>OO:7WZ_/3IT/\YB/_@UY_:<B<J-3<)U ,UWC
MGJ<>6><8ZDGO7P]^VQ_P17^/'['/A./Q3K\-YJ\#;?W5JMQ.P&QG^ZZ#/ (Q
MG\Z_UF:\/^,W[/?PT^/.E+H_Q%T*TUJQ7I#=6\5PHX*_=E!'0G\Z\++?%3B+
M"58>VK*I0Y^:I"VLUIIKTTNM?([:^09?6B[481J<JC&?*M-O+R?WV/\ %4MX
M-6T7?!K^AW^F/_RR:]MC%D8P"I;W!Y'>I8YU\P-+^\5C\O<#O@9YQC'Z5_H-
M_P#!8?\ X(6>$?B1X?T[7_V??#-CX?&B:(?[06QLX[8RW"3W4A;_ $=#N/EE
M!SC..:_A>^.?[/?BG]GO7;_0/%MI<0S6<\D >='7<48J2ID R,CKW!ZU_2G
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M!#.J9:-RT("@E9!C!Y'K@[N^.E?3\1Y)E/&%)5L)&E5DTJM*HK2Y7V?E9O\
M/3IXN KX[)JLHU_:>SG/EG"[5HNSLK[/1.Z6EFDG<_U\OV+_ -O'P'^U)X9T
MK4-"OK9Y[RVAF\E9(C(N]%."JL2#E@,>]?HP#D9'(K_*B_X))_\ !2[7/V2?
MB9IJ^-]6NKCPW=W45G:VK3,T42R2H$^21E0!4!''0>E?Z:_[,WQY\+?M"?"/
MP?\ $?P[J=G<Q>)=/-X+:&5'E@Q-)'LD52<'Y,XST(K^2>,L@ED>8U*7LITD
MY?#)/5_SQZ6D]D?K>5XZGC,/"5.2G%16JZ;>[*^MUZ?AO]#4445\:>H%?F5_
MP5L/_&&/Q/\ ^P!K'_I":_36OS(_X*W9/[&'Q/Q_T -8[?\ 3@W\^E=> ;CC
M<*TKM5Z>G?WD14^"7H?Y!.@112)=;ERWVNZ/(S_RV<GG(/.<C^=:92(3^6JX
M8G /'?WSGWJ'PRBF*Y!Z_:KG)/\ UWDQSG]/ZUJ7!ADD\B-0LQX#XZ'USG/3
MO_.O[XX9PU'$9-A%4;]^G",U=^XG&.FBT:ZM?Y7_ )]S2G6JYGBU*4N52GR-
M.T4^9-7_ *O^9^N7_!+K]M/PI^Q+XF\0>)/$,1D.IZ?<P0% A(DF=64_,5Z%
M<'\<#/-?(G[:O[3/B/\ :F^,WBCQ7_:,\GAK4M0O+FTM99',:12SLZ#82R#"
MG&!VSVZ?*%^;=;9%O )PN.ISC [9]/3![^M4]*MM0\1:CI^@^&=-NKJYO[F*
MT5;2(R,K2':,[<D#WQZ5RU,JR'(\;C\ZQ,E&O5H*G)R<>5Q@KQT=M?U9[V4X
M_&RP5++:<)5)<[O46MHNUM>FY'!%J"(;31-&O-5,/R2?88&FPW7#;!P<$=?J
M:_2K]AW_ ():_&?]NLWG_"*Z=J&ABV*"3[5%/;YWYQC:&SC!Z^O%?T^?\$+O
M^")FAP_#E/BE^T%X;MM<L_'%PVK:7;:G:+<26UIY<5L(RERF%/F02' .!GJ<
MFOZS/@/^R1\%/V=S+_PK#PO8:"9L;_LEG!;9QG&?*5?4U_/?%/BMB98BO1R:
M+HPIU)TW.6L9<K48N/9:7T7;MI]OEW#&$H2I5L5>I7FN9J3NFW9M-/JOSZ:'
M^?4?^#7;]IA8C&NI,N[)(\Z[ZD=?]7S_ )QVQYE\5?\ @W,_:,^#'@;5O&NH
MW,UY::7!-<20(UU(S"",R$!3&,DKD<U_J"5RWC'P=H?CK0[OP]XAM([W3+V-
MXIX)45T=)%VL"K94Y4XYKY+#>*/$U"K";Q"<%.+G&SU2:NM6>Q/),!*G*"HQ
MNUO97OI;[FK]C_$Z\>^ _&GP]\076DZIX;U:"UM)YK>6>2SD6(O"5&=Q^7GD
M_P"%<BBQ;_/D3:O.8R.?0Y&>QSV[9ZU_JJ_MO_\ !'CX ?%WX3:Y8^!O ^DV
M7C"ZO#=1WT6G6T<N#;W._P#>1IOYD:,XQU /6OX/?VZ?^"3GQ*_94DUCQ)JZ
M2+HEK+/(!B78(][%<9C5>!^''UK]PX.\4,+FR5+%-T\1[2,)0E)?!:-Y6];_
M / /AL[X=^K-3HQERN-Y2U:<K_"DKV>B2]+Z'XXA8?,^T%/W /*8Z\>F/?\
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M*TH=5:R>E^K/VPHHHKXX]<_SRIK2WL&!ME"J3\VT8/!]O8?3^EB:XB$8DC7
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M251QU;M>U_\ .WR/;P^78Z\*DN;DDMGS7V5E;7<ZR.031GR1AD'SD \G&>N
M>G^<<5F_V@RR%#G /(&>>O;!]..M4[+Q#:PR- ;>XW@XE_<2]>/]GT(K6GN]
M)E4/'!*IP2VZ*08/'J/\C!QC.<Z'&7#V)J4J%&MAW!I62<.=*7*U;73I;U]#
MFG'%4N:+BKQE+XE=V;36^OE\B11%< 2Q+M6+YI!T)'TXSZXQ[_6NU[&)56,%
M8^ R_0\_7./>G07,4GRVN!$!^^'0[?0Y(]OK3'CMS*KQX,>?FQCKGG/YX[5]
MQE]>E74*D7!T%!N+33MMUO\ %J[7\CRZDG'2;2U5KKSV77_@^>HV:: S(ZJ
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MG2?.E*ZYW*[LNUK+^K&S1117X@?:A1110 4444 %%%% !1110 4444 %%%%
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MMW]M/QS^TS\;?%E]J&MWMYX2N]1O9;"SEGF>%(WG9HPL3\* AQQVX%?U^_\
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MJMT/]+ZBJ>GRM-I]C,WWI;.VD;_>>%&/ZFKE?SD?I85_'S_P=HRM'^RY:$'
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MCB0,O#<]>#7Y2:A<"RBM3*?W\M[:Q*>?]7)*%;IVP0/ZGM_H;?\ !O?^P/\
M!S4/@]X8^/DNEVA\8&&.Y^U?9U\W?OV#]YLST/K7PGC1GT\IR6EAL)4C>O\
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MRZAI<LL,YSDDP,5<9!R<[3GGKBO]GO\ :*^'>A>._AIXL@UFWCG2'0[UU\Q
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M9?(C8[L*O\3-UR<\YKY#Q;SNA2P]3+W.K[:LTH<C_=WBTY7UZ;+_ "1ZW"6
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MNSO.<3G6-J8JO4E)-M4XMNT87=M'L[;G[5A</##THQ44I<J4FENTDNG331=
MHHHKQCI"BBB@ KYM_:6_9Q\!?M(>!+[PIX\T:UUFWCL[T:?'=6\4ZQ3W**I9
M1)D*3Y:\CVST%?25%--K;^O->?8F45*U[Z.]EI=^9_EI_P#!7G_@E1XP_9-\
M;^(?B/863KX-O[^Z?3K*VV&.&&61Y8@L,;%5"HN/NC\Z_ VUCDF FN$9%//E
M2<%2>Q'J/3_]8_V*OVY_V/?AK^U+\+]?TWQ[I=K>)I^E75Q;^;;)(1+%"P0C
MY#SSQ]>*_P I+]N3X1P_ W]I'QOX+TNRDL_#6F:IJ5M8#R'CA"QW+10A?D48
MQM &!Q7[[X3<59DZ_P#8=:I.MAY<OLFVY*FY-+WVW91[*VWJ?GW%^3TJU">,
MHQ5.M9W4M)-)+6"MOZ:W[]/D34UM7M)(W0,2I X!P2.W'O\ RZU_3#_P;:_M
MZ^#/V6OB\_PLUV+.H?$VVE\/Z>?)+8F,T%]U56QE+1NI'IWK^:'=$K#[9R)"
M-G?.3VQGU[X_,5]"_LB>,-!^$7[5_P %OB5KDYM]"\->)3?W\FYE1838740+
M;3G&]UZ_CVK]A\0N&/[8X=Q,*5!2Q2I2JPE&/_/M*;2=FW>S5NI\[PGBZF7X
MFE0J-JE7ERRET;LDK/OZ:::6/]G70-8CUG1=,U>(?N]2M(KM!@X"RKN'7'./
M\]**^+OV%OVMOAI^U)\*O#NI?#^_BO8--TFUMIVB9FQ)#""P.>>A'X=J*_BK
M$4)8:M.A7A*G5IR<9Q::::=M5^/_  3]82Q%E[*<7#2U_P#MW[^ORNNI_*Y^
MTU^SUXI^ DMJFKVKVJ3L0<C;G&/KSAOP_/'RL7MI3"R<!E0L>?O$9;]3WZFO
MZ0O^"NOP-\9_$2&SU+PQ9E[.Q$LERT,2 ! %8[L*.RGKR.*_G$N]+:PDFLL?
MOK!VM+E<\K/;DQS CKD.ISQ7^TGT9?%C$^(V5RQ&;U*5/,XT[U:5&7+3BN91
MV>MWI9_T_P 7XJR6EEM1_55:AS*-K6M=+X?S\_4T8Y(U@95Y0CG@D8QZ]O;%
M0Q36GE^6WW<$=<_U]?Q[4RP\LQGS/NC.>IQQSGCW'O\ K49BMS<%L?N<^_X?
M[77'_P"NOZD5/GE6YO>ZPE'6]K:-_P W9+1GP]&BYSE><YJC)-1>RV=W]V^O
MKH1F2%IO*/\ Q[_3_ ]<\=,_RI-MLD[!?]4 ",>O/?CG/Y#IS5P16@DR!\GT
M;D_SS[?K4"_9OM,G_//:-O ZY;/O_DUK0A&G%M*JW[-7];JZ6GQ:[/I\CKJT
M5'EVBZB4E..CMH]^[:^?DQ+>6 RE92=@X'7J.,C!S_GUJWBU^?=]W:<=>N#M
MQGWQG/2JR10)*SR >6<[?Z=,=O\ .:IRR*\FQ3^[!Y_W<].OX5K:-6IRQE--
M1BWKHMMNM^_F^Q=*MRTJBE+VG-'D4KWVMHW;7]"S;?9B75SUX7OZ^G;ZG%3Q
MP+%NWX#OQ#G'WNO&.V.>?RJJT<9:-HQC!!.,_P"&/?MU_"M2XN;9X V1YL.&
M7Z\CL!GC([_7K6%=XCWO9\SC4LK:\T;67XLS@U*"E*/(G=+F6C[VZ_YE*1$2
M)OM'^M.=GT]#SC_(J"T>WV,#_K>=G4_3N1],^]3P3P70Q.<R9(7J.>W'Y#GK
M^5-N1::=&UR_502% R3@9 PN2?P&#S7@YKF=+*<-*K5J2IRBFYJ4N5-JSTOT
M?W&E.'M)QI0A>,MM--UH_/\ 5OU*=[?1V,(=ANNV(3:@9CN9MO0 GOG !Z?E
M])_#C]COXO\ QCT.'Q#X:TVZDMY\,C"-5&"VWD/@C/7W_'GUW]B/]BGQG\=_
M'.E>+M=TV:;P%>20W:M)&1'Y#@2)U ;T/./RR:_K<^$'P+\'_"/PY9Z%H&GV
MT=O#!$,>2K?-M!;EUS][W[5_ 'C5]*NID6)KY-PVZ5?&Q<HU*J?-3IV?*X2E
M%W52+W72WR/TS(N$(U*=+$55*$6HM1EIK9.Z5ONM8_ +]D7_ ()BZK>:I<#X
MNZ0QM +?R_.0=3O+\I]!Z^IXK]/+?_@F%^S_  9"Z1;#(Y.R3_Z_7_'UK]+$
MMX(O]7!%'V^2-%_]! I^Q<YQU_S]:_AGBGQ?XUXIQT\;B<WQ6%YX0A]7PU:<
M*/N)*_+>UW:[^9]_1RK#T*<:<80J).]ZBNUZ-?UL?F"?^"67[/1FEF_L>WW2
M-DG;)Z#/TR,?_6KQ#XN_\$OOAQ'IMP/"&DQFX,;A=BN3NP0/O'\OUQW_ &M"
M+S[FD\J,_>16_P!Y0?YBO/R?Q/XQR?'4<;2SG&UY47&U*O6E*G)12LI*^RM_
M5C#%9)A,7#DG1IT[_%.$?>LFFDG\ONT/XWOB)_P31^.5GK+)X7T>Y^PR7#*V
MR-"!"=^.IR1G;7E7C']@WXY?#WP_=>(M<TNZ33K**26=O+7[J+O;&T$G@=NU
M?VY&TM&^]:V[?6",_P UKB?'OP[\/?$#PY>^&M8L;5K&^BDBE7R(QE9$V-]U
M<].]?O>5?3%\0\"\/1J4<$\+"=-5$E/F]FK*5KNS;2_S/'Q'!.5UH.-FGO%Z
M:225NG?_ #/\_P BUFT@N)[*6"=7MY&BES#*N&7Y6&2H'X9_7K>C,;OY@;_1
MCR >>#TY)SG\.._>OZK_ (O?\$MOA WA;7+SPMH\/]N7*7,T/EJX8S.F5QGC
M[P'H/;M7\^OQ@_8Q^+GP;L+S7M?TVZCT*WDE(8QAAY8DP,;,L?U&.M?V%X3_
M $I<AXI<J.9XV. KRJT:*IXJ<:<ZE2:M>BFW=)JWJUYGP^:\(XG+XRG0IRFI
M7UI*_N+E_B-:;K_ANORX([<3"3'[CKG_ #R#^1IOFQ7<OE3X,(^YQ^ ^[@_R
MQ45EJ=G=1E/*F1%+(S/%(H!#$'DJ._3/3Z5?,-K !(^-G53SVZ>_^'&:_KK+
ML^R_.8TZN&KNO22C&,J<U*TM'>ZZOY/73S^,J4\1@VG6@X7F^5I644N7XOO_
M  ^29/%!;1[B/W7&T<_A@>G'7CK^%,\/WK6.LVNM1G#:?,LD+9Z%65\C( QD
M#^>.*<7CG!$Y_<D83M],8'TZ\_RJA=0O:P2K'PDJL8AP,@C'ISSG^?M6?$>5
M4L\RK%Y?B.64*E%OEDTU).*NK/K9MOR_#3"UI/'T\7S0DK1C&^JBXVO+\_Q/
MZH/^"8/[1.N_%72/[%U.[:>'2XH88P2,!0"O\EY'<_2OV<K^2'_@E?\ M%>#
M_@GX@ETKQC>+!/JT\45JLA8;F+LO 7_? [XK^LO1=5M]<TC3=8M#NM=4LK:^
MMV'0PW,2RQG\585_AEX\<+KA?Q S;"T,(\/@:E7FPTHPY:51VO/DM9.S>OGN
MS]_R#$_6<OI2<XSDE9V;=M%:_;R_#3;3K^,'_@Y4_8EMO$'@T?M$Q:6\][X?
MN;NP6XCA>1U6_@-PP&P$@$V?7&!CUK^SZOGK]IK]GKP9^TQ\+M6^&GCBSAO-
M'OB]R8Y4W SQVUQ%'T&?^6QK\LR;-:F3XZECJ5*G5J4G>*J1YHI_S)=UNGW/
M2Q6&CBJ3I3E*,6U?EZJZNGW3ZKJ?XKNG7C3"<,KQW4<\T6V4%&'ER,G1@#T
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MAB<1&=6I3G5FZ3K.\U!N\5+5ZVW\S]MPM)T:%.#C",E%*:A\/-UL%%%%>8=
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MT73]+V/N."E!4IJ-^91L^UERV^?<^S:***_%#[T*_,?_ (*WY_X8O^)^.O\
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M/\!_ECO^?\ZH3PA'WI_JRPP1W!/].G./?M5DE2Q!'[KG;WSZ8Z]/Z\\U-&4
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M+Y?MTJJO_P ))J.&P!^]A[D ?Y('MQFKL/\ P7V_;B@3]_XEU#+#"CS8<Y_
M^_H.>O>OQHGU"W,('V&ZVC&T?9)^H/RX/E^N.N?QZU36_C?_ (^;*YP,;/\
M19NG;_EGZX]>O6N:EP!PVJK;5-6>BJ<J6O5>FMK/;7;04L\SBI2=J4HM7O9.
M[M9I1U>NGO?*VA^R[_\ !?7]NA6_Y&;4?F/&)8N?YU\._M(?M?\ QA_:VU__
M (2[XK7TU_JY2!%>9D=MEO$L4/*YZ(BCMTZ=Z^4+C4;2- 7L;G*C*_Z+/U.,
M'A#]1_.H[#7))T):SNL*Q5<6LXX&0O\ !Z#/O7O9+PMPSDN*IXG"UZ<,13YH
MN<7%2LW%M)I)]/OU/)S#-LZQN7.-7"S<74CHX/>.B>^OG\O(VK=8I%*78 DY
MVCGTP.GXY[_CDUCZQ+#!)8P)U%]: <<#_28\<?AP/QI]SJ\**6-I="0#Y?\
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M&/\ @H?\-C#]S_A+]"[8_P"7JVSU/Z=N*_%=1'U/_'OMYZYSM]N_K[5^UO\
MP;T>5_P\-^&_D_<_X2[0L8]?M5MG]:_;?$C#<_!>/K56^;V564(K[,>1.TO/
M96Z:GRW"#MF?+II))VVW2U_O/\V?ZM%%%%?P<?LI\R?MA\_L[?$H?]0"]_\
M22XK_'1_:$FBB_:+^)RMD.VOW@3Z_:9_[O;H?KZ8K_8N_;#S_P ,[?$K'_0
MO?\ TDN*_P <O]H8P_\ #2'Q)\S.[_A(+S;_ .!5Q_7IFOV;PAE&&85Y.-Y)
MQ4=%:_G^A\GQ<E++I*2O%:V6[:V^1YI*DR7*I>9PY!3/]T_=Y _ND<?RZU]L
M_P#!-.T5?VV_A:889&7^WM')948J/^)@O=00/7KTYKXTUMUCC1Y\"7RT\OIT
MVC9C;QD#N>?J:_HW_P""'/[/'@3QQ\2?"WC;5[>%]6L-2LY('?E@8Y8Y%_\
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M2<O[-A"4>5J[=_BUMN?3+;L';U_S_G^7-?F-_P %:U=OV+_BB&Z_V!K&.O\
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M-I/";EF6-49C_:-X,D@ DD<<\C%?HK7YX?\ !+!HV_8,_9X"LIQX1?H0<?\
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MCS/]?_PD-YMSD\>8<Y[9^O7BF2/"DY[.?E'![\#_ #TI]YY/_"<>./,_U_\
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M37*XM2@FTE=.[WO>1^65:5; N\E%J_.I?:2C9VT_)OL_,^G/V1_VK?'/[/\
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MWR/\*^6AXBYU"4Y)4O?:?73I_7HCM?#]!_\ +ZMJTWK>[5M?56?]/3^4]O\
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M3:??0K]Z6SN8U_WGA=1^IKXZ$G"49)M.+336ZL>O**G%QDKQDK-/9H_QK_\
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MWCVW80#[1]KN?7/_ !\29[X[>]=(0/+8@$76#CZ[2/7KC_.#6%X<%L[7;_\
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M6^B6:%E.0590P(/T(K;R,X[U^!S]QM3]UIV=]+/MZGV8M%%% !1110 4444
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M"_$D*SZ5JD$UO<1N"04F0QL./4'%>DT5492A*,HMJ46FFMTT)I---73T:/\
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MRM[E^7"2^->[+]TOA[]GV?<_",*K9Q*=Y.V(IKE>VM1:OTN?Z'G_  :M[?\
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MXHXHWD9I'5%"HI8\L0.@K$USQ3HN@V4U]?:A91Q0JS.&NH%.%&3P7S7\Q?\
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MB#%RH892<(NT*=M%M:51*ZNM&<=)</$/(8C[)QW'?![<]3Z\?I5(1-(Y\O\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\S?M-?LT>
M?VEO 6J>"/&^F6EWI]W9SQ_/ A8L49E^95WGY\=Z^F::R[ABJA)PDI)V:>_5
M:[KS)FG*+2WW7^3\F?Y:?_!7;_@DOXQ_95\>^)OB3X/T*ZM/AAIKW>H-+%:R
MB 6\2/+*=_ECC*M_%7X%VVHV]VP>Q#"0_>RK?^S<@_UZXK_9$_;>_8T\&_MA
M_"+Q!\,_$EO!'!K&EWUD]P,QR8N89$/SJRG/S\'.<]\<5_GM?MV?\$2OB9\"
M;K5KCX5^%=2U:QL7F?S(;:ZNE\B/<=VY2PZ=^PZ=Q7[]X9<?RP5.K@\RQ'[B
M@H.FZC7-9OE45=ZI::(^)X@X=AB9+%4(6Q,XN+C&Z@[6=Y>?;?J?S\S*MS#Y
M=UU !/\ ,GZC\?4'BL);06]Y#=Z?<SQ20.''E3S)T.1]TCKCH/R].C\2Z?J7
M@C6;KPSXLA;3M:M'>"ZM9E,3QO&=C@HWS###!SCGC@G-9UI+8,X*2APQYP??
MCG/X]A^M?T!#,LLS^@IQ]G4]U<NB;=TMUK?RW]._YE3AF>5U*\^6JI*=HQM+
ME=FEMI=?\#8^YO@=_P %*_VDOV9;,6OPXUS4((PJH0)RW"#"_P"M9O?GK^F/
MUS_8K_X+^_'Y?'>AO\8O$UQ_8*WT8OS<SQ(@A%S\^3E< 1Y^E?S>W=I:219M
M\2<98AAD9!_VC^O-8"6!,<BVTCQ$E_FC<J5.3D@@\$'_ #V'QN8^'F79@Z]>
MKA$J]9-1DHJUFK7O97<='VZL]K!<8XZA"-*M%^SA*%WROF<='*_RV_I'^HAX
M=_X.#_V.!H>FF^\5:3]L%G%]IW:A$#YH7YLCS_7MQZ5HG_@X8_8L''_"5:1Q
M_P!1"+_X_7^6U%IFIJC;M;O@F<G_ $EP ,<@<D=!TZ?AS66^G:F;E=NN7QAP
M=S"Y? .1@=>F,_G]:^*7@G@ZMW"M4YKZIU$M7:UM&[;Z?+L?7T>-,&X\S;47
M9QO&RZ:+?5O9=OD?ZH/_ !$(_L7E-_\ PE6D?7^T(L?^CO\ /Z5Y3\6O^#A3
M]E)O"M^OA;Q5IG]JFUN1;^5J$1;S2H\O \TG.<U_F+_8]8,OEIK5^8NF?M#D
M<>ASCK_G&:I7&GZTMP -6OW08.TW#$<GD=<>Q[<<UZ&$\$<MHU*=6M6G)P>L
M'45KVUO==+[='ITUSEQMA)<])R<9\O,G966L;7=]'W274_H<_:,_X+[_ +6(
M^*&OS^ ?$UY_PBKWES_9YAEC,?D^:3'@@G^#'?U[<U^<7[3/_!2;]H7]L?PW
M_P (E\6==U"XTK?!)&IN"H\RVD2:$YB93]]$SSU[>GQ!;1--&L5^<A<?/(1N
M/;J3W[]L^U7#I]HNU@0%5E(((P0O0#U]/SK[#!>&O#^!A*3PU*M*F^>/-&,Y
M.6CMKT7373?HSP:_%6+JJI2E-Q=9<E*5/M=<KZ:OKW_$R+#2T@?_ $N>XG!/
M[OSY9)"![;V8$>P]JW9C!:(-^ C#CGD_AC^8^F.]'5-0T^!5,DP4IT^8<D=N
MI/'?^7%>T_ O]F_XN_M+ZS:V7PX\.WNN6J3(D[V=K-<!49AR3$I&, \\?A7T
MZQF291156O4H4%!<J@Y**6BCY;=;_P# /"AE^*SJLERU9<C5YNZBVN5Z-WVM
MK^AR_P &])U_Q9\1]'T'X?17#^*+RZMX[#R$=G\Z24"/;M!R=Y_3M7^GI_P0
MZ^%7QT^&OP3M[?XS17L=W<VR2V8O$9&\I[= F P!QUQ_2OQ^_P""3W_!"'1=
M$E\(?%[XD:?-IWBC36MKY[.[\V$B6WF,J@PNX!)( P5_0U_:#X3\.V'A?0].
MT:PMHK>'3[2&U41*%RL2[1DCKP!7\D^)'$E7.,ZQ="E*'U+#590HRI-6K1OI
M.5KJ3Z:.W8_5\ARBCEU&G*49.O4A=RGJX64;J+T]?GLD=+1117YJ?2'\H/\
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M?VD[[+^[YKSW/UN_X(6;1_P4G\!_WO\ A'M1V].G]J:/TQQG/3'-?ZS.D_\
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MZ<WRN*IRTEO?2S2[KIO]]CXF-VN?*)_T?'0C&3CKD>_X'D]#7[8?\&\OE?\
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M<*65@P*G<"58;6QSD'C'Z5<EM+69O,<[7Z<9!Z#H1Z5^O7_!3?\ X):_$_\
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M8Y [9XY;^^M[V>V_3\3_ &7OV:\_\,^_!;/7_A67@S/U_L*RS7MM>)_LV_\
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MP\":<)/VDZD(.;?QV;@U&S;MO;2Y[LN-,(HJSM)+7FC9/973;OOY'^I[J/\
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M'C/!G!2J0J*I-<[7/&G-6C%6V5M';^NJ^LI\7X>C1Y.9N32<.=:N3WZWM?\
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M-&46_LM--_?;KT\]3^=3_@W%_9[^)OP6^#%SIWQ#T.[T2]+.1#=6\MNQ_<1
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M_AC%6**\U-IW3L^YT*3B[IV>JOZZ,0#  HI:*0@HHHH **** "BBB@ HHHH
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M -75FKIC%C5>P)]<4^BBFVWN))15DK)=$%%%%(84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 48SU&?PHHH ,8Z#'X5"TC;L <>O\
MD?Y[5-3=B^E2Y34O=C&2L]^_30F46U92<;-;=ET&>6&(;OU_K_GK4M, *G Y
M!_3_ #^M/I0J2FK25G'1JVGR[C48QO9;ZM]7;37S"BBBK&%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,,:8^Z![XI57:,4ZBG
M=[$J,4[J*3M:Z5M-/\D%%%%(H**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH _BS_P""H>E6=Q^U5XKE$O[_ /MW43M#+G_7RYX_'/Y5\0.T
M<%D("PW[!P>O4?Y]NHK[F_X*@101_M4>+)XI-UQ_;NH_N]PZF:7/'7MZ=>^1
M7P?+&DD0EE;;-@?)GG''..O Q]<8K_<7Z.5""\.N%9T5=O!8)STMK[*"?S[=
M-_,_G_B?_D;XI\\G:<UR2345K?1_=V6U]AO]GP+"EPDN9F8ADR, #!!QQUY[
MU9(CMXE96#.V,C/U/0=#21PK]G5HW+2%CE2>B\<X///3O23VT;(I4DR<%ESG
M![\<8P?\\BOZ7CRWY7.33J2;5E?T=E\*NK/7MJ>!5E"I3BVE=1C"47I&T>6S
MOIJ[)[A-"KB-T.2PR^.<>WMZ^O-/?RX @0[MQP>IP>!V]*1MD"1A3DN/G!R=
MI_IZX/K39X$)0QDMD_-WQWQ^OUIIIN*E*7)>7+IO9K1]K=/UZ\[2=U*,/9KD
MY7S;Z1TOVMJ++;QEXBAW!F^<\_*,'T(QR>]/8QQND2G*-U//<\]..E#>7"8T
M0Y$AVOWVC'Z=,5');IYJ;"60XW'K[=<\8_\ UTD[VYY3M9VNK7MM?S71==.]
MQM7NI1CRJ4.5W_PV_KJON"2W3S4V$LAQN/7VZYXQ_P#KJ0F/S3!N_=]-W/3'
M7/3K0QCC=(E.4;J>>YYZ<=*C-O'YY&3Y6<[OUSG/_P!:B][<\II*#<=-]5K_
M (EK9=>SM835V^>,4E-<NODOZZ6UT(9H%64%6/E\?,"?4<]?KVQ^@J>[L$AA
M693NR<]?;/IW[4X^4THMV(\KCYN>GKGIUJ.\E;9Y/(C48!Z^@ZCKZ?C67+5G
MB:3<G[.,4[-6NO/^\UT_S!73FZC2OI&":MIRN_J[K^D26UPMRJPS855/'N?K
M^/3_ .M2WVGQ7GEF5C&(1^[.X#< <\_B3Z50LDB=SYC;<=#GOD8_7'ZYJ:YE
MD:5(CE8U(52#]Y3SGZYS_045XTG6C2O:]Y--74;6=XWW;ZKM<VA/EIRO%/FM
M%2ZJSC?YV\B55MI4VS*H$8^4G@G'U S_ "[\5'%$]RCO%.\90LJ(C;00N0.,
M]^IQZ^U:DVG1-"A9P&*\<@?I@<^U9L:/9[L#N<#)Z=N_/IT[UX&(R_*\77G[
M3"4VVTDW37DOQZ_KN>C1]L_X=67LX0?+O=W4;I+KK\RN99HP?M#,Y!P YW9_
M#OGMC\3UJY;F$QM.B@3*0%4>AZ\9R1G'3^G+6:.Z(>;"G\O?U(__ %GMFFL(
M(%WH_(XP#VZY^OZ5OA,BRS#3YJ>%ITYJ24>2":;=DDWV]/+R//JYA43Y(*:G
M%.#_ +U]+ROJ_6[[>M@JK#SB3Y_7;D ^GI_GMQ4:PK=$!B?,Z =<^^./2I(P
MLJ>:A!EQ]S/OSQUZ5&TJ1#=&?]+[1CKGD#C@\\'_ .N*]>,51C-4XM-7VCK%
MZ::;07=Z._4Y9QG.TW:%HZSC9R>VEMO1V^ZXYUCL3F(AF/##KC/7TQV_/U-0
MW,<<L8D5LR'!9,]!W&!^/O3+-?,E9KLE2<Y!.!DG/Z>I_P#K5:N+>%3NMG$F
M2-X!R N?F/'H,_SXZ'EIREA:B<YN4I/FGV:=G;3^MCMC&G*$.?G3=N9-/FM[
MOO)=WO:VOR([:98U,>\GS  ><C\N3W_3DBNA^&<"6'Q4\)21C>9-3@)Y#$$S
M1<X![?YQ7,2012,AMV+,#^\P1_D?YZYK7\&W9M?BIX+CBRQ.IP9 YQ^^A]^#
MSZ<_2OA/$Z%'&<*YRG'7ZE7=VK.ZI-]=MNGX'7A7)XW"\F'LH5(\TE>^KBD^
MNO?\#^]WX3,6^&/@!O7PCH)_\IMO7H-><_")L_"SX>L>,^#O#['\=,MJ]%#
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M\<IP-"K"E.$4L+[**@HZK2,5JNGK^6Q_.V:QG/-*U%74%=Q;OH]'9;W3ZLC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2
M$@#)Z4M,==ZE?6FMU?:^OH!_'#_P5 ^%OC:+]I'Q5XV33;EO#\FMZC,MUY4O
ME>6\TF"'QMQR.<X[\]_SLS!>1>8KYE "E!S]WC&!SV_SU']9'_!4SPCI5O\
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M;VXR,MY4[Q <=>!VQ]*R([2.6U>>1B)DSL7(&2 "./?MC]#DU_2Q_P %RO\
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MD( !G'>EHHKEC%15HJR71&@4444P"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@CK5VH"X444QY%C4NY"J.230 ^BN+NOB%X1L]0CTJYUFUBOI6"I;M(@=F)P
M 7!//'2NS!! (Y! (^AY%-IK=- +113))$B1I)"%1 69CP !U)S2 ?17&6WQ
M \)7FH2:7;ZQ:R7T3%9(!+'O4@[2"H<L.>.178HZR*'0[E;D$=Z=G:]G9]0'
M4444G>SMH^C[>8#5;-.KA-?^(W@OPS<"#6]=M+"8_P#+.:6-2><?Q.,>GO\
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MN)#$HPN.AA.,GN?3C]W[LXM;D^EO-_Z+:OY2/VMH[?7OVO[W3+JY6*.&+3F
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M>/3[=&4SQ9!5 #G$E=/:?&/X<WMPEK:^)M/EGD("1K-'DD]A\_X?6OQF\/\
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M?!S\UC$MLWXYB.:^>_VQ-.^&7Q0\+7]^GB;3I+JRMI7A02Q%F8(2 /WG)R,
M5XM_P2Y\<Z)I?AK6_#^J:M%'=0:_KUK:0RR*&DA35+N.!E!8$AD"D<=_SJ5.
MG7R7VL4ZE6C.*<K.Z4WT[W2OIHK=S5.I&O&*A&%/E>UES/3\O+??>Q^TE%,C
MD65%D0[D<!E([@]#3Z^=.L*YWQ:-WAK6QTSIUQ_Z#715S_BK_D7-:_[!\_\
MZ#50^./^*/YH#\ _V=+O3/#O[6OC&]U?4(K2%M2OR#*RJ/\ C]R0=S#/I7[F
MQ_%WX>(FT^); 8'.9HN/_'_Z5_*5\='\66WQW\5-X1-T]V;^\RMIYA?FX/7R
M^>O^>@KFID_:%F1G']O+O&/^7KC(/KCZ#^=?H..X?AB,)0QL\5"BI4H15)M<
MS:47>S=U?KM\CS(5I0;5&#G%R::U7*[I-W9^\G[9G[8GAWP9X:OO#^@7UOJ<
MFJVTL \B56(+(5'"EN?G_/&*^:_^"6UEJ5WXF\2^(+R&2--3N5N$W@D$.TK9
MYX_BX/U[XKY._9L_9%^(?QSU 7?C:XOT2VD1@MXLK9R<G[YQSCOU[] #^]/[
M/W[/]C\&K%+:V1 RHJLRH%+%5V\X)_7\NE?)XRG1P<'0IU/:5'I-K96LULVO
MZUUN=W-.3A[B<7JV_LOIH_GY[?/ZAHHHKR#4KW?_ !ZW/_7O-_Z+:OY3?VYP
M3^T!=D$IB_0D]. 1G^>?QK^K*[_X];G_ *]YO_1;5_*C^W)"MS\?KZ$MLWWN
MS=Z$J!_GZ5ZF5NU9MJZ2>ETKZQ[_ '?/J<./M[.#:;2E=V]4?M+^Q3\4O OA
M[X'Z18:QXBLK6[6\D9HI98U< V]L.07'<'M7UX?C7\,P4!\4Z<#(0J?OXOF)
MZ8_><U^$WP<_81\=?$_P+8>)M(\7WMC:33,BP1-)L!$<3]!,O9E%>R3_ /!-
M;XF2OIS#QWJ(%G<12O\ -+\P3J,?:. ?QXK#&1I>TG*G*[<W>/\ +MIYV-:,
MYNG2M3M%V6^T;*S_ *_S/V]T[4;/5;."_L)EN+2X7?#,A!5USC(()'45=KS?
MX1^$+SP'\//#7A._N7O+O1[(V\US)G?*WF.^XY+'.&QU->D5Q'2%<]XG_P"0
M5<?[C_RKH:YCQ=(T6C7+J-Q"/Q_P'/\ 2M*7\2%]N9?F!_/=\:'"?M9>%%!V
M@ZI9<?\ ;X?QY/?/-?T86G_'K;?]>\/_ *+6OYO_ (P*UW^UEX5ED/EE=5LR
M%.<G%Z>@X]>XSUS7](%GQ:6H]+>#_P!%+7?F/+_L_+_S[=]+6^'_ (<YZ%/D
M=5K_ )>34MK6T2L6*YWQ:-WAG6QZZ=<?^@5T5<_XK_Y%O6O^P?<?^@5YT;\T
M;?S+\SH=[.V_0_GK^ 0-A^UQXNF9MP?4[[KVS>CISQZ#CIQ7]#^B2^=IEI(!
MC='G]3Z5_/1\%(MW[6'BLQ-O8:G>Y _Z_!GH?RK^A'PZ"-'L@1@B/D>G)KZ'
M-WS8/".UG9*U[Z<JU:U_R\CCPD734XRMS.<GYV=K=OR]#;HHHKYP[ KY6_;$
M8CX,ZMAMO^D+D_\ ;M<?Y_6OJFOES]KV$3_!S5D)V_Z0AS_V[W%=N72Y,=A)
M6ORUZ;MW]XQQ%O854U=.#7WZ'\_O[(MX_P#PTW;Q;<C^T&^8#V)_2OZG;3_C
MUMO^O>'_ -%K7\NW[)5M'#^TO;@88_V@PSWZ'J<]>?Q]:_J)M/\ CUMO^O>'
M_P!%K7L<43C4QT)*/+>DKKSN<65*U"2TLIM:==%^7ZEBBBBOFCTPKR_XS''P
MW\3GTT^?_P!%25ZA7E_QF./AOXG/II\__HJ2JA\4?\2_-"E\,M+Z/3Y'\E/P
M+B^T?M67LF_R]OCF_P#E!QG&KS?X?S%?V#^%>/#FC#TL(/\ T&OX]O@8AG_:
MMO7W>7CQOJ'RCVU>;MQUVX_$BO["/"O_ "+FB_\ 8/M__0:[L=)-THI6<8)-
M=K*VYYN6IJG/2WO/\;?Y'04445YYZ9^3G_!6" WGPM\*6*ML-WJ&H0;O3S$M
M1VY_S^%>=?\ !.7]DBX\!6.G?$5[UY5U*WBF"%3@>;LE[MR<#K_^NO2_^"J2
ME?A_X'DSA5UB\9CT '^B$YY'3^5?37[&'B+1[OX,^%K*WO89+I-/LP\2L"P(
M@ P><]>.GH/05Z4:LZ."7(]*DI*?I?;;3YW..,ISQ4HMJ,8)-1MJ[VZ_CVW[
M'V'1117FG8%%%% !1110!',GF0RQ_P#/2.1/^^U*_P!:_G<_X*&?LC>(=#\=
M1?&S0//NIKGY988$?*K92M."S*<\_:&';'IGI_1/7*^+_"6D>,=(N=+U>SBN
MXY(98XUD (5I  2-V1VKIPF(>&KPJVND]5M==O\ ,4ES*S_*Y^&?[*__  4'
M71=/TOX>^(X?L,^GI%;2O/+M.8E$39#*ISD>HS_/]EO!/QF\%^+M/M)[;6[2
M2XN53$2RQEMS@<8#]?IFOR-^+/\ P2[GU?Q-KGC#P]J#:<':XNHH;>/;C+F1
M0-CKC\!QQ7Y_Z=-\;/@'X]N;9EUF_P!,T"XEE9_W_EM':,3Z,,;5^GKWKW%@
ML'F4*E7#U%2J4USU(/K>VSZOIIIU.!U<53J:T^:GHDKVMM=_T_(_K.BE29%D
MC8,C#(([U)7YF?L8_MF)\:T?1M906%U8!(F$TGS,W*]&"G.5QSU_6OTOBE29
M%DC8,C#(([UX%>C.A4=.:LU_7]=SO3ND_P"O,DHHHK$84444 %%%% !1110
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M*B5YS?Q2U=GO)^1]LE9)+9))>BT%HHHIC"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _DV_X**0@?M(:[+Y@Y\07/R>_P!I
M;C_Z_P"%?NA_P3V;/P5TH?\ 3NA_\?Q7X3?\%%UA3]I/79&N #_PD%R2G&0?
MM3C'7MZXXQ7[K_\ !/217^"FEE<$>0G(.1][_)KZ[-:LYY)@H2:M%4[+JERK
MY[GC81)8ZO9/K?JMU^6^^MK'WW1117R)[(4449STYH _!K_@JNH;Q9X !P"=
M?&&R1M_T*\YK[;_8&C,?@- 9/,_=+C/4#RU]S^-?$G_!5?RV\5> D=PA.O#!
M./\ GRNSW_7G_P"O]K_L!1K'X#4+)YF8ASG./D'X5Z\JC661@MG)77G=?=Z>
MIYW*UCW)K1Q]W7_#?3I\^Y^AU(W*L/4'^5+2,<*Q]C_*O(/1/R;_ ."CMFS_
M  ZO'WLHWQ_^CU]_;T[]J]N_X)Q)L_9QTL;MY_MB]R>O2"U[UXI_P4<OTE^'
M-Y:%@AWH-V1_SW0_R'3^9(KVS_@G'$(OV<M*4-O!UB\.1_UPM:]&OIA:5Y)M
MV:\E9:6Z>OR,(0J1J2<JBE%[1MJOZ[_YGWM1117G&X5^*W[>H_XR+^!)_P"I
MS'_IKO\ _P")_6OVIK\3O^"@-Y9:?^T!\$+Z^N$M[>W\8AY9'("J/[+OQG)(
M Z<_Y!WP_P#$UCS>[+2[73?3MO;J8UTY4[)7?-!_=)-_D?L?X2('AK0QD?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTCPF\IF.G6T$)<C&?*C">I].G;U->LT45FVY-M[O5EI622V227HM KY^^/\
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M/R J_@>@_*N6M7]K*[C:/\JT5].V_P ^XW&7*E&7*[K6U]%NK/815"JJJ,*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 (<D''!J*)'4G<<@]._X?AZU-12:NT];KS=ON)<4Y*6MXWM9M+7NNH44
M44R@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0O!W@# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***0C..O!_S_ )^M3)R2]V/,[K2]M+ZZ
M^2 6BBBJ **,]N_I10 44@&,]>3_ )_S]*6IBY->]'E=WI>^E]-?- %%%%4
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%96MZWIGAW2[O6=8NH[+3K&/S;JYE8+'$F0NYF8@ 9(')
M[T*[T770#5KRSQI\:?AK\/9%B\7^*-/T9WW;5NIXHR=GWOOR+T[U^,G[<_\
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M]_R[FW1117$;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% !1110 4444 %%%% !1110 4444 %%%)CG/<TFY:62>OO7Z+NN[ 6BBBF
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+W^-]CA;DIPBG#:5T]]E;YZ_,J^5&@9&^^Q8K]#T[?TXJ188A"T;8\XD;?\
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M%%5[6ZAO((KFWDCEBFC217C=74AU##YE)'0CO5BOSD]<**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%.$;2<5RZJ,?L]_+H?)26)I2C/%U)5X3]^I"3YF[=$GW[?HR!YK.7]T1^_Z
M_P#ZA_3Z=:=.UK;Q#[/S*<;_ .7T&#['V'6J;I;"X\]?O YXR>G3O_D=^1E1
M +EB8AR,Y[?7J<=3^?K7H5L+[>,557[N,G)\ZTL[::VT_#4['*@J'-15.+FN
M9Q:2G!.WNI;W5MG;OKT<4M;JVD"C,C B4C(()&.,8[8/%?>'_!.;XVW_ ,)?
MC#H/AC2[R:.#Q1<MIUS&TK$,A4SXPQ/\40Z=.P KX-G,-IL2/ 8X\WZ_7D=
M/\:]@_9G%LG[1WPKGA. FO,9""1Q]DN <X]^F <_@<?@GC=PAE.<<%<05:^%
MI5?8Y;C:M/VD4[3I49SIN-E_-&+C\M#HX?KXFAF5&4INTJU.RIMW2YHW^6OO
M:6LI/R/[P= NVOM%TR\<Y:XLX96/J67-:]<=X"O8KOPIH1C.<:;; ]>NP>O^
M?2NQK_"[%4W2Q->FXN+A6J1LU:UIM(_HBG)2A!Q=TXK7Y(****P+"BBB@ K\
MD_\ @L)^T3XM_9O_ &8O$7C;PA=/::C#83[9$(!^9C&>3[&OULK^;G_@X?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>3W_  X]O\.E,>>*TF94;JQ!R>.3SCGW]OI7UCXP_8I^*/@;6FT:]EDNKU9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTMDV];(^@A"-.*C"*C%;**LE\@HHHKF*"BBB@ HHHH ***JSWMI;<W$\</\
MOMM_G3C%MVC%MO6T5=O[MPN3>4N[=W^GX]?K^-25CGQ!H@ZZI9CZS+5B+5=-
MG.(;VWD)_N2 _P"3[5HZ-=*\J55+NZ<TOO:%S)_:71+7[O\ @&A12 A@"#D'
MH1T-+60PHHHH ***8[A.M&KT$VDKMV2W8^BD!R 1WI:!IWU6S"BBB@ HHHH
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M]BKQ07&1]AD'YS'_  K_ "U]#@B@2^N73*/J-\JC&<$3L<C@XXYQ[\8K^C_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<!AGM^I'^@=^RQ_P1(_9,^$7AV/3/'?PNTCQC=BP6W>ZU62X\QI0T9,A%M+
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M)1O[S3:5GLB2BBBF4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG&:<5A:71)J7LXV72[N[=3\,S><?[5QKBG*;Q-I1YOAO))V;T\U;]+'['?\
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M]\53'5H[:[@!>R(6. 1J)=Q'S0;N%'WJ_<&SM+>QMXK:UB6&"-0J1J  J@
M# '2O\H?'GZ2&;\29YCLKX8Q4\+E-*57#5:M.5UB++V<XQ=[KD::YEO:Z9^U
MY'P]1C2P];%+FJQIP;@_L\T(NSZ?EYH\5T7]GKX7:?I=E92^%=-DDM[>.)G,
M$62R  DYCY)KN]"^''@WPT^_1=$M+%^F88T4]<_PHM=Q17\C5LUS+$<WML?B
MZBG?FC.O5E%WW5G)JQ]A##T8148TH)+^ZNG5Z;Z?U<:%5<8&,# ]A6'K/AG1
M-?B\C5K"&\B_NRHK#IC^(&MZBN*%6I2FITYSA-:J49.,E\UJ:.$6K.,6ELFE
MH>)ZO\ /A?J%I=1#PKIJS3H5\S[/!G)!&<^5G\<^GI7Y#_M>_P#!,:T\:65W
MXH\.!+,Z7-]M6VMX0/,4AHRN%QQ^\!Z<[?S_ 'DJ"ZMH+R"2VN8Q+#*-KHPR
M&&<\@\5]QPGXB\4<(8ZEB\MS+$)*O0J5J=2K.HJD*4XR<%S2=N9)J_F>=C<I
MP6/CRUJ,;I-1:2C:_71*Y_!5\5?@EXX^&&K30S:!>M8VLC*]QY$BH%0X))V$
M#  [UY"TL,Z?;8R')Y*@_AT]B<>V#[5_<Q\<?V9? WQ2\&ZMH2:'9PWU_!/&
MET(8RZM(A4'[H/4Y.",U_'/^T!^RY\1/@?\ $[5_!FE:#?ZMI]GJ%U!'<QP2
ME'2.60*1A'7!4 YR:_T@\%OI18;BR5; YW5AEN+PZI<D*M5<M6BK1J5>9VC=
M2Y='WTT/S?/N$'0PSE1E[2[M!1A=QOT>]^FOEVW\)-UNM0_E=SE?0#'T_GZ\
MUU_PVL?&&J^*]'C\&M=Q72W\!F^Q[]VT.-V=F".<?UK$F\#?%*VGB4>#-39+
M@K&0+>7"Y[G$7OW]OK7[4_\ !,']FC4+?Q8GB7Q?H#K'< 3+'=PXV,[HW\:=
MA[# Y[U]GX[^)W#U?@3-/J&.PN-JK#R_=*I3DY:)6MS.^E^E_N/'X:X>J4,9
M0E*53F<TI/EE%)I^B6C3WMZ;G[W_ +*T&K6WP$^'<&N&5M4CT<B[,V[S3)]H
MF/S[N<XQUKZ$JI86-KIEI#9642P6T"[(HD "HN<X   '))X%6Z_QWQ-7V^(K
M5^7E]M5J5.7^7GDY6TTTO8_<8+EA&/\ +&,?N204445B4%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %9^I:E:Z3:RWU]*L%K I>:9SA44
M DDDD   ')S6A7Q7^W-\7_"?PT^!OC=-:\1VNA:I<Z%=2:=YTR12.QAG56CW
M2(?OK@8ST]:TI0E5J1IQCS2FU%+;5NR,ZLU3IRDY<J6M[7VUVZZ7/P@_X+O_
M /!7KP[\"/A5K?PA^'NKP:IJOCEET&2YL+I3+8$![II#Y19@0;4)U7[W7M7^
M=WXD\<>(_'?B/4M<\3ZA<:G+J%[-=))<N\AC$KEPH+L^,9Z<?G@UZS^U'\2_
M%OQ%^._CP^(M>NO$&EKK=W)IKW$K2QQ#[1,%>,N[@#8<?*>A KPXJL'^CQ@/
MOP-XYQGCM7]9^%7 ]'+LM6:9A2;Q-9\\8N]J<;1LM+IWWOOJ?F7$V=/%SG@Z
M;_=0Y5S1_P"7FSE)6V:VM?IH6)T0$D#<HYW#GCKZ9]C]>.E0Z9INO^+M3MO#
M?A/2I]4U6\N8K6*WM49YF>>14 "(C'G?V'Z8S+I.FZ_K^IP>'O#FG3ZMJ,T\
M< @MXV>7YW"' 52W /I_0U_:3_P0V_X(K&[UGP;^T7\3=(+1V]]IVJ2Z+J-I
M@%89XG*,)1W5 >4Z'I7J\8\>X+AVGB:-#$1>*G2G"E2B[\LFM&WTM;7Y7/+X
M>X8KXG$PQ%52^JJTHWO9JZTL]-GZ66Q]._\ !$W_ ((DZ1\,M*T/XS_$K28M
M1GUFTM[N33=1M%)A>X6.<@B4-R,$?<'O7]<G@WX8^"/ $/V?PEH-EH\6<[+6
M*.,9P!T1%[ 5TNA:!I/AK3H=*T6SBL;"W54AMX5"HBJ,* % ' ]JV:_D;,<V
MQN9XBKB,37J3=63DTYRMJ[VM=K0_8*5&G1C&$(12CM[JOVN%%%%>8:B8&,8X
MI:** "BBB@ I"<$#!Y_S_P#KI:*F2DU[LN5W3O:^G5:@>:^-?A-X$\?6=Y:^
M)O#]EJBW4,R.+F*.0$R(RY^=&[MGZU_(1_P42_X-W-/^+OQR_P"%M>#3'I.F
M7_E0G3;2V"QJ8;J:9F.QD'S"<#[O.*_M!JG>6%I?JJ74*S*IRH< @'UY!%>G
M@LSQ>!GS4:TXJ4?9R7,_@T]WTT_K0YZ^&IUXI2BDXR4HNRTDNMK;[GXO?\$O
M?^";.B_L>:9HVLQ6T2ZI%8M#+.(5CD9IK1X7).2V3O.>3Z=Z_:VH8((K:-8H
M4"1J  HZ #BIJY,17GB*LJM1WE+\C6G!4XJ*^?J%%%%8EG\_O_!Q""?V*/%&
M ?\ CQDZ?]=C7^6AX<G:$7X9=X;4KT;>H'[]O\],X';D5_J9_P#!PZVW]BGQ
M0<9_T%QTS_RV-?Y:NA[85U"XQO9]1OAY8'(Q.Q]\?XU_3_@'-)UHRDDG.246
ME9O3J]OO/A>-*CCAHQY;J4DD[];)[?J3WX$=O<S!=Q>&0;<#Y<JPYP,]\_AW
MK^U/_@TQR;KQ,<8^>VXQTRTQ_I7\4]Q>%4NG,9(:*;Y.PRI'?T[' ].]?VL?
M\&F1W7?B9NGSVW'U:;_"OL?';F_L)*3OVTM9.<;+[CPN!H<F*KMOFDW'6^R2
MTC9=N_4_O.HHHK^+S]7"B@G')Z"O*?%OQL^&?@8,?%'BG3M)"D@FYGBCP1_O
MR+5PA.I=0A*5M7RINWK83:6[2OM=VN>K45\P_P##8_[.0_YJ9H'_ (&VG_R1
M7:>%OVAOA!XTE$/AKQGI6J2$@!;>Y@<Y/3[LK53HUEHZ51/MR2_#37?^K,'*
M*5VTEWO_ %W1[2>A^G:D3IQGKWI(Y$FC26-@T<BJZ,.C*PRI'U!I]8-2YT[V
M233C;=^NZ_X PHHHJ@"BBB@ HHHH **** "BBB@ HHIK-M&<9H$VDFWHEN.H
MK#UGQ'I'AZT^VZS>16-OAB9)6"J @!;.X@# /K7A>H?M;_L_:7=265]\1M"@
MN8F*R1/>6RLI4X((,X-6J51VM"3N[*T6[OLK;@I)J]^E_EN?2%%?,7_#8W[.
M?_12] _\#;7_ .2*]"\&?'+X7_$%VB\(>*]-UF15W%;6XAE(&0,_NY'XR1_*
MM/JV(U_<5=-_<EVOV["<HK=H];HJ..02+N'(."".X-29K%IIV:U0XM22:V:N
M@HHS12&%%%% !1110 4444 %(!@8I:H3W31S",(Q''/;GU]/Q!R*(TN>::7O
M13UO;3KZ@7L\@8/U_P _YZ4M(IR <8R*6DE).5W?WM%:W*NVFX!11FJE[?6N
MGV\EW>2K!;PJ7DD<X55 R2?P!JDFW9)MO9):OY";25VTDNKT1;HKY]UG]J7X
M%:!<26FK?$#1;.XB8H\<MW;JP8<$8:9:R(_VPOV=I7"1_$K069C@ 7MKR3_V
MWK7ZMB+7]A5LK7?LY==NGF)3BU=2BUWNCZ9HKC/"'Q \)>.[1K[PKK-KJ]JF
MW=+;2)(J[\[<E&8<X/>NSK.490=I1<7VDFG]S&I1EK%J2\G<****D84444 %
M%(2 ,G@4 @C(Y% 7%HKCO%/C[PKX+MS=>)=6MM*MP,^9<2(BXZ]791^M>,3_
M +8'[/%O*\,WQ)T%)(SAE-[:@@]>09P?TK6-&M+6-*I)=XPD^W9>?]69*G"5
M[23MO9[;;]MSZ8S^O2BOFNP_:P^ &LW]M8:?\1M#N+RX?9# EY;,SM@G  G)
MZ GIUKWW2]<TS6K9;K3+J.[A=0RR1L&4@]#E212=&O#F]I1J02:2<HM)WMU:
MLGKMV$I^]).RMK'5/F75V\GH:]%-1BR@_P">E.J&FM&4G=)K9I->CU04444A
MA1110 4444 %%%% !1110 444$X&3P* "BN&\5_$CP;X(M6O/$^MVFE6R8+2
MW$L:*,G')=U[FO'I/VP_V=HW:-_B5H 93@@WMKQ_Y,5JJ%:5K4JCYM5:$G?T
MT)4HN]I)VWLUH?35%?,L?[8?[.TC!$^)6@,Q["]M<_\ I17L/@_XD>#/'MLU
MWX4URTU>W7;NDMI8Y -V<9*.PYP>]-X>NE)NC4M'XGR2LO730'.*LG**;V5U
M=G<T445B4%%%% !1110 4444 %%%% !1110 4444 %%%(3@$^E -VU>R%HKR
M/QC\=/A=X!G^R^+?%FFZ-/\ \\[JXAC;KC^.1.]>??\ #8W[.?\ T4O0!SCF
M]M!S_P"!%;+#UVN94:CC_-R2Y?OM8F,X25XR4EY,^G:*\C\'?'/X7>/YFM_"
M/BS3=9F3;N2UN(9"N[.,[)'ZXX]>V:]6,O *C.<>_P#GT_3WJ'3G&RE"4;[<
MR:OI?K83J05[R7N[I:V^XFHI <C-+4%IWU6S"BBB@ HHHH **S]1U6PTFWDN
MM0N([:")2TDDA "J!G)SCBO ]3_:Q^ 6CW4UEJ'Q$T.WN8)'BEB>\M@R2(2K
MJ09P05(P<CK6L:-::O"E4DKVO&$FK[;I>9//&_+S*_:ZO]Q]&45\S1_MA?L[
M3.(X_B5H+.Q  %[:\DD ?\M_4BO8O"WQ"\'^,X4N_#>MVNJ02 ;)+>5)%;/
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MU=2L%CB3(7<S,0 ,D#DU_GDW*3;;<I-W;>K;?5]VS] VV5C5KR7QM\<OA?\
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M<84X4)2AJK64%97MIKZ:]3\FR/"5,UQE.$Y-0DY.3^)R;EOKJK;6].Y_5O\
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MX.S<&A=<>FY"/T)_'UK^SG_@U!O;32AXLU"^G6"UA^SR2R.0JQH#,Q))( P
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M3[6>:*.4I(LBDJCJ. K#IWK\[SOP;I1P4JF"3A5<E.4TF^6/,FU;;6/Z'T&
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MOQ-I?AW4=5T^RNI;.ZNX5DCDN(T9D(=T.5+X/RCZ<U_E%FRLHU-N+=)!(.6
M!QGCL#T_STKM?#_Q6^+W@R.VTKPGXOU71]+M7B$4-M//'&L4+*RKA) , +CI
MT/X5^8YYX,X?EQ&*RZ2@H0FXT59WDTFFFWTMU_X)[D.+J<W1H5)^RNXRG/\
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MYP/V]_\ @OUX-_9AM[R;PE<6GB(P744*"UND.X/.D61L$F>&SU[=^#7\X/\
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M.._>O\1W2_$7BWPK>V^L>%-8NM&N;>:.91;221N!&ZMCY&4C@8/Z#%?W/?\
M!OQ_P6*7Q+HX_9P^*.K^3<Z%<6=S%J^I77S7 OHA;>6#,1G8;//#'[_;O_/'
M'_ $N'O9XC!4Y2H*U.HXIRO+2\G9/^D?J>1YU#,(R56:55R;4):6T7NW>[6I
M[%_P=J@']ENT!&0=6\,CI_U&-.Z^U?Y]>GV,#V$1\I<E <@=.!V_PZ8K^_\
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MWVT/TN-^6-W=V5WW84445)04444 %%%% !1110 4444 %%%% !1110 4444
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MK5DFVY:::M7=_5>?I_%!\%/V-/CQ\4?%\6BZAX UNPM+B2UC$LEG=! )V?+
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MU*7$V4QB^63Q5*SM?_EY'HSGQ;_V:O\ ]>Y?D?Y^FG?Z)80#_6%T!Y_AX_\
MK_RJOJ;'[%+ %\QI58@]=NX'([]"?T_)= )%G&L^>4&"W&.!TZX^GZBK\B"U
ME\MAY@=MV3V#] #["O[TP[O2=*KJHTH>_MS7BKI)?<?@->O*GB)5*;YI4JCE
M*%[*5I)IIOM;IY:G[1_LZ?M]:O\ ";]@7X@_ CP_?S:5K/B'6]$NXKR"<QS+
M'96.KP.B[2K88W:Y^;G@<U^,^N^)]>US5;K5O$UW-JM_-<S3&[N2SN=\CL#N
M<G^$^HX Z&E>^N[.W(BD86[8W1!CM)QQQZYR!Q_];W;]G;X%^,/VAO&VE^#M
M,T&[EAU.]M[0744+N!Y\B1YR%YQO/?\ #T^"_L'A_)\QQ6>3H0I5*]YS<US*
M4TH[.7PI\NZV^\]RCF>/SO#NA*3=.D^916EDK*R2^+[F>&:-H/BSQ]/]@\%:
M'=:Q>H1OBLT:63@X.1&C'J>_0^I->J:%^R[^T+X@UC3-*E^&^O0I/(D4DIL[
MK^)P"3^X'8]R> ,FO[SO^"2__!!SP[^S_JEK\1_'UC;ZW'J,,<K6-]:*1'YI
M24KB3?R,8^[7]*-O^R)^SW;2K/#\-]!21&#*RV=J"".>H@!_6OR+.O&7$QQM
M>EA,+%4J<G2BU-.\8NW16U1]I@^$L(\/3E4NY2BI:WTYK7NOO/\ ,8TW_@D!
M\49/ Y\3G0M26Z6R^U?9_LDV[<(RX'3.>W3Z^M?F3XD_9D_:%TOQ!JEA!\-M
M>>#3=0NK-&6TN<2+;2O$&'[C'S! >O\ 6O\ 997X(?#!+0V*^%--%J5V&+[/
M#MVXQC'EXZ5P,W[(7[/5Q+)--\.-">29V>1C96N6=R2S$_9^I))-<V&\;L9A
MHN,,!H[-_O.JU?1];]>WJM(<'X1.3G+FO\.Z:5EIIO\ UW/\9/Q/I?BOP-<Q
MZ?XRT&ZT.\D#;(+N-XG8+PYQ)&AX++GCV(XK&6\@F@\^-%9N2%&,_3(!/_Z^
MM?Z-O_!2W_@WV\)?M6^/+#QMX*@M?#5GI5IJ9>TM+1 DC3"&1"=C1 E?)(!V
M]\<U_#M^W'^P_P".OV-/BKJ7A"YT>]N- TZ5U?4C;ND CC4NS%L%<#:3G=C'
M&:_3>&/$7+<]JX93K^QQ=51=2C9M4ZO,DG?9Z)/MZ'RV=<*RI.3H75.#Y^5-
M>^DEI?SU[^1\5H-ZI,5Q(I#1''S(^,@\]Q_4=.:_=_\ X(W?\%4?&W[''Q M
M/ .NZC>:UI'BOQ!%]@MY[B3RK*"9+6V,<:L9%"[U9^ H);D#FOP1&KJ[#:H
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M-PQD9<_CQCVXZ55B=T;8Z$L#C<>3Z_X]SVQ7^@7"6#E2X1HQ<H2O3IN>JO\
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MM>?V?]J-D]I-OW+%NV= <EAUV]Z_TN(OV0/V>89$EC^&^@JZ'*L+*T!!_P#
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M814GS-)7=K!1117,6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP<91YXI[==4UKUO;R9WU%%%?AA]D%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!_/]_P<0*6_8H\48Z_8)/_ $<?_P!=?Y9'A^ZD@DOU*EP=2O1C
MDXS<-SWZCKCTS7^IU_P<.L5_8I\4$#)^PR>G>8^M?Y:NC1-!%?W,2;YFU*^!
M4C< !.Q'RG.">F>WZ5_3_@1B/9X?&4U=.;DD[=W%VO?RWMY=SX+C5WHT4VDO
M:1:UL[V3M_7FC7N!Y<?G(,O)@;>>-W^&?P_#%3:>+CFUC1KJ\N?E@A&2[,>%
M50,DG)';VS4%B9C+++.ORA6<JP^50 >BD@# Z#_ U]?_ +%W[.'Q*^/'QO\
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MJ\Y592FY2;;U_P O3IL?L%!0C&G:"4$E[JTT[$,4A:/=M(YQ@_Y_SD>M3T@
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M]J]3HHK^2*M6=:<JE23E.3NVVWK\S]/C%0BHQ5E%)+Y!1116904444 %%%%
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MPT>K:AI(4".QNY;5CS\OEG!R>Q^N/K3)8R&$,.6B;EGZX/89 ]SQ_D_T0?\
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M[9KXYB$T0+JA8R\OQG!&1C@#!P.?S[U]F?\ !39W7]MKXG&-=Y_M_5\]]O\
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M;L=Y7KD\U_G-_P#! ;]@+PG^VQ\2=7\4^*W:*X\#^*4@M<;%XAMK&['WU/\
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MHNT4];7?YV9^T9+A?J^7X>G.*O!)Q:^]/O=/3\-2Y1117YX>P%%%% !1110
M4444 %%%% !7S[^TK\.M#^(?PN\36>MV=O>166C:C-$MQ&KA6:)>1NX!^7K7
MT%7(>/[&34O!?B:PA4M+=Z1=P1J!DEGCP /<FNC"UZN&Q%*O1DX5*<XRC);I
MW_R(J4XU82IS5X35I+NMS_'6_P""ANF6_AK]L#XCZ%I4$:6UMK.L1K%&H5$2
M.[D4X Q@ >OM7R/:*@#K]YFZ^WOC.1ZGGMCUQ^RW_!9;]E#Q[\&_V@/'7Q5U
M?1+NUT75]<N_*O);:1(F74+\(F'*[>?-&"#SZ5^,]BN%64=9,$CMW/MV)]?S
MK^UO#[,7FW#U*=>HW4MRRY/>YFHP4;ZZ-MZ_CIM^*<7488/&0]C*4.>S45>S
MLU=2=EJOZZ'V7_P35@-M^W%\, OS*VOZ*<GJ,WT9_GGGW]J_V"/A7_R3GP9_
MV +#_P!%U_D ?\$WBR_MQ?"U0,C^W=$[>MY&3T'7(_6O]?\ ^%?_ "3GP9_V
M +#_ -%5_./BI%PS^I!N3<9U+W5NNEM7^GH?I?"[;RK#-K5TXO>][QCJ_P"O
MP._HHHK\O/HPKYD_;$_Y-U^)?_8 OO\ TDN*^FZ^9/VQ/^3=?B7_ -@"^_\
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MT35?B#HEJ9?$-A;S36EK;HI,DD2M*HV*I8DL<8![\5[WT>/%F/AWGCPF+]W
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M?RPMO?1-WZ'Q6?<+8?&RE7I)1J22;MWBT[W\W]UC^0LS30E)%7,;!60X."I
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MMPS5A2E"O",Y6BXMQZ6U>NE_ZW)7%&<N$)?5'RN3U]ZZBK6OY;:^OJ?TYO\
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M .@FFMUZK\P/X+?^#CZ?9X<NA$ S?:W]"?N2]<<]>.OZXK^+/1)9KG3X5E7
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M]12PU"C3]E3IQC3O?E2TOI_D@'''I112 DCD8KQW)*2CK=J^SMIYFXM%%%4
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M.K=1<FTNFLX,\?P]256O9*[FN:SOT5O1=GU_ _O.HHHK^-3]="BBB@ HHHH
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MOI_URK^N>BHGGV:U(SA/&591J)*:<F^9)65]1K"8=--4H)K9V7E_E^+/SO\
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M%^NW$B3/X;\07&B+L)8!=#D&GJ#RW3[,.X^@%?E%:/+)#B1 &C& ",<8Y/\
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M;^AJBBBOY;/T8**** "BBB@ K^/;_@[2S_PR[9\?\QCPQ_Z>=-K^PFOX]O\
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M + %[_Z2W%=&%_WFA_U^I_\ I2$]GZ/\C_&X^*%V!\:_C6O\?_"S_'( ]?\
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MN#85E5KX9^XUS.FE[S;>R5];?U8_ B!V3F(;_-.9.^TXZ>W %220[1MMQO\
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M\.)V:BVVETUG \?P]455K\MK\ZY[._:W_ _I+^\^BBBOXU/UT**** "BBB@
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M:J=U=[6[(_5'_@DO_P % /&W[$_QFT[PEX3B,EMXX\2037;!9#@S"TM#DHP
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M76)WAU+4WD4.5VG"RH<9XR*_U<V4.K(PR&4J1ZAA@_H:_CV_X.G?@OX5TOX
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M[UWCTMOVV7J?M5_P;TO(G_!0[X:H!E?^$OT+)P> ;NUS]>.OICZY_P!6*O\
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M ))UX-_[ -C_ .BZ_P ?_P#X)IP);_MO?#$( ,Z]HS'Z_;H\_7)/T' ]S_L
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M7'T92PM'E<%:JG+FZQY>O]V_XFMJ*W+:?/Y>=WDMNX7IL.[^N,=>O2O[1?\
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M3G^?.*_O;ABFWE2<D^=1LKZ/EY%97[;^I^%YE4G2Q-"-1)<TU']YIRJ\=?\
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M8WD=9;F&-@(U+-E6<'H#VI%%FXN(K:)Y9I$C1%+$R.J# YZL0*_G9_X+A?\
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MJPI^SM",&ZE1+W6_=Y5%K39Z^>Q_HZ Y&1R#T(Y%%8'A;[=_PCFC?VGG[?\
M8+?[7GKY^WY\X[YK?K\A/J0K^.O_ (.W"/\ AEJTST_M?POG_P '.G5_8I7\
M=?\ P=NX_P"&6K3=T_M;POGZ?VSIU?2\(2<>(LK:;36*I:KI[\3FQG^ZU_\
MKU+;T/\ /LTEV6T@^R="HW=/09Z]_3&1Z^M'B9;DV$K*2%,9W9QC.WG'^/Y4
MFD*SVEN;/LH+=,]!_>'7Z8'UIWB=KE+"4#.P1G<3MQG;STY^HZ8Z>E?WS%J6
M53<7.7^S;[N_(KK7\/QT/Y\IZ9IAU5^#VTE#VEN;F]I'XO/>W_#'^CK_ ,&I
M?_)I?CWU_M'PYG_OSJ?_ ->OZL:_E-_X-2FS^R7X]/\ U$?#F?\ OUJ=?U95
M_ ?%EUQ%FB_ZB7_Z3'^F?T%@O]TH?]>T%%%%?.G4%%%% !4<W^IE_P"N;_\
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MQ'FX>J*Z5XUM7M9)?Y]T?CN12?UR";BTJKLE\2NX[^7ZW/\ 7'_9<W?\*,\
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M6[U6W];6/R7BY_[=/1[+\H[>?_!.6UH2'3IS;?ZK:V[./[N3G_/0?G_J*_\
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M[7M'\3OZ***_,3Z0*^8_VQ3C]G3XEG_J 7O_ *27%?3E?,?[8HS^SI\2Q_U
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MHF?>X+,</CH1G0;:ENM+QVM?UO\ @=-1117QAWA1110 4444 %%%% !1110
M4444-V3=F[=%O\O, HI!G'/6EI1ES13LU?HU9H HHHI@%%%% !1110 4444
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M1@>3Y0Q@  _=V]1GK7Y-?\$T/^"!^G:9XE\*>(OCQX:476AW5MJR-<Q9Q>V
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M='U/R7B;#-U\/:4&E7DVW\2YHO27EKI\D?7/_!/6<3?MZ_LX"/!(\9N7]O\
MB67P_F1T]:_V*/A7_P DY\&?]@"P_P#1=?XY/_!.M)(/V^?V<R>K>,Y.<?\
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M%>?=:;_@?D&4T)T,?"ZC:55.+^TXMQM?Y:W\S_7)_9=W#X&^ 0W4:+:9_P#
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M/FVEAQ*<\\U_)%_P4A_X(!^%H/A_XIUCX ^&5'B9;'4;FS-M$<^>(I9$QO\
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M;ZIIR( #SPOZ<5_!YI_VB[LXG@Z1J-W3/3('//'_ ->O]!+_ (.TA(?V6;4
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MQ?Q$^'WB/X3^+]2\%>);.XMM<TN>6WO%FA:/#Q2%)!N90A^8=CCTX!K]=O\
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M;P7RAODH8JOSQ?O<TE:VG^?EZ]2%QI.$HJM['E<5*\>J=E9:O6_Y_)_V[?\
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M;?LNWYWN?YFCZI,BXAT^_"OQ+_HER..2<DQ^O7_Z]?H%^S=_P37_ &E?VK=
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M^CUW6E[[&.3\(U7B8NO3J1BD_B5HVM?_ (;;<_S2%UC4M0F2UCL+_,SK&O\
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M/[?OPQ^R3G.7/_3+ICTZ^IJ-=.UF%F:/3K_R,$C_ $2?ICCK&#G'XU_JD/\
M\$#?V.9+N_O'\,V!EU">2XF/DRY+RDEC]:8W_! W]C@0^5_PC-ALZ?ZF7GZ_
MU]J_9LN\5:F$H*A*G*R@H*,5ILE?U_X/4^%S'A26)Q$ZT90M*5VY=M/>]5W_
M ."?PR_\&\\>H?\ #Q+X;--97<<?_"7Z%EY;:9%&+NV_C9 /S/:O]7&OR/\
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MWXR?$C6OB5XFOI=1U.^EELFGF=I7V6]W.Z@L^3P9B1S_ #KA&:6/]\7+*_"
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MN!46PL5^[96B_P"[;0C^2595$081%0>BJ%'Y "G447?G_7_#( HHHI %%%%
M!1110 4444 %%%% !2$!A@TM% ;Z-70@ 48%+111<%IHMEH%%%% !1110 44
M44 %%%% "$ C!I%4*,"G447>W05E>]E=*U[:V[!1110,**** "BBB@ HHHH
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M45-11=]W_7_#(=O+\/Z[+[@HHHI %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0G R:3:2
M;;LENP%HHHIIWU6S **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M444 %%%% !1110 4444 %%%% !1110 4444 %(,@<G-+14\JYE/6Z36^FOD
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MG#JLRZCY^FM.AG,,0BA"A3,O&)$8_+WYZ\5^X/AS0X]"M(["!52TMHQ'!&H
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MVG*9!W<=>*_O>^#'P6\%_ [P?I7@WP+I5OI.CZ=96MK%;6T4<$:I!"B !(\
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M7+[K3O*^SZ*W]?@>V+1115 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\.]=?117/5K5:TE*K.5225N:<G*7WMMEI**LDDNR5AI4-UIW3@445F,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH>J
M:>ST?S 0# QUI:**48J*44M%MU ****8!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1165K>MZ9X=TN[UG6+J.RTVQC\VZNI6"QQ)D+N9F( &2!R: -6O
M&?''[0/PD^'-_'IOC+QCI>B7LP=HX+NY@B=A'@.0))4/R[AGCO7\]'_!1?\
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MHHKQ3L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEC@<5W]M<PW<*7%NXDAD 9'7D,#T((JG&44FXM)[-JU^NGW@3T445(!1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8RRD*J@1MS\Q X^OUK^2;XA>"?%/QH_:%U>WMM7N=4TC^V)VCA4M)$(_M7
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MKDQ,Z<YJ=-6YE>:W][KJ=48\L5%;+1=[>?F%%-9=W?%%<$YU8RM&ES1TUO\
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MW\328SA_L^GX /.1:0<_G^/X5]#_ /!,_P",WPV^&OPPUO2_&WBZQT:^GN+
MPPW7G%F6-+G?C9&P&"RYSCJ.M> ?\%6[XV_Q81< CR-.Z]O]$@S_ )^E>-?
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M/K7O8SEGA:%-1C",4FVG[SYK=6W?;32QY<<5556<N5N#T22=M+=>^J_3K?\
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M_45\-!CP5H0'(%G#S_VS2O4Q]O98?OR?=LGM]VOKO<\W I^TK-K1NR?>UO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8>_=JQK4:W.UR5'>4MT];/?_ (/^3+INZUC&*Y8<O>UEH[KH[6^1]5  # &
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MO_1;58JO=_\ 'K<_]>\W_HMJYUNO5?F,_DD^*-I;WO[2.K)<MA?[<FZD8/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /P-_X*;_!+Q]\1OB-]L\,Z/<W]
MH8;%3)#!)( 5MH5;YE4]"#_+WK[)_P"":OPX\1_#CX8:SIOB.SFL[J>?3V2.
M9'1B(TN=W# =-XZ>M?HO>:-I6H/YE[86UR_'S31!SP,#D^PJ>TL;.P0QV=M%
M;(<92% BG&<<#TR:V]M+V+HO5733[6:=E]PK:WZ_U_D6Z***Q&%%%% 'X%_\
M%.O@K\0?B#\0SJ7A72;N_MQ#8@-##)(,I:PJ1E0>C#'X=*^Q?^"9W@7Q5X$^
M%^M:?XJL)K"[DGT\QI-$\3$(MR&X?DX)'/3GWX_1R\T;2M0??>V%M=/Q\TT2
MN>.!R?8"K%I865@ACLK6&V1L96% BG'3@5VSQU:>%AA&W[.'+97?V;-:>IFJ
M--5'544IN]WZ[_>6Z0  D^M+17"XIM-J[B[KR9H?CK_P5&^$WB_XE1>'QX8T
MV>_\C3!')Y,3R%6^T7!(^4'LRY[X-8O_  3'^#GC+X;&^/B73KBR\PQX$T3I
MTW]-P'K[X]J_96\TS3]0Q]NLX+K:,#SHP^!R>,^Y-%GI>G:?G[%96]MGKY,8
M3^5=JQ<UA_JZ5HO=_P!?Y?YD*G%3<TO>>[_#]"_1117&6-?E''JK#]#7XH_M
MJ_ [Q=X]^U)I>F3W&9'*-'$['^+'*CM_GV_;"J$^EZ?<Y^T6<$V>OF1AOYUM
M0KSH5(S@[--.W<35U9G\?4O[&_QMA>1K:WUQ$4C9&@G"+QT48Z?Y[5FS_LD?
M'J\MIPUMKP:)<QC;<\\XQTS[^AQSVK^PO_A&]!.?^)38\]?W"TT>&/#XR!I%
MCSP?W*UWRS6M)IM:I-)]5S*SZ^OW_?+IJSU:\S\VO^";/PY\9?#_ ,"SV/BV
M.\2X)8*+L2!_]6@'#\]OZ5^H55+2PLK%2EG;0VRGJL2!!^E6Z\R4G.3D]V[L
M<4XQ4;N5E:[W853U!#)972*,EH7 'OBKE!&1@C(-).S3\RC\ OVN/@A\0==^
M-F@ZQH>CW5W9+=6[S2I!*ZKMG!.2HP, ?EBOVV^$ME=:=\/_  Y9WL;17,%A
M"DJ,""K") 00>00017:3Z-I5U();BPMII%^Z[Q L._!K0CC2)0D:A$7@*HP!
M]!717Q$JT8*7V$EY:)+]/^ 9PI4Z;;A%)R=V^XV:&*X0Q31K)&WWD<94_A7\
MV_[:7[.WQ%U_X[ZOK7A+0[I-/DUF>6.6RMY0NPW!8$,G !'.>N37])M95QH6
MCW<AFN=.M)Y6))DDB5F)/4DFIHUY47)QW<6O+U_ *E-5(V>Z=T^S[KS/F#]B
M[PYKOA?X)Z5I7B))X]1CO)&=;@,) IM[91D-R!E3C_ZU?6E06]M!:QB&VA2&
M(<A(UVJ. .@]@*GK%MR;;W>Y<5RQ2NW9)7>["OPR_;U_9Q\5_&KX_P"EQVUC
M<R>'YSI45S<1QR-&JB"W20[@"HQALY]3GBOW-JA-I>GW$ZW,]G;RSKC;*\8+
MC;TPW7BML/7GAJGM*>DN5QOZV_R!J^C/F']EO]G72O@'X1M=+TYF8SP*\H8K
MD.Z*&R% ].G45]6T@ 4!5  '  & !["EK.I4G5FYS?-*6[[CVT2L@KY5_:L^
M NG?&_X>:YI=YS-!IEQ<6J@*2;BVB,L*@$$DF2-<8(/I[_55-95=61U#*P*L
MI&00>""/>JHUJF'JPJTI.,X.\6A-75FM&?C7_P $Y_@GXL^%/B;Q%;:S87%M
M9+<E;9YHW160/)@@L #QCIQSQZ']EJHVVF:?9LSVMG! S'+-%&JDGU)'>KU%
M:JZU1U&K.6_K8:T5@J"Y!:VN%'5H)5'U,; 5/160'\P7Q._9L^)FK_'O4=;M
MM#O#8/K$LJS+;S%60W)8'<%P>.<YZ<BOZ#_V?M$O?#_PVT/3;^-HKF"TMD='
M!# K$ 0<\YS7J[Z!HLDAF?3+1I2<EVA4L3USFM.**.%!'$BQH.BJ, =N@K2=
M6I424Y.2CHK_ "_R)C",%:$5%>7?KJ24445F4%%%%  >01ZU^.'_  4]^#_B
M_P"(W]@#POIUQ?&/3A'(T,;R%'^T7!P-@)'# YXQFOV/JC>:9I^H8^VV<%SM
M&!YR!\#.<#/N:TIU9TW>$G%^7;2_Y=_\R91C.+C-*47NF?QU)^R#\=;(K%!;
M:ZL=R=KJHN0%7K@# Q@@=:@U']D?X]PPM;PV^OD2*=Q N,_-QT_S_C_8:?#/
MA\X)TBQXY'[A:#X8\/'DZ/8G'_3!:[O[0;WIQUM?Y6\_+^K$PIQII*%X\KNK
M=/Z_K0_.W_@F=\-/%?PU^%^MZ;XL6\6]N+C3W07@??B-+@/C> >I&>M?I?56
MUL;2Q0QV=O%;(<96) @..G ^M6JX)RYYN5E&^MELM-;?,U;;UD[M[ONPHHHJ
M!'GWQ*^'VC?$?PGJ_AC5K2":+4X/),DB*63YU;*D@X/RXSZ5_/!^TY^P9XG\
M&ZI>S?#Q-1:.>228+:;]NYB> (P/3IGVK^F"L^ZTG3;TYN[*WN#ZRQAOYUU8
M?%5*%TG>#:DX]+H3BGNOF?R(VGPD_:4M_"\>C?V7K9V1K&&\JZW'&!G.3U'/
M^<U]$?LP?L5>.?B3X@\OXF6^IPV5G+!-"+M950EF;>!YN?0?H>,"OZ5O^$5\
M.?\ 0%T__P !UJ[::-I5@Q:RL+:V8XR88PA..F<>F:VK9A6K<K^&2M[RLM%;
M3;7KV>I/LXM--73T:?:]_P!#S/X5?"+P_P#"_0K+1M*M($%I%'&LJHH8B-0O
M)'TS^I["O7Z**X)2<FW)W;ZCA"-.*C!6BNB"BBBD4%8OB.)Y]"U6&,%GDLIE
M0 9)8KP/QK:I" 001D'@@]"* /YL=>_9Y^)-_P#M*'7QHET-,'B1;D7'V:;9
MY2WRR;MV-O(YR>*_H>\ V4VG>$]'LYU*RPVL:NI!!!"*""#SFMS^PM'\[[1_
M9UIYV<^;Y2[\]<Y]<UIJJHH55"J.@ P!5RJ3FDI2;4=K]-$OT#;9#J***@ K
M%\1PO<Z%JL$8+22V4R(!U+,N !]:VJ0@$$$9!X(/0BFG9I]G<#^6'XR?LV?%
M2[_:/L_$>G>'[RXT[_A+[*Y:86TS(L(U2*1FW 8P$R<_CWK^EOX56=SI_@/P
M]:7<9BN(;*%)$((*L(T!!!Z<@UU<GA[0Y91/+I=D\P;<)&A4ONSG.3W!K71$
MC4)&H15X"J, ?@*Z\1C*F(A3IS;<:2M'[E_EZ+8A0C&4I)>]*UWZ;#J***XR
MPKPWXM_!#PW\4M->PO[2W0NI!DV*&R00220>N<GU_$Y]RHK2E5G1G&I3DXSB
M[IKHR914XN,E=,_ ?]I7_@GA_P (CI-[KW@ W;ZI*,[;3EOWK@,/W2[L8)].
M!VK\\=&_9]_:'\.371M]/UZ09.W='='OZ@=/0_X8/]?EU96EZGEW=O%<)_=E
M4,/UK*/A;PZ<DZ-8'/7]PM=E3,:]:I3JUI>TG"ZYFE=K2R;TT6OW]3)X:C+>
M">B7R6Q_*/X#_9L^.OQ!\866G^*+77;+3;BYCBFE*7$85#(%8DN"/NC/Y5^Q
M7P'_ ."<_A7X5>+])^(0O)KO5H+/8QGD1W5I7BD<9VY'S1#@_CS7Z9P>'-"M
MG$D&DV43J<AT@56!]0?6MD    8 X '0"LOKE9747R1:LXK:SW73?;_@DPPU
M.#DXW3>S7V59:*]UNB*W4I#'&1CRT1!]$4+VX[?YQ4U%%<KWVL="322;;:25
MWN_,:RJZE74,IX((R"*^#OVM?V0/#?QUTQ=2>-;;4=+E%W;O;A4D,FUHO[I)
M.V0]/PK[SIK*KJ5=0RGJ",@U5.I.E-3@VI1:>GET%*,9JTE>S3^:=S^2WXD_
MLD_&?P'XKC?PK#KEY:6\P*;%GD7"N<?<4# P.,CT]*QK+X!?M!^._%>G6FM6
M&N6U@(65W\NYC'S/&H!9QCID].W/&<?UJ3^'M$N6W7&EV<S=27A5C^=1Q^&/
M#\+B2+2+&-QP&6!0?6NN6.G.?-42FM'RNUKJWEY?.RV,5AHJ;G=M-W<>EU:W
M]*VQ^6'[(_[!NE_#?7](^(E_/.^M6DUO=LL[*6\R)E;'*YZ@8_PK];*CBABA
M4)%&L:CHJC _2I*Y:M6567-+Y+LNQT!11168!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44@&.E
M+4Q<N5<R2EU2=U]X!1115 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
K 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
